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Arterial stiffness is one of the major risk factors and markers of cardiovascular 
disease (CVD). An increase in the arterial stiffness is influenced by various 
factors such as age, lifestyle, genetics and the presence of other cardiovascular 
risks such as obesity and diabetes. Arterial stiffness is a consistent thread in 
this thesis. This thesis investigates the effects of exercise-based management 
programmes for CVD and risk factors with a focus on carotid-radial applanation 
tonometry which is a specific non-invasive technique for measuring arterial 
stiffness. Erectile dysfunction is a marker of CVD and is associated with 
endothelial dysfunction that leads to arterial stiffness. The effects of centre-
based, supervised and exercise-based cardiac rehabilitation (CR) programmes 
were studied on the changes in arterial stiffness, erectile dysfunction and quality 
of life of patients with CVD. Despite the effectiveness of CR programmes, there 
is poor attendance at these programmes and unsupervised home-based, IT 
(information technology)-supported programmes could improve patient 
participation and cost effectiveness. Moreover, earlier identification of risks and 
appropriate management can reduce the incidence of CVD. There are no such 
programmes for early stages of CVD in practice, especially in developing 
countries such as India. A 12-week, IT-supported home-based exercise 
programme in India, for patients with metabolic syndrome was developed and 
studied. In general, arterial stiffness was improved in both centre-based and 
home-based exercise programmes. There were acute increases in arterial 
stiffness following exercise in healthy Caucasians and South Asians as well as 
people with metabolic syndrome. Carotid-radial pulse wave analysis could be a 
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GLOSSARY OF TERMS 
Anaerobic threshold: Exercise oxygen consumption that marks the transition 
between no change or little change in arterial lactate concentration and the 
sustained increase in concentration of lactate (also known as lactate threshold). 
Postulated by some authors to be oxygen consumption above which anaerobic 
energy production substantially supplements aerobic energy production. 
Borg scale: A scale, which is used for an individual to rate his/her perceived 
level of exertion during exercise. 
Bruce protocol: Treadmill exercise test which is conducted in three-minute 
stages. Each three minutes the workload is increased by a combination of 
increasing speed and the grade of the treadmill.  
Functional capacity: The maximal capacity of an individual to perform aerobic 
work is defined by the maximal oxygen consumption.  It is expressed in 
metabolic equivalents (METs): One MET = 3.5 mL O2. kg-1.min-1. 
Incremental shuttle walk test: A progressive 10-metre shuttle walk test to 
measure functional capacity with audio beeps played from a pre-recorded CD to 
control the speed. 
Oxygen consumption: The amount of oxygen utilized by the body’s metabolic 
processes in a given time, expressed in millilitres per minute, STDP 
Oxygen uptake: The amount of oxygen extracted from the inspired air in a 
given period of time, expressed in millilitres or litres per minute. This can be 
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differed from oxygen consumption under conditions in which oxygen is flowing 
in to or being utilized from the body’s stores. In the steady-state, oxygen uptake 
equals oxygen consumption.  
Peak oxygen consumption: The highest oxygen consumption achieved during 
a maximum work rate test.  
Respiratory Exchange Ratio: Ratio between percentage of oxygen uptake and 
carbon dioxide release in breathing. 
Tidal volume:  The normal volume of air displaced between normal inspiration 
and expiration when extra effort is not applied. 
Variable: A variable is a quantity whose value may vary over the course of an 
experiment (including simulations), across samples, or during the operation of a 
system. Variables are generally distinct from parameters, although what is 




CHAPTER 1. INTRODUCTION 
1.1. Context 
Arterial stiffness is one of the major risk factors and markers of cardiovascular 
disease (CVD). It is defined as a reduction in arterial distensibility (Lacolley et 
al. 2009). It is caused by reversible or irreversible changes in both the structural 
and cellular components of arterial wall.  A number of studies have established 
the association of arterial stiffness with coronary artery disease and myocardial 
ischaemia (Barenbrock et al. 1995; Cameron et al. 1996; Gatzka et al. 1998; 
Hirai et al. 1989; Kingwell et al. 2002; Leung et al. 2006; Lim et al. 2004; 
Triposkiadis et al. 1993; Waddell et al. 2001). Arterial stiffness is also identified 
as a marker of cardiovascular disease due to its relationship with many 
cardiovascular risk factors such as diabetes (Salomaa et al. 1995), 
hypertension (Payne et al. 2010), dyslipidaemia and metabolic syndrome 
(Scuteri et al. 2004). Arterial stiffness has also been found in the early stages of 
conditions such as insulin resistance (Sengstock et al. 2005) and  glucose 
intolerance (Henry et al. 2003). Various invasive and non-invasive methods 
have been developed to measure arterial stiffness. This thesis focuses on the 
diagnostic and prognostic values of arterial stiffness variables measured from a 
specific non-invasive technique.  
Erectile dysfunction is a marker of cardiovascular disease. It often occurs in 
association with or as a precursor of arterial stiffness in central and peripheral 
arteries. Earlier research work at Bucks New University, carried out by Hodges 
et al (2007), reported that 66% of men with CVD had erectile dysfunction and 
only half of them discussed the symptoms with a health professional. There was 
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an opportunity to develop the previous work on erectile dysfunction with 
advanced equipment. In this thesis, the relationship between severity of erectile 
dysfunction and non-invasive arterial stiffness was studied.  
Cardiac rehabilitation is an established programme in the UK for patients with 
CVD or cardiovascular risks. The effects of centre-based cardiac rehabilitation 
on arterial stiffness and erectile dysfunction were studied in this thesis. Despite 
the fact that cardiac rehabilitation is proven as an effective intervention, the 
uptake of cardiac rehabilitation is poor (Dalal and Evans 2003). Various factors 
are responsible for this poor participation including limited places in the hospital-
based or outpatient-department based rehabilitation units, distance & transport, 
low self-esteem, socioeconomic status and lack of education (Daly et al. 2002). 
Van Elderen-van Kemenade et al (1994) offered a health education and 
counselling programme for myocardial infarction patients during hospitalization 
and followed it up by telephone for twelve months. The programme improved 
their lifestyle during hospitalization and for the first two months after 
hospitalization. Many studies proved that home-based exercise programmes 
were as equally effective as supervised hospital or centre-based group exercise 
programmes (Dalal et al. 2010; Jolly et al. 2009; Jolly et al. 2007; King et al. 
1991). This thesis has evaluated a home-based programme for people with 
cardiovascular risk. 
Metabolic syndrome is a cluster of cardiovascular risks such as increased blood 
glucose, increased blood pressure, high triglycerides, low level of high-density 
lipoproteins and abdominal obesity (Grundy et al. 2004). In the current thesis, 
the effects of a home-based exercise programme incorporating IT (information 
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technology) support for people with metabolic syndrome were studied. The 
effects of this programme were assessed by observing the changes in arterial 
stiffness, associated cardiovascular risks and quality of life.  
Earlier diagnosis and exercise-based rehabilitation programmes are well 
established in the developed western countries. However, those facilities are 
not generally available in the developing counties. It is important to undertake 
research and improve health care using alternative methods in those countries 
to minimize cardiovascular health risks. In this thesis, opportunities were 
provided to establish research collaborations in various health institutions in the 
UK and the developing countries. The Investigator, who has a physiotherapy 
background from India, had distinctive opportunities to progress as an exercise 
scientist with helping the people in South Asian countries as well as UK through 
the research work in this thesis. In addition, it was made possible to use the 
cutting-edge equipment in the developing countries for investigations on 
different ethnic groups. This thesis explored the prevalence of cardiac risks, 
clinical associations of arterial stiffness and early management of cardiac risks 
in the developing South Asian countries such as India and Nepal for the first 
time. The findings of the thesis could help to improve the health care in such 
countries and to develop further research. 
1.2. Aims and Objectives for the Thesis 
Over the years, non-invasive measurement of arterial stiffness using various 
methods such as oscillometry and tonometry has been developed. In this 
thesis, the measurements were taken using a SphygmoCor, one of the common 
systems in use, which records pulse waveforms from an arterial applanation 
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tonometer. It is a recently developed technology, which measures central aortic 
pressures calculated from peripheral arterial pressures (Smulyan et al. 2003; 
Yasmin and Brown 1999).  
Firstly, this thesis aims to establish the reliability of the arterial stiffness 
estimates using the non-invasive and less intrusive applanation tonometry and 
its relationship with specific cardiovascular risk factors. Secondly, the thesis 
aims to establish the effects of a structured supervised exercise programme on 
arterial stiffness. Thirdly, the thesis aims to establish the effects of early 
management of cardiovascular risks in people with pre-existing metabolic 
syndrome, using an unsupervised, home-based exercise programme, enhanced 
with IT (information technology) support.  
The objectives of the thesis were: 
 To review the existing literature regarding arterial stiffness and determine 
future research directions 
 To assess the reproducibility of non-invasive equipment on measuring 
the variables of arterial stiffness 
 To establish the relationship between non-invasive arterial stiffness 
measurement and adiposity 
 To establish the changes in arterial stiffness following acute exercises in 
different ethnic groups 
 To establish the relationship between arterial stiffness and exercise 
capacity using simple and advanced techniques 
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 To establish the changes in arterial stiffness following acute and long-
term exercise in patients with metabolic syndrome 
 To review the existing literature regarding metabolic syndrome and its 
development, prevalence and current management 
 To establish the prevalence of metabolic syndrome in the specific 
regions of South Asia such as Nepal 
 To establish the relationship between non-invasive arterial stiffness 
measurement and other cardiovascular risks such as erectile dysfunction 
 To review the existing literature regarding cardiac rehabilitation and 
erectile dysfunction 
 To establish the effects of supervised exercise-based programmes such 
as cardiac rehabilitation on arterial stiffness and other cardiovascular 
risks 
 To establish the effects of a non-supervised exercise programme on 
cardiovascular risk factors such as metabolic syndrome 
1.3. Structure of the Thesis 
This thesis conforms to the modern style where each chapter represents a self-
contained study, which contributes in a coherent manner to the overall aim of 
the thesis (figure 1.1). Each chapter will take the style of a conventional paper. 
The consequences of this is that certain elements of the methodology are 
repeated in different chapters. To make this clear to the reader and to save 
unnecessary repeat reading, the section which use the same methodology have 
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been shown in a green font. The final chapter is a brief summary including 
recommendations, written according to the style of the British Medical Journal. 
This includes two sections: (1) what is known of the topic; and (2) what this 













                                                            Figure 1.1 The structure of the thesis 
Literature review on Arterial stiffness – 
Pathophysiology and the development of 
non-invasive techniques (Chapter 2) 
Erectile dysfunction is a marker and 
a risk factor of CVD, associated 
arterial stiffness 
Literature review on the 
pathophysiology of erectile 
dysfunction and associations with 
arterial stiffness (Chapter 6) 
Literature review on cardiac 
rehabilitation, a supervised exercise 
programme for CVD and its role on 
erectile dysfunction (Chapter 6) 
Changes in arterial stiffness and 
erectile dysfunction following a 
supervised centre-based rehabilitation 
programme (Chapter 7) 
Metabolic syndrome is a combination 
of risk factors of CVD and is associated 
with arterial stiffness 
Acute changes in arterial stiffness 
following exercise and the relationship 
between arterial stiffness and exercise 
capacity in healthy adults (Chapter 4) 
Prevalence of metabolic syndrome in 
Nepal 
(Chapter 9) 
Acute changes in arterial stiffness 
following exercise and the relationship 
between arterial stiffness and exercise 
capacity in people with metabolic 
syndrome (Chapter 10) 
Changes in arterial stiffness following 
an unsupervised, home-based and IT 
supported exercise programme for 
metabolic syndrome (Chapter 11) 
Reproducibility of a non-invasive arterial 
stiffness measurement (Chapter 3) 
Literature review on the 
pathophysiology, global prevalence and 
management of metabolic syndrome 
(Chapter 8) 
Arterial stiffness as a marker of cardiovascular disease (CVD) 
Obesity is a cardiovascular risk factor – 
Associations between body adiposity 
and arterial stiffness (Chapter 5)  
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Chapter Two is a review of available literature, which is related to the 
mechanism of arterial stiffness, development of non-invasive measurement 
techniques and clinical implications.  
Chapter Three illustrates the immediate and 24 hour reproducibility of the non-
invasive measurement technique on healthy adults.  
Exercise capacity is related to arterial stiffness as cardiac output is determined 
by aortic compliance. Acute exercise results in immediate changes in arterial 
compliance by increasing vasodilatation. Exercise capacity varies with a 
number of factors such as ethnicity, lifestyle, presence of cardiovascular risk 
etc. Chapter Four demonstrates changes in non-invasive arterial stiffness 
immediately after a sub-maximal exercise. The non-invasive measurements are 
compared with exercise capacity measured by a standard metabolic analyser. 
Further, this chapter also compares the findings between two different ethnic 
groups living in the UK.  
Young people with obesity have higher risk of arterial stiffness. Earlier diagnosis 
can help to reduce cardiac risk. Chapter Five demonstrates the relationship 
between non-invasive arterial stiffness measurements and adiposity, which is 
calculated from skinfold thickness in young Indian adults.  
Erectile dysfunction is a marker of cardiovascular disease. Chapter Six is a 
review of available literature on the pathophysiology and relationship between 
erectile dysfunction and arterial stiffness and the role of cardiac rehabilitation 
programmes in treating erectile dysfunction.  
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Chapter Seven investigates the effects of supervised cardiac rehabilitation 
programmes on non-invasive arterial stiffness and erectile dysfunction in people 
with erectile dysfunction who had a cardiac event and were undergoing a 
cardiac rehabilitation programme in the UK.  
Metabolic syndrome is a cluster of cardiovascular risks. Chapter Eight is a 
review on available literature, which is related to the development, 
pathophysiology, prevalence and management of metabolic syndrome.  
Chapter Nine reports on the prevalence of metabolic syndrome in Nepal. This 
is the first study on the prevalence of metabolic syndrome in Nepal. This 
chapter observe the difference in the prevalence in the general population with 
different demographics and lifestyles. 
Chapter Ten is a development of chapter four. It demonstrates the changes in 
non-invasive arterial stiffness immediately after exercise in people with 
metabolic syndrome.  
As a modified development of the previous chapters, Chapter Eleven 
investigates whether a 12-week, IT-supported, home-based exercise 
programme has a specific effect on non-invasive arterial stiffness 
measurements and exercise capacity in people with metabolic syndrome in 
India.  
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CHAPTER 2. ARTERIAL STIFFNESS – A LITERATURE REVIEW 
Abstract 
The aim of this chapter was to review existing literature, which has evaluated 
the mechanism of arterial stiffness and the methods of measuring arterial 
stiffness non-invasively. The association of arterial stiffness with coronary artery 
disease and myocardial ischaemia is well established. Arterial stiffness is a 
marker of cardiovascular disease and mortality. Several cardiovascular risks 
such as hypertension, diabetes, obesity, dyslipidaemia are also associated with 
the stiffness of arteries. A number of molecular, cellular and genetic causes 
underlie the mechanism of arterial stiffness with an associated increase in 
collagen fibres, a decrease in elastin fibres and endothelial dysfunction.  
Systolic pulse wave is reflected backwards to the heart throughout the vascular 
system. In chronic vascular stiffening, there is an early or premature pulse wave 
reflection. Analysis of pulse wave has a long history. In the modern era, several 
invasive and non-invasive techniques have been developed. The non-invasive 
techniques are simple, portable, less time consuming and cost-effective. 
Tonometric, piezo-electronic and oscillometric techniques are commonly used 
and have established their clinical validity. Applanation tonometry is considered 
as a gold standard method. Many of the arterial stiffness variables such as 
pulse pressure, augmentation pressure, augmentation index and pulse wave 
velocity are established for individual predictive values for cardiovascular 
disease and mortality. The variables are of more prognostic value than 
diagnostic. More studies are needed to establish the clinical validity on various 
ethnic and clinical populations. 
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2.1. Arterial mechanics 
2.1.1. Structure of an artery 
Arteries are composed of three layers; (i) intima- the innermost layer which is a 
single layer of endothelial and connective tissues, (ii) media- the middle layer 
which is composed of elastic and smooth muscle tissue and (iii) adventitia- the 
outermost layer which is composed of fibrous connective tissue. These layers 
are embedded on each other by the extra cellular matrix (ECM) that is 
composed of collagen fibres, structural glycoproteins and proteoglycans (Fig 2.1 
& 2.2) (Jacob 2003).  The arteries have up to 40% of elastic fibres in the 
thoracic aorta and then decreasing gradually towards the periphery (Bader 
1983).  The collagen fibres are responsible for tensile strength and the elastin 
for elasticity (Jacob 2003). 
 
Figure 2.1 Structure of an artery  





Figure 2.2 Layers of arterial wall  
From Jacob (2003) 
2.1.2. Mechanical properties of arteries 
In the main, large arteries have conduit and cushion functions. The conduit 
function is to deliver blood to the organs of the body as per demand with 
minimal loss of perfusion pressure. The cushion function is to adjust and 
streamline the blood for a steady flow by smoothing the flow pulsations caused 
by the heart (O'Rourke 1982; O'Rourke 1995).  The cushioning function of the 
artery is called by various generic terms such as arterial stiffness, distensibility 
and compliance (O'Rourke 1995).  
Hales (1733) was the first to introduce the simplest model of the arterial system, 
which was later developed as the ‘Windkessel’ model. The model explains how 
the continuous blood flow is maintained in the aorta without being much 
affected by the pulsed pumping of the heart. Greenwald (2002) illustrated the 
Windkessel function with the mediaeval German fire compression chamber (Fig 






Figure 2.3 Diagrammatic representation of Windkessel function 
A pulsatile pump (P) is connected to a reservoir capacitor (C) through two one-way valves (V) 
which supply to the capacitor. The capacitor is connected to a high resistance (R) tube. The 
capacitor pressure maintains the constant flow at the terminal end of the tube (Greenwald 
2002).  
Windkessel function in the heart is illustrated in Figure 2.4. The stoke volume is 
ejected from the left ventricle to the aorta during systole. Approximately 50% of 
the stoke volume is directly pushed to the peripheral circulation and the 
remaining 50% is stored in the aorta. During diastole, the aortic valve is closed 
and the remaining 50% is pushed to the peripheral circulation due to the 





Figure 2.4 Windkessel function of the aorta  
(Belz 1995) 
However, the Windkessel model is a simple theory, which could not explain 
much of how the complex arterial system fits with elastic theories. Windkessel 
theory suggests that conduit and cushion functions are separate, where they 
are actually combined functions. Secondly, the model did not address the 
heterogeneous character of the arterial tree.  For example, the pulse wave 
velocity increases towards the periphery, because the conduit and cushioning 
effects are lower and there is an increasing vascular resistance towards the 
periphery of the arterial tree (Laurent et al. 2006). 
Stress is a force distributed on the internal or external surface of a body. Strain 
is described as a deformation of a body compared with its original form in 
response to the stress. Vascular structures are influenced by three types of 
stress: (i) longitudinal- change in length, (ii) circumferential and (iii) shear stress 




Figure 2.5 Schematic representation arterial wall stress 
Circumferential (A) and longitudinal (b) stresses in the arterial wall (top) and shear stress at the 
vascular interface (bottom) (O'Rourke 1995) 
Shear stress (rubbing and sliding) is a comprehensive stress that results in 
angular deformation, a displacement of two points in parallel planes in a 
direction parallel to those planes (Nichols et al. 2005). Concepts of elasticity are 
important in the understanding of the functions of arteries. A body is called 
elastic when deformation occurs after an applied stress and then it readopts its 
original shape after the stress is stopped. The response to stress differs 
between solid and liquid bodies. The liquid bodies will undergo viscous flow 
where the solid bodies do not. Some bodies such as arterial walls are called 
viscoelastic as they have combined qualities of solid and liquid. They respond to 
stress depending on the size and rate of the stressing force (Nichols et al. 
2005). 
Hooke’s law states that the deformation produced by a stress is directly 
proportional to the deforming force or load applied (Encyclopædia-Britannica 
2012). The body can reform to its original position until it reaches the elastic 
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limit. Beyond that yielding point, the body will break and undergo a permanent 
deformation. However, these theories apply to homogenous bodies. The 
arteries are complex structures with different elastic properties. They are 
composed of different proportions of elastin, collagen and muscle tissues, which 
are arranged in parallel and take different amounts of load (Bergel 1961; 
Wolinsky and Glagov 1964) . Arterial stiffness develops due to the reversible or 
irreversible deformations in the arterial wall. 
2.2. Mechanism of arterial stiffness 
2.2.1. Definition of arterial stiffness 
Arterial stiffness is defined as a reduction in arterial distensibility (Lacolley et al. 
2009). There are number of molecular, cellular and genetic causes underlying 
the mechanism of arterial stiffness (Lacolley et al. 2009). The distensibility of 
the arteries is decreased if intra-luminal pressure is increased or when there is 
an increase in arterial stiffness due to aging or any pathological changes 
(Stratos et al. 1992). 
2.2.2. Structural changes 
Arterial stiffness is caused by reversible or irreversible changes in both the 
structural and cellular components of the arterial wall. A schematic 
representation of these changes is illustrated in figure 2.6. In general, the 
mechanical aging characterised by degeneration increases the arterial stiffness. 
During aging and pathological conditions, imbalance in the structures of the 
arterial wall and remodelling of extra cellular matrix (ECM) occurs (Jacob 2003). 
A decrease in ECM is also found with aging (Cattell et al. 1996). 
21 
 
Metalloproteinases (MMP), collectively called matrixins, are a major part of 
collagenolytic enzymes. With age, the balance between MMP and their 
inhibitors is affected and it degrades ECM (Nagase and Woessner 1999; Visse 
and Nagase 2003). This results in a newly synthesized ECM (Jacob 2003) with 
damage in enzymatic cross-links in collagen as well as elastin fibres. This 
results in a decrease in elastin fibres and increase in collagen fibres (Gillessen 
et al. 1995). With the new combinations in the ECM, the vascular structures 
change with an increase in intima-media thickness (Jacob 2003).  
 
 
AGE-Advanced Glycation End Product; MMP-Metalloproteinases; Mφ- Macrophages; 
VSMC- Vascular Smooth Muscle Cell; I-CAM- Intercellular Adhesion Molecule; TGF-β- 
Tumour Necrosis Factor-β; NaCl- Sodium Chloride  
Figure 2.6 Schematic representation of changes in structures and function of an artery in 
the development of arterial stiffness  
(Zieman et al. 2005) 
Advanced glycation end products (AGEs) are strongly linked to the 
development of arterial stiffness in cardiovascular disease (Schram et al. 2005; 
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McNulty et al. 2007). They are forms of a wide range of carbohydrates that are 
produced from fragmentation of non-enzymatic protein glycation (Baynes 2001). 
An increased level of AGEs affects intra and extra cellular structure and function 
(Goldin et al. 2006). AGEs bind to specific cell receptors such as receptor for 
AGEs (RAGE) and produce cross-links (Schmidt et al. 1994). These cross-links 
form in collagen fibres and result in abnormal fibre distribution and an increase 
in stiffer collagen (Verzijl et al. 2000; Zieman et al. 2005). The cross-links also 
affects elastin which results in weak elastic matrix (Konova et al. 2004). 
Normally, specific AGEs receptors and anti-AGEs antibodies maintain the 
homeostasis, but in aging and pathological conditions, the homeostasis 
becomes inefficient (Konova et al. 2004). The RAGE-AGEs binding also affects 
stress signalling and induce inflammatory response (Yan et al. 1994). The 
influence of RAGE-AGEs bind on the structure of endothelium resulting in 
endothelial hyper-permeability which leads to an increased vascular leakage of 
protein and plasma fluid in the paracellular area (Goldin et al. 2006). This may 
be due to AGEs induced reduction in the endothelial isoform of nitric oxide 
synthase (eNOS) (Xu et al. 2003). The reduced availability of nitric oxide results 
in endothelial cell proliferation (O'Rourke and Hashimoto 2007), abnormal 
vascular remodelling and endothelial dysfunction (Rudic and Sessa 1999). 
These increase vascular smooth muscle cell tone, depress endothelial flow 
mediated dilation, and diminish response to vascular injury, affecting 
angiogenesis and promoting atherosclerotic plaque formation (Schmidt and 
Stern 2000; Stern et al. 2002; Wendt et al. 2002). 
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2.2.3. Genetic relations 
Arterial stiffness, having a multifactorial nature, is linked to a number of genetic 
polymorphisms (Zieman et al. 2005). Lacolley et al (2009) state in a review that 
many candidate gene polymorphisms, that are responsible for arterial stiffness, 
have been identified. For example, a number of proteins were established to 
have links with arterial stiffness due to gene polymorphism such as angiotensin 
converting agent (ACE) (Cambien et al. 1994), angiotensin II type I receptor 
(Benetos et al. 1996), endothelin a and B receptor (Lajemi et al. 2001), collagen 
1α (1) (Brull et al. 2001), fibrillin-1(Medley et al. 2002), AGF-1 (Schut et al. 
2003), α –adducing (Balkestein et al. 2001), aldosterone synthase (Pojoga et al. 
1998) and MMPs 3 and 9 (Medley et al. 2003; Medley et al. 2004). Mitchell et al 
(2005) carried out a genome wide scan on the Framingham study population, 
and found correlations with reflective wave amplitude, forward wave amplitude 
and mean arterial pressure. They established the arterial stiffness linkage with 
specific genetic loci on chromosomes 1,2,4,7,8,13 and 15.  
2.2.4. Clinical implications of arterial stiffness 
2.2.4.1. Atherosclerosis and arteriosclerosis 
The cushioning functions of arteries are disturbed in diseased states such as 
atherosclerosis and arteriosclerosis. Atherosclerosis is a focal and occlusive 
disorder that primarily affects the intima. The conduit function is affected due to 
narrowing of a major artery and ischaemia to the distal organ or tissues (Fig 
2.7). Arteriosclerosis is a diffuse and dilatory disorder and primarily affects the 
media. The cushioning function is affected due to the stiffening and dilation of 
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major arteries, which results in raised blood pressure and pulse pressure, and 
the disturbance of the load upstream to the heart (Fig 2.7) (O'Rourke 1995).  
 
Figure 2.7  Atherosclerosis and arteriosclerosis:  
Atherosclerosis (left) narrows the arteries due to localized patches on the intima and thus 
limiting the blood supply downstream. Arteriosclerosis (right) causes dilation and stiffening due 
to a generalized degeneration throughout large central arteries. It predominantly affects the 
cushioning function of the arteries and increases the load upstream 
(O'Rourke 1995) 
2.2.4.2. Aging and arterial stiffness 
Stiffening of arteries is considered a normal process of aging. Comparing with 
any other cardiac risks, arterial stiffness increases more steadily with age 
(Mattace-Raso et al. 2006). However, the arterial stiffness in aging is 
characterised by a diffuse stiffening across the arterial tree i.e. arteriosclerosis 
rather than a stenotic and localised atherosclerosis (Vlachopoulos and 
O'Rourke 2000). The arteriosclerosis in aging is caused by changes in arterial 
media. The elastin fibres undergo thinning, splitting, fraying and fragmentation 
and there is an increase in collagen fibres and ground substance (Nicholls and 
O'Rourke 2005). These changes in the arteries are progressive throughout life 
(Nichols et al. 1985). Moreover, the arterial changes with aging that are found in 
various ethnic populations confirm that they are true age-related changes 
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(Schimmler 1965; Avolio et al. 1983; Avolio et al. 1985; Lanne et al. 1992; 
Sonesson et al. 1993). Most of these studies have confirmed the changes 
especially in the aorta and central arteries with little evidence on peripheral 
arteries. The peripheral arteries seem to be protected by smooth muscle and 
collagenous elements. Moreover the peripheral vessels do not expand to the 
extend which central arteries do (Boutouyrie et al. 1992). Normally, central 
arteries expand by 10% for each heartbeat and the peripheral arteries expand 
by 5% (Isnard et al. 1989; Benetos et al. 1991; Boutouyrie et al. 1992). 
O'Rourke (1995) compares the arterial distensibility with natural rubber which 
has similar characteristics to the arteries. Natural rubber fractures after 109  
cycles of expansions in relation to central arteries’ expansions whereas the 
central arteries reach such a state after about 25-30 years of life with a normal 
heart rate (Cadwell et al. 1940; Lindley 1974). The peripheral arteries need 
3×109 cycles to achieve such damage, which is about 100 years of life 
(O'Rourke 1983; O'Rourke 1995). 
2.2.4.3. Coronary artery disease and arterial stiffness 
The association of arterial stiffness with coronary artery disease and myocardial 
ischaemia is established in many studies (Hirai et al. 1989; Triposkiadis et al. 
1993; Barenbrock et al. 1995; Cameron et al. 1996; Gatzka et al. 1998; Waddell 
et al. 2001; Kingwell et al. 2002; Lim et al. 2004; Leung et al. 2006). Arterial 
stiffness is a predictor for cardiovascular disease (CVD) (Laurent et al. 2001; 
Boutouyrie et al. 2002) and is associated with cardiovascular and all cause 
mortality (Stork et al. 2004; Vlachopoulos et al. 2010). For example, increase in 
aortic pulse wave velocity (an index of arterial stiffness)  by 1 m/s increases by 
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15% the chance of a cardiac event and all cause mortality (Vlachopoulos et al. 
2010).  
In chronic vascular stiffening, there is an early or premature pulse wave 
reflection. This increases the systolic pressure and afterload that leads to 
systolic hypertension and left ventricular hypertrophy (Kelly et al. 1992; 
Mattace-Raso et al. 2006). A reduced diastolic pressure increases the pulse 
pressure and reduces coronary arterial pressure and thus perfusion. There is a 
reduction in ejection fraction and an increase in oxygen demand. This increases 
the mismatch between demand and supply to the myocardial tissue (Nichols et 
al. 1990), resulting in ischaemia.  
2.2.4.4. Cardiovascular disease and risk factors 
The associations of arterial stiffness with cardiovascular disease such as 
hypertension (Arnett et al. 2000), diabetes (Mather and Lewanczuk 2004) and 
chronic kidney disease (Kimoto et al. 2006) are well established. The changes 
in arterial stiffness are observed in the initial stages of CVD risks such as 
glucose intolerance (Henry et al. 2003) and insulin resistance (Sengstock et al. 
2005). The severity of arterial stiffness is proportional to the number of risk 
factors present, such in metabolic syndrome (Scuteri et al. 2004).  
2.2.4.5. Other factors influencing arterial stiffness 
As with every other cardiovascular diagnostic feature, arterial stiffness has 
racial and ethnic differences. For example, Hispanic and African people have 
higher arterial stiffness compared with Caucasians in young as well as in 
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increasing age (Heffernan et al. 2008; Markert et al. 2011). However, there is a 
lack of ethnic studies in specific cardiovascular risks in developing countries 
such as in south Asia.  
Environmental factors also affect the haemodynamics and arterial stiffness 
variables. Low outdoor temperatures and high air pollution were identified as 
influencing factors of haemodynamics and arterial stiffness by reducing 
subendocardial viability ratio (Adamopoulos et al. 2010). 
Dietary salt intake is shown to be influencing arterial stiffness. Excessive 
sodium chloride (NaCl) increases the levels of asymmetric dimethylarginine in 
the circulation, which is an endogenous nitric oxide synthase inhibitor. There is 
also an increase in angitension II and endogenous natriuretic sodium pump 
ligands. All these factors reduce the availability of nitric oxide and thus leads to 
endothelial dysfunction (Bagrov and Lakatta 2004). 
Exercise showed positive effects on arterial stiffness. Exercise capacity and 
exercise training shows negative correlations with age-related changes in 
arterial stiffness (Black et al. 2009; Sindler et al. 2009; Walker et al. 2009). 
These studies claim that exercise increases the bioavailability of nitric oxide and 
thus reduces oxidative stress and endothelial dysfunction. Lifestyle modification 
as a management strategy claims significant improvement in arterial stiffness 
(Tanaka and Safar 2005; Aizawa et al. 2009).   
2.3. Development of arterial pulse wave analysis 
The use of measuring arterial pulses in the diagnosis of various health 
conditions were in practice in ancient Indian ayurvedic medicine and Chinese 
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medicine 2600 years ago (Ghasemzadeh and Zafari 2011). In Greek medicine, 
Herophilus (335-280 BC) compared the pulse rate with musical rhythm. He also 
developed a portable water clock or Clepsydra (Figure 2.8) which was capable 
of containing specific amount of water for natural heart beats for different ages 
(Ghasemzadeh and Zafari 2011).  
 
Figure 2.8 Clepsydra or Greek water clock– used by Herophilus for measuring pulse rate with 
different water levels according to age 
(Ghasemzadeh and Zafari 2011) 
In medieval medicine, Avicenna (981-1037 AD) established the importance of 
the quality of the pulse such as size of dilation, strength, duration, temperature, 
fullness, compressibility, equality and regularity (Ghasemzadeh and Zafari 
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2011). In more recent medicine, Santario Sanctorius (1561-1636 AD) invented a 
device ‘Pulsilogy’ following Galileo’s pendulum (Figure 2.9). Pulsilogy consisted 
of a scale of inches and a pendulum i.e. a cord with a movable weight. The 
weight was marked with a transverse line. The pendulum was moved 
downwards by increasing the rope-length until the speed of the pendulum 
matches the frequency of the pulse that was noted by the same physician’s 
finger.  Then, the pulse rate was measured in inches by the length of the rope.  
       
Figure 2.9 Pulsilogy of Sanctorius and Herrison’s sphygmometer  
In the Pulsilogy of Sanctorius (Left) the speed of the pendulum was matched with the pulse rate 
and measured in inches. Herrison’s sphygmometer (Right) has a glass tube with mercury. The 
semiglobular steel ball was placed on a arterial site and the regularity, force and rhythm were 
monitored by the changes in mercury level (Ghasemzadeh and Zafari 2011).  
   
John Flyer (1649-1734 AD) introduced the modern measurement of pulse rate 
continuously for 60 seconds. In the 19th century, Jules Herisson invented the 
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‘Sphygmometer’, which is composed of a graduated glass tube with mercury 
and a semicircular steel ball at one end (Figure 2.9). The steel ball was placed 
on the arterial site and the pulse rate and force was measured on the tube 
(Ghasemzadeh and Zafari 2011). In 1847, Carl Ludwig, a German physiologist 
invented the ‘Kymograph’, that was the first device to record haemodynamic 
variables (Figure 2.10).   
 
Figure 2.10 Ludwig’s kymograph (wave writer) 
(Ghasemzadeh and Zafari 2011) 
In 1855, Karl Vierordt designed the fist sphygmograph that can measure the 
pulse wave on the unbroken skin (Figure 2.11) (Lawrence 1978). Von Basch 
designed a sphygmomanometer in 1881 (Figure 2.12). Despite its complicated 
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appearance, it was also a simple model to measure the arterial pulse. Von 
Bosch’s device was the first one to demonstrate pathological differences in 
pulse wave in clinical conditions such as atherosclerosis  (Booth 1977).   
 
Figure 2.11 Vierordt's sphygmograph 
It had a pad (b), which was placed on the radial artery at the wrist. It had a larger cup in which 
weights were added until a pulse wave was traced, and then weights were added in the smaller 




Figure 2.12 Von Basch's sphygmomanometer.  
The wrist was placed on the stand and the India rubber cap (A) was placed on the radial 
artery. In that position, the arm was clamped between E and G. another pad (K) was also 
placed on the artery for the quality of the pulse wave recording by adjusting the screw H 
(Booth 1977) 
In 1860, Etienne Marey (1830-1904), a French physiologist, modified the 
sphygmometer as ‘sphygmograph’. The sphygmograph was considered as the 
first convenient instrument to record a pulse wave graphically (Lawrence 1978).  
The equipment was applied on the wrist (Figure 2.13) and the pulse waveforms 
were recorded. Etienne Marey established the difference in pulse waveforms 
between elderly and younger adults (Ghasemzadeh and Zafari 2011). Marey’s 
sphygmograph was continuously studied and modified by many authors (Foster 
1868; Garrod 1871) and differences in various clinical conditions were 
established. Later, Mahomed (1849-1884) revised the sphygmograph. By 
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adding a screw, the device was capable of measuring the pressure (Figure 
2.14) (Ghasemzadeh and Zafari 2011).  
 
 
Figure 2.13 Marey’s sphygmograph 
The device was applied on the wrist and the screw was adjusted to elicit radial pulse. The 





Figure 2.14 Mahomed’s sphygmograph 
This device was a revised form of Marey’s sphygmograph with an added screw. It was 
capable of measuring the pressure needed to occlude the arterial wave along its graphical 
recordings of the arterial pulse wave dynamics (Ghasemzadeh and Zafari 2011). 
In 1905 N C Korotkoff, a Russian surgeon reported the current technique of 
blood pressure measurement with a cuff and stethoscope on the brachial artery 
at the cubital fossa (Booth 1977).  However, Mahomed (Mahomed 1987) 
interpreted arterial stiffness using pulse wave analysis long before the 
introduction of the sphygmomanometer. In the 20th century, the sphygmograph 
was modified to a digital measurement (Waller 1900; Baldwin 1929; Baldwin 
and Panzer 1946; Panzer et al. 1947; Herman 1978). The digitalised 
Mahomed’s sphygmograph is one of the currently used techniques in the pulse 
wave measurements and analysis. There is another technique used currently 
which was introduced by a German Physician Otto Frank (1865-1944). Frank 
was the first one to derive mathematical formulae for the Windkessel function 
and to detect the pulse wave reflections (Frank 1926; Sagawa et al. 1990; 
Parker 2009). Following the controversies in the Windkessel model and the 
35 
 
development of new hydraulic and elastic theories, new propagation models 
were developed for the circulatory system by Frank (1920) and Bramwell and 
Hill (1922). Bramwell and Hill (1922) introduced the concept of pulse wave 
velocity. They modified the Moens–Korteweg equation by a series substitution.  
Moens–Korteweg equation: 
CO = √(Eh/2Rρ) 
CO - Wave speed; E- Young’s modulus in the circumferential direction: 
h- Wall thickness; R- Radius; ρ- Density of fluid. 
Moens–Korteweg equation with Bramwell and Hill’s substitutions; 
CO = √(V. ∂P/ ρ. ∂V) 
CO - Wave speed;  V- Volume; ρ- Density of fluid; 
∂P - Change in arterial pressure; ∂V- Change in arterial volume. 
Cohn et al (1995) developed a circulatory model to examine pulse waves non-
invasively. Pulse wave reflections and arterial compliance were measured using 
a tonometer and calibrated with an ocillometric method using a cuff on the 
opposite side. The results were not identical to invasive measurements. 
However, their results were able to confirm abnormalities in the pulse waves in 
CVD and the early detection of CVD.  Otto Schmitt is one of the pioneers of 
electrical impedance theories and he constructed the first electrical impedance 
plethysmograph in the mid twentieth century (Valentinuzzi and Belalcazar 
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2006). What followed was enormous progress on pulse wave research 
(Ghasemzadeh and Zafari 2011).  
2.3.1. Modern equipment 
There are several advanced non-invasive techniques to measure local arterial 
stiffness such as arterial distensibility and pulse wave velocity. The change in 
arterial diameter is measured by relating change in area to the distending 
pressure. The most commonly used techniques are Doppler ultrasonography 
(Lehmann et al. 1993; Pannier et al. 2002; Kullo and Malik 2007; Jiang et al. 
2008) magnetic resonance imaging (MRI) and computed tomography (CT) 
(Grotenhuis et al. 2009; Joly et al. 2009; Nelson et al. 2009; Ohayon et al. 
2011). Despite having accurate measurements, these techniques have some 
disadvantages such as the need of expensive equipment and high level 
expertise to operate the equipment (Stoner et al. 2012). Comparatively, there 
are many automated, less expensive types of equipment available using non-
invasive pulse wave analysis. They are simple to assess, need comparatively 
low expertise and time to operate, are portable and cost effective (Stoner et al. 
2012). 
Asmar et al (1995) validated new automatic equipment that used a pressure 
sensitive transducer measurement on pulse wave velocity for the first time. 
They established significant accuracy and reproducibility of the measurements.  
These findings initiated the development of many automated devices (Stoner et 
al. 2012) such as: (1) Complior (Artech Medical, Pantin, France), (2) 
SphygmoCor (Atcor Medical, Sydney), and (3) Arteriograph (Tensiomed, 
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Budapest, Hungary). A list of commonly used automated devices is given in the 
table 2.1. 
Table 2.1 Commercially available automated equipment for pulse wave analysis 
Device Type Relevant supporting research 
Complior Peizo-electronic (Baulmann et al. 2008; Jatoi et al. 2009) 
SphygmoCor Tonometric 
(Millasseau et al. 2002; Hope et al. 2008; Jatoi et 
al. 2009; Wassertheurer et al. 2010; Kracht et al. 
2011) 
PulsePen Tonometric (Salvi et al. 2010; Palombo et al. 2011) 
ARCSolver Oscillometric (Wassertheurer et al. 2010; Weber et al. 2011) 
Arteriograph Oscillometric 
(Horvath et al. 2010; Nemes et al. 2010; Gavaller 
et al. 2011; Nemes et al. 2011; Rezai et al. 2011; 
Gaszner et al. 2012) 
Omron Oscillometric (Rezai et al. 2011; Seibert et al. 2011) 
PulseCore Oscillometric (Lowe et al. 2009; Climie et al. 2012) 
Vicorder Oscillometric (Hickson et al. 2009; van Leeuwen-Segarceanu et al. 2010; Kracht et al. 2011) 
PulseTrace Photoplethysmographic (Chowienczyk et al. 1999; Millasseau et al. 2000; Millasseau et al. 2002; Padilla et al. 2009) 
 
2.3.1.1. Oscillometric devices 
Oscillometric devices such as Arteriograph and Vicorder (Figure 2.15) use a 
unique technique. A high fidelity pressure sensor is used which is connected to 
a conventional blood pressure cuff. The blood pressure is measured using an 
oscillometric method and then the cuff pressure is applied about 35mmHg in 
excess of the measured systolic blood pressure. Then, the pulse wave 
reflections are recorded by detecting the oscillations in the pressure.  The 
measurement is digitalised using a three level algorithm and pulse wave 
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velocity is calculated from the pulse wave return time (Rajzer et al. 2008; Jatoi 
et al. 2009; Wassertheurer et al. 2010). 
 
Figure 2.15 Oscillometric devices: The Vicorder (Left) and Arteriograph (Right) 
2.3.1.2. Piezo-electronic device 
Complior (Figure 2.16) uses mechano-transducers which are directly applied on 
the skin at the arterial sites and measurements taken simultaneously from 
different arterial sites: carotid-brachial, carotid-femoral and femoral-dorsalis 
pedis (Asmar et al. 1995). It measures the pulse wave velocity by calculating 
the beat-to-beat time delay between the two ends of an arterial pulse. A 




Figure 2.16 The Complior- A piezo-electronic system 
2.3.1.3. Tonometric device 
SphygmoCor (Figure 2.17) uses the applanation tonometry with a high-fidelity 
tonometer (Miller®). Applanation tonometry is considered as a ‘Gold Standard’ 
method in non-invasive pulse wave analysis (O'Rourke et al. 2001). The 
tonometer has a coplanar sensor that is placed on the site of local artery and a 
mild pressure applied to flatten the arterial wall. The pulse waves are calculated 
and displayed on a personal computer using specific internal software with a 
generalised transfer function. Pulse wave velocity is calculated using foot to foot 
method by consecutive measurements at arterial sites. It is derived by 
calculating the time between the R waves of ECG, which is measured 
simultaneously. The quality of measurement can be monitored using the 
operator index calculation. The central pressures are calibrated from 
peripherally measured blood pressure. Generally, carotid-femoral pulse wave 
velocity was used in most of the epidemiological studies. It is claimed as a 
standard method as femoral artery is a direct branch of aorta, which can give 
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accurate propagation.  However, it is difficult to access the femoral artery and/or 
measure accurately in few clinical conditions such as metabolic syndrome, 
obesity, diabetes and peripheral arterial disease (Van Bortel et al. 2002). The 
carotid-radial method is recommended in such conditions and the transfer 
function is better in upper limb arteries using SphygmoCor (Van Bortel et al. 
2002). Usually brachial artery pressure is used instead of radial artery when 
carotid-radial pulse waves are analysed. This is considered a disadvantage as it 
can cause errors (Verbeke et al. 2005). However, O’Rourke claims that the 
difference between brachial and radial pressure is negligible. More studies are 
needed to establish the validity of carotid-radial pulse wave analysis which is a 
less intrusive technique. 
  
Figure 2.17 The SphygmoCor – A tonometric system 
A number of studies tried to establish reference values for the measurements 
used in applanation tonometry. Wojciechowska et al (2006) established 
reference values of pulse pressure and augmentation index for a limited 
European population. The reference values for pulse wave velocity are 
available for Americans (Elias et al. 2011), Chinese (Li et al. 2008; Wang et al. 
2009) elderly Caucasians (Alecu et al. 2008) and Africans (Shiburi et al. 2006).  
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Khoshdel et al (2006) carried out a meta analysis to find age specific reference 
values for pulse wave velocity in Caucasians. However, so far there are no 
generalized reference values available for all the arterial stiffness variables 
using applanation tonometry. Further, there is a lack of research on populations 
in developing countries such as in South Asia. Applanation tonometry has been 
used in epidemiological and interventional studies for its established prognostic 
value (Shiburi et al. 2006; DeLoach and Townsend 2008; Rajzer et al. 2008). 
Nonetheless, Medical Services Assessment Committee (MSAC 2006) reports 
that its diagnostic value is limited due to the lack of generalised data.  
2.4. The parameters of pulse wave reflections in applanation tonometry 
2.4.1. Pulse wave 
During systole, after the blood is ejected into the systemic circulation, the 
intravascular pressure undergoes a small change. The wave motion through 
which the change of pressure is transmitted toward the periphery is known as 
pulse wave. A small part of forward travelling pulse wave is reflected backwards 
to the heart at every branching artery throughout the vascular system. The 
forward and reflected waves summate and produce wave deflections (Dart and 
Kingwell 2001). Many of the arterial stiffness variables such as pulse pressure, 
augmentation pressure, augmentation index and pulse wave velocity are 
established for individual predictive values for cardiovascular disease and 
mortality (Laurent et al. 2006). There are a number of definitions and formulae 
to calculate arterial stiffness, which can be derived from the change in pressure 
and size. The indices of arterial stiffness are listed in table 2.2. A normal pulse 
wave and the variables are illustrated in fig 2.18. 
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Table 2.2 Indices of arterial stiffness 
Elastic modulus 
The pressure step required for (theoretical) 100% stretch from resting 
diameter at fixed vessel length 
(ΔP · D)/ΔD (mm Hg) 
Arterial 
distensibility 
Relative diameter (or area) change for a pressure increment; the inverse of 
elastic modulus 
ΔD/(ΔP · D) (mm Hg-1) 
Arterial compliance 
Absolute diameter (or area) change for a given pressure step at fixed 
vessel length 
ΔD/ΔP (cm/mm Hg) (or cm2/mm Hg) 
Volume elastic 
modulus 
Pressure step required for (theoretical) 100% increase in volume 
ΔP/(ΔV/V) (mm Hg)=ΔP/(ΔD/D) (mm Hg) 
(where there is no change in length) 
Young's modulus 
Elastic modulus per unit area; the pressure step per square centimeter 
required for (theoretical) 100% stretch from resting length 
ΔP · D/(ΔD · h) (mm Hg/cm) 
Pulse Pressure The difference between systolic and diastolic pressure Ps-Pd  (mmHg) 
Pulse wave 
velocity 




Relationship between pressure change and flow velocity in the absence of 
wave reflections 
ΔP/Δv [(mm Hg/cm)/s] 
Augmentation 
Pressure 
Contribution of arterial pressure wave reflection to systolic arterial pressure 
(Difference between first and second systolic shoulders in a pulse wave) 
Stiffness index 





Difference between the second and first systolic peaks as a percentage of 
pulse pressure 
(Ps-Pi ) / (Ps-Pd) 
Capacitive 
compliance 
Relationship between pressure fall and volume fall in the arterial tree 
during the exponential component of diastolic pressure decay 
ΔV/ΔP (cm3/mm Hg) 
Oscillatory 
compliance 
Relationship between oscillating pressure change and oscillating volume 
change around the exponential pressure decay during diastole 
ΔV/ΔP (cm3/mm Hg) 
Ejection  
Duration Duration of systole calculated from the arterial pulse wave 
Subendocardial 
Viability Ratio 
Ratio between systolic and diastolic area in arterial pulse wave and it  is 
related to the energy supply of the heart 
SEVR = Tension Time index/ Diastolic Pressure time index 
P - pressure; D- diameter; V- volume; h- wall thickness; t- time; v- flow velocity; s- systolic; 





Figure 2.18 Structure of an arterial pulse wave.  
A average aortic pulse wave obtained from a SphygmoCor and adopted from Stoner et al 
(2012) 
2.4.2. Pulse wave velocity (PWV) 
When the heart contracts it generates a pulse or energy wave that travels 
through the circulation. The speed of travel of this pulse wave is termed as 
pulse wave velocity. In other words, it is an estimation of the velocity of the 
propagation of the forward and backward pressure between two points of the 
arterial tree (Lacolley et al. 2009). Pulse wave velocity is considered a gold 
standard for any diagnostic technique in measuring arterial stiffness (Laurent et 
al. 2006) and it has established clinical implications (Accetto et al. 2007) . A 
schematic representation of changes in pulse wave velocity with arterial 





Figure 2.19 Schematic representation of changes in arterial pulse wave velocity with arterial 
distensibility 
Top: Distensibility and pulse wave velocity in a young healthy artery – Moderate 
amplitude and contour of pressure wave. Middle: Decreased distensibility but normal 
pulse wave velocity in an aging and nearly healthy artery- pressure wave with slightly 
increased amplitude. Bottom: Decreased distensibility with increased pulse wave velocity 
in an aged and unhealthy artery- Pressure wave with increased amplitude. (O'Rourke MF 
1987). 
 
Pulse wave velocity is most commonly measured using foot to foot algorithm. In 
SphygmoCor, a sequence of pulse waves are recorded from two different sites 
e.g. radial and carotid arteries (Fig 2.20). The pulse waves are synchoronised 
with electrocardiogram (ECG) and an average pulse wave derived for each site 
with a time difference between the pulse waves. An intersecting tangent 
algorithm is used to identify the foot of each pulse wave. Then the foot to foot 
distance is calculated (Δt) (Fig. 2.21). The distance between arterial sites were 
manually measured on the skin (D). Then the pulse wave velocity is calculated 




Figure 2.20 A sequence of pulse waves, captured from radial (top) and carotid (Bottom) arteries 
that are sycronised with ECG in Sphygmocor 
 
 
Figure 2.21  A schematic diagram for calculating pulse wave velocity using intersecting tangent 
method in SphygmoCor 
The pulses waves are matched with ECG and intersecting tangents are derived from the 
foot of the each pulse wave. The time difference between the pulse waves from different 




2.4.3. Augmentation pressure 
The ejection of blood from the ventricle into the aorta generates an aortic 
pressure pulse. In many cases, the timing of the peak pressure does not 
coincide with the timing of peak flow, such that peak pressure may occur later. 
In this event, there is usually a systolic shoulder on the ascending limb pressure 
curve, which coincides with peak flow, then a rise in pressure to the systolic 
peak. The increase in the pressure is defined as augmentation pressure. When 
there is an increased peripheral vascular resistance and arterial stiffness, there 
is also an increase in premature pressure wave reflections. The accumulation of 
these premature reflections increases augmentation pressure and thus aortic 
systolic pressure (Wassertheurer et al. 2010).  
2.4.4. Augmentation index (AIx) 
The amount of augmentation pressure is quantified in terms of the relative 
change over the whole pulse.  It is the percent ratio of augmentation pressure to 
the aortic pulse pressure (Wassertheurer et al. 2010). That is, once the early 
systolic shoulder and the peak (T1) or the late systolic shoulder (T2) is 
identified, the absolute augmentation is calculated (T2-T1). Then the 
augmentation index is defined. SphygmoCor calculates AIx in two ways: (1) AIx 
= change in pressure/T1 (2) AIx = pulse pressure/T1. Augmentation index is 
considered as a key tool to reflect endothelial function. This was confirmed by 
significant reduction in AIx after the administration of a β2 agonist endothelium 
dependant vasodilator, for example salbutamol (Chowienczyk et al. 1999; 
Hayward et al. 2002; Wilkinson et al. 2002). These studies claim that β2 agonist 
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induces the release of nitric oxide, which is responsible for smooth muscle 
relaxation. Thus, it reduces the reflection of arterial pulse and AIx. 
2.4.5. Pulse pressure (PP) 
Pulse pressure is the systolic pressure minus the diastolic pressure. 
Theoretically, the systemic pulse pressure can be conceptualized as being 
proportional to stroke volume and inversely proportional to the compliance of 
the aorta. It has a strong association with mean arterial pressure (Redelinghuys 
et al. 2010). Pulse pressure shows significant haemodynamic changes with 
advancing age and conditions such as hypertension (Mitchell 2006).  
2.4.6. Ejection duration 
Ejection duration is usually measured by detecting the beginning of the pulse 
and the closure of the aortic valve, using the incisura as a marker of the second 
heart sound. The duration of ventricular ejection is measured in applanation 
tonometry despite the absence of a sharp incisura. The transfer function derives 
the corresponding point and calculates systolic time (Fig 2.22). However, 
ejection duration that is derived from applanation tonometry is less frequently 
studied and the validity of this measurement is not completely established.  
2.4.7. Subendocardial viability ratio 
The ratio of energy supply and the demand of the heart is termed as 
subendocardial viability ratio (SEVR). By transferring the ejection duration, the 
area under the systolic (Tension Time Index) and diastolic (Diastolic Pressure 
Time Index) part of the curve can be calculated (Fig 2.22). Systolic area is 
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associated with the work of the heart and oxygen consumption. Diastolic area is 
associated with the pressure and time for coronary perfusion. Thus, they are 
related to energy supply of the heart. This variable is also less frequently 




2.22 A schematic diagram for calculation of ejection duration and subendocardial viability ratio 






Various molecular, cellular and genetic causes are responsible for the structural 
changes in arteries and arterial stiffness. Arterial stiffness has a strong 
association with CVD and is a marker of CVD. Arterial stiffness increases with 
age irrespective of the presence of other cardiac risk factors. Pulse wave 
analysis in the measurement of arterial stiffness has a long history. Applanation 
tonometry is a recently developed non-invasive technique for pulse wave 
analysis. Simple, reliable and portable equipments are commercially available 
for non-invasive applanation tonometry. Variables such as pulse wave velocity, 
augmentation pressure and augmentation index are established as reliable 
indices of non-invasive arterial stiffness measurements. More research is 
necessary for establishing generalised reference values for applanation 
tonometry and to establish the efficiency of less intrusive non-invasive 
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CHAPTER 3.  REPRODUCIBILITY OF ARTERIAL STIFFNESS 
MEASUREMENTS FROM NON-INVASIVE PULSE WAVE ANALYSIS  
Abstract 
Background: Non-invasive pulse wave analysis is a non-intrusive method to 
measure central arterial stiffness. Reproducibility of this method has been 
studied less frequently. The current study has been designed to test the 
reproducibility of the various pulse wave analysis variables in different time 
durations. Methods: In total, 181 young adult Indian students (mean age 22.0 ± 
2.2) participated and arterial stiffness was measured using a SphygmoCor 
system. The variables include pulse wave velocity (PWV), pulse pressure (PP), 
augmentation pressure (Aug. P), augmentation index (AIx), heart rate corrected 
augmentation index (AIx@HR75), subendocardial viability ratio (SEVR) and 
ejection duration. The participants were measured consecutively twice and once 
again after 24 hours duration. Results: There was perfect reproducibility 
between the measurements taken consecutively on the first day (ICC= 9-10). 
The reproducibility was less 24 hours later. Pulse wave velocity and 
augmentation index @75%HR showed strong agreement.  Augmentation 
pressure, aortic pulse pressure and augmentation index showed moderate 
agreement. There was a fair agreement in the measures of SEVR, ejection 
duration, aortic systolic pressure, aortic diastolic pressure and mean pressure. 
Conclusion: In healthy people, the variables of pulse wave analysis are highly 
reproducible when re-measured immediately. However, the reproducibility 
reduces with time. These reproducibility values are important and should be 




Central aortic pressures have an important clinical value in cardiovascular risk 
assessment. Techniques for non-invasive measurement of central aortic pulse 
and arterial stiffness, using peripheral pulse wave analysis have been 
developed recently. The SphygmoCor is one of them. It is a computerized and 
portable device to assess pulse waveforms and one of the common systems in 
use to measure arterial stiffness (Yasmin and Brown 1999). It uses an arterial 
applanation tonometer for recording pressure waveforms that includes pulse 
pressure (PP) and augmentation index (AIx). In addition, pulse wave velocity 
(PWV) is measured from the foot of the carotid waveform to that of the radial 
waveform using sequential recordings referenced to the electrocardiogram 
(ECG). The advantage of this technique is the ease of performing applanation 
tonometry at the artery sites. ECG recordings are also used during 
SphygmoCor measurements for synchronization of carotid and radial pulse 
wave times.  
The validity of non-invasive pulse wave analysis has been proven with invasive 
measurements in previous studies (Chen et al. 1997). The reproducibility of the 
SphygmoCor has been studied mostly on measurements, which were taken 
consecutively. Only a few studies have addressed the measurements, which 
were taken over a longer time (Frimodt-Moller et al. 2008; Papaioannou et al. 
2007). Wilkinson et al (1998) studied the reproducibility of consecutive 
measurements of pulse wave velocity and augmentation index on a mixed 
population aged 20-72 years. Filipovsky et al  (2000) assessed intra-rater 
reproducibility of SphygmoCor on healthy people aged 19-53. The duration 
between the measurements was not clear in their study. There is a paucity of 
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studies, showing reproducibility of pulse wave measurements both 
consecutively and over a longer period.  
The current study assesses the reproducibility of the arterial stiffness measures 
from a SphygmoCor, consecutively as well as after 24 hours on a specific 
young adult age group. To the investigators’ knowledge, this is the first study 
conducted on young Indian adults. 
3.1.1. Objectives 
To assess the repeatability of SphygmoCor measurements on the arterial 
stiffness variables: augmentation pressure, augmentation index, pulse wave 
velocity, pulse pressure, subendocardial viability ratio, ejection duration and 
augmentation index@75 and mean pressures. 
3.1.2. Hypothesis 
The measurements of arterial stiffness variables using a SphygmoCor will show 




After obtaining ethical approval, the students from Father Muller Medical 
College, Mangalore, India volunteered to participate in the study. In total 181 
students, aged 19-27 were recruited. None of them had a history of any 
cardiovascular conditions or any other serious disease. They were measured 
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for arterial stiffness twice consequently within five minutes and once again the 
next day. On the days of testing, none of them had any remarkable change in 
their everyday activities such as excessive physical activities, use of any 
medications or alcohol, which might alter their physical conditions.  
3.2.2. Arterial stiffness measurement 
Participants were asked not to smoke for three hours before the study. 
Measurements were performed while subjects were in a quiet environment after 
at least 10 min of supine rest.  Local blood pressures were assessed using a 
conventional measurement of the ipsilateral brachial artery blood pressure 
according to the recommendations of the European Society of Hypertension 
(O'Brien et al. 2003) using a validated oscillometric device (BP-300, Kernel Intl 
Ltd). The mean of three brachial blood pressure values was used for the auto-
calibration in the measurement of arterial stiffness. Arterial stiffness was 
assessed with a SphygmoCor system (SCOR-PVx, Version 8.0, Atcor Medical 
Private Ltd, USA). The SphygmoCor is one of the recently developed 
computerized portable and simple to use devices to assess pulse waveforms 
and one of the common systems in use for measuring arterial stiffness. It uses 
an arterial applanation tonometer for recording pressure waveforms that 
includes pulse wave velocity (PWV), pulse pressure (PP), augmentation 
pressure (Aug. P), augmentation index (AIx), augmentation index corrected for 
heart rate at 75 bpm (AIx@HR75), subendocardial viability ratio (SEVR) and 
ejection duration. An electrocardiogram (ECG) recording during measurements 




The measurements were taken under optimal conditions for applanation as 
advocated by Rietzschel et al. (2001). The flat tonometer’s end was placed on 
the arterial site with a small amount of pressure that was applied perpendicular 
to the artery, so that arterial wall was flattened and the tangential forces were 
minimized. The difference in the pressure waveforms due to the applied 
pressure on the tonometer was calibrated in the SphygmoCor with the manually 
measured brachial artery pressures, obtained using ocillometric devices. The 
waveforms were displayed on the personal computer screen. A 10-second of 
stable waveforms with a satisfactory quality were captured and fed into the 
SphygmoCor system. An averaged pulse waveform was derived from the 
recording using the integral software. A validated general transfer function was 
used and aortic pressure waveform was derived. A computer algorithm, 
comparable to invasive techniques, was used to derive augmentation index 
(AIx) from the ascending aortic waveform, It is “the height of the second systolic 
peak above the wave foot divided by the height of the first systolic peak above 
the wave foot expressed as a percentage” (Rietzschel et al. 2001). Brachial 
artery pulse pressure was derived from the difference between systolic and 
diastolic blood pressure. Aortic PP was assessed from radial artery waveforms 
applying a radial-to-aorta transfer function and carotid artery waveforms 
applying a carotid-to-aorta transfer function (Rietzschel et al. 2001).  
Pulse wave velocity (PWV) is measured from sequential recording of ipsilateral 
carotid and radial waveforms. A foot to foot comparison of these two waveforms 
was used. The time delay was derived with a reference of simultaneous ECG 
recording and gating the peak of R waves (Oliver and Webb 2003). The 
waveforms’ travelling distance was measured from a common point 
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‘suprasternal notch’ using a tape measure. For the distal pulse, it was measured 
between suprasternal notch and the radial artery location. For the proximal 
pulse, it was measured between suprasternal notch and carotid pulse location. 
The difference between the proximal and distal pulse distances was calculated 
automatically as a travelling distance in the SphgmoCor. PWV was calculated 
as the ‘distance:transit time ratio’ and is expressed as metres per second. All 
reported data are mean values of three consecutive high-quality recordings. 
Care was taken to place the transducers over the same point of the arteries and 
the same distance was used.  
 
Measurements were taken twice consecutivelywithin 10 minutes and once 
again at the same time on the next day i.e after 24 hours. 
3.2.3. Statistical analysis 
The statistical analysis was carried out using SPSS (Version 18.0). The data 
were checked for univariate and multivariate outliers using standard Z-
distribution cut-offs and Mahalanobis distance tests respectively. A Kolmogorov-
Smirnov test was used to assess the normality of distribution. A paired t-test 
was used to test the difference between the measurements at Day-1 test-I, Day-
1 test II and Day-2 test. Intra class correlation coefficient (ICC) was calculated 
for each variable to test the repeatability. Bland-Altman plots were drawn for 
first and second day measurements of each variable to assess the reliability 




In total, 57 males and 124 females aged 19-28 (mean age 22.0 ± 2.2), were 
measured on day-1 and four males and 34 females on day-2. The physical 
characteristics of the participants were: mean height 162.3 ± 11.0 cm, weight 
was 58.8 ± 10.9 kg and the mean body mass index (BMI) 22.1 ± 2.2 kg/m2. 
Their blood pressure was 113.8 ± 11.3 mmHg systolic and 76.6 ± 9.1 mmHg 
diastolic. The means and standard deviations of each variable from test- I & II 
on day-1 and the test on Day-2 are listed in table 3.1. The test-I on Day-1 was 
considered as a baseline measure and compared with the other two 
measurements. There were no significant differences between the consecutive 
measurements taken on Day-1. There were significant differences between 
Day-1 measurements and Day-2 measurements only on heart rate, ejection 





Table 3.1 Paired t-test results for the arterial stiffness measurements 
 
Day 1- Test- I 
(n=181) 




Paired t Test 
Significance (p) 











PWV (m/s) 7.98 ±1.03 7.96 ±1.17 7.65 ±1.33 NS NS 
Aug P (mmHg) 3.37 ±3.00 3.35 ±3.16 3.48 ±2.41 NS NS 
Aug Index 13.17 ±9.43 13.38 ±9.99 15.19 ±8.83 NS NS 
Aug 
Index@75HR  13.21 ±10.24 13.51 ±10.59 14.51 ±8.59 NS NS 
Aortic PP 
(mmHg) 24.64 ±6.05 24.88 ±7.26 23.31 ±5.17 NS NS 
Aortic SP  
(mmHg) 102.40 ±9.72 102.53 ±10.00 99.76 ±8.57 NS NS 
Aortic DP 
(mmHg) 77.78 ±8.85 77.68 ±9.11 76.47 ±7.94 NS NS 
Mean P 
(mmHg) 89.57 ±8.85 89.61 ±8.99 87.73 ±7.75 NS NS 
Ejection 
Duration (ms) 39.95 ±4.77 39.76 ±5.24 39.48 ±4.24 NS * 
SEVR 136.46 ±28.03 137.18 ±30.01 139.51 ±24.25 NS * 
HR (bpm) 75.06 ±10.38 74.76 ±11.22 77.11 ±8.96 NS ** 
**Significant at p< 0.01  *Significant at p<0.05 NS- Not significant 
(PWV- Pulse Wave Velocity; P-Pressure,SP- Systolic Pressure; DP- Diastolic Pressure; 
SEVR– Subendocardial Viability Ratio; Aug – Augmentation; HR- Heart rate) 
 
The agreement between the measurements are listed in table. 3.2. The intra 
class correlations coefficients show strong agreements between test I and II on 
Day-1. The Day-2 measurements have lesser agreements compared with the 
agreements between the two measurements taken on Day-1. The values of ICC 
range from -1 to +1 in which -1 indicates perfect disagreement, 0 indicates 
random agreement and +1 indicates perfect agreement.  ICC values are 
designated as follows: 0-0.2 indicates poor agreement: 0.3-0.4 
indicates fair agreement; 0.5-0.6 indicates moderate agreement; 0.7-0.8 
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indicates strong agreement; and >0.8 indicates almost perfect agreement 
(Rietzschel et al. 2001). According to this approach, the current results show 
perfect agreements between the measurements taken consecutively on Day-1. 
Heart rate showed an almost perfect agreement after 24 hrs. Pulse wave 
velocity and augmentation index @75%HR showed a strong agreement.  
Augmentation pressure, aortic pulse pressure and augmentation index showed 
moderate agreement. There was a fair agreement in the measures of SEVR, 





Table 3.2 Intra class correlations between arterial stiffness tests 
 
Day 1- Test 1 vs. Day 1-Test 2 
(n=181) 
Day 1- Test 1 vs. Day 2- Test 
(n=38) 
 ICC F value Sig (p) ICC F value Sig (p) 
PWV (m/s) 0.902 19.322 ** 0.724 6.248 ** 
Aug P (mmHg) 0.972 71.466 ** 0.629 4.396 ** 
Aug Index 0.961 49.646 ** 0.58 3.767 ** 
Aug Index @75HR 0.967 59.924 ** 0.652 4.739 ** 
Aortic PP (mmHg) 0.952 40.894 ** 0.45 2.635 ** 
Aortic SP (mmHg) 0.990 204.478 ** 0.313 1.913 * 
Aortic DP (mmHg) 0.993 275.5 ** 0.421 2.453 ** 
Mean P (mmHg) 0.992 255.806 ** 0.338 2.023 * 
Ejection Duration 
(ms) 0.949 38.228 ** 0.328 1.977 * 
SEVR 0.96 49.087 ** 0.321 1.946 * 
HR (ppm) 0.964 54.92 ** 0.94 32.239 ** 
**Significant at p< 0.01  *Significant at p<0.05  
(PWV- Pulse Wave Velocity, P-Pressure, SP- Systolic Pressure, DP- Diastolic Pressure, 
SEVR– Subendocardial Viability Ratio, Aug – Augmentation, HR- Heart Rate) 
The Bland-Altman plots (Fig 3.1 and Fig 3.2) show some examples of the 
further agreement between the arterial stiffness variables measured on the two 
different occasions. Complete Bland-Altman plots with gender comparison are 
given in the appendix 3.1. From the plot, the degree of agreement is observed 
by the percentage of points that fall within ± 2SD from the mean and the 
variation is observed by the points that fell out of ± 2SD from the mean. Less 
than a 10% variation has been observed in all the variables on both consecutive 




Figure 3.1 Bland - Altman limits of agreement in pulse wave velocity - Consecutive (left) and 24 
hours difference (Right) 
 
Figure 3.2 Bland - Altman limits of agreement in augmentation pressure - Consecutive (left) and 
24 hours difference (Right) 
3.4. Discussion 
3.4.1. Statistical clarification 
More than one method was used to analyse the reproducibility of the variables. 
Papaioannou et al (Portney and Watkins 1993) state that there is no simple 
method to describe all the important areas of reproducibility. Filipovsky et al 
(2007) have used a Spearman correlation test. Pearson or Spearman 
correlation coefficient is an inappropriate method as it could be used only to 
assess the linear relationships, not the concordance (Filipovsky et al. 2000).  
Intraclass correlation (ICC) seems to be a better option, because in ICC, the 
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data are centred and scaled using a pooled mean and standard deviation, 
whereas in Pearson correlation, each variable is centred and scaled by its own 
mean and standard deviation (Kramer and Feinstein 1981). Coefficient of 
variation is another method of testing reproducibility, however it is considered 
as less satisfactory and misleading (Scheffé 1999). The Bland-Altman plot is a 
standard statistical method to see the agreement between two measurements 
(Bland and Altman 1986). The Bland-Altman plot illustrates a qualitative report 
on the limits of agreement between any two measurements. Most of the 
previous studies have used this method (Bland and Altman 1986). It can be 
seen that although there is a fair degree of consistency between the results 
from different statistical methods, they do provide slightly different outcomes. In 
the case of heart rate, for example, the results from Day-1 to Day-2 appear less 
reliable using t-test compared with ICC.  
3.4.2. Factors influencing reproducibility 
To the investigators’ knowledge, very few studies have studied the 
reproducibility of radial pulse wave analysis. A number of authors (Filipovsky et 
al. 2000; Frimodt-Moller et al. 2008; Siebenhofer et al. 1999; Wilkinson et al. 
1998) studied the intra-rater and inter-rater reliability of pulse wave analysis 
using the SphygmoCor system. They found augmentation index as a reliable 
parameter of pulse wave analysis and found central aortic pressures and 
peripheral pressures to be less reliable. The variability of peripheral pressures 
was found to be high in their study. However, the central pressures are 
automatically calibrated to the peripheral pressures by the SphygmoCor 
system. In their study, although the measurements were taken on two different 
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visits, the time difference between the measurements was not clear. As the 
cardiovascular function has been shown to be influenced by circadian rhythm 
(Scheer et al. 2010), the peripheral and central pressures might have altered at 
different times of day. Moreover, the circadian rhythm itself could be altered due 
to various factors such as working hours, behavioural disturbances, sleep and 
social life etc (Harrington 2001). Changes in heart rate were also found to 
influence central pressures (Williams and Lacy 2009). Papaioannou et al (2007) 
found significant changes in heart rate hour-to-hour measurements using the 
SphygmoCor. However, there were no changes between week-to-week 
measurements at the same time of the day. In the current study, the t-test 
showed a significant change in the heart rate after 24 hours. However, the intra 
class correlations showed perfect reproducibility.  In contrast to these studies, 
Avest et al (2005) found no influence of circadian rhythm on the measurement 
taken at 9.00 hours and 14.00 hours. They strongly suggest that food intake 
could be the only factor, which affects the sympathetic function and 
haemodynamics of the pulse wave.  
Wilkinson et al (1998) studied the reproducibility of pulse wave velocity and 
augmentation index from two different studies. They found that both variables 
were highly reproducible with pulse wave velocity being less reproducible than 
augmentation index. However, the current results show that both the variables 
have perfect agreements on consecutive measurements and pulse wave 
velocity had a better reproducibility over a 24 hour period compared with 
augmentation index. Similarly, all the variables showed high reproducibility in 
the current study on consecutive measurement and lower reproducibility after 
24 hours. Papaioannou et al (2007) also found similar results. They studied 
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hour-to-hour and week-to-week reproducibility of augmentation index, heart rate 
corrected augmentation index and the arrival time of reflected waves in the 
central aorta (pulse wave velocity) using the SphygmoCor. They also found 
higher reproducibility on hour-to-hour measurements and lesser reproducibility 
on week-to-week measurements. As they suggest, these findings are clinically 
important for the interventional studies. The correct design of studies, such as 
sample size and expected differences, could reduce the effects of the 
reproducibility errors in interventional studies which repeated measurements 
over a longer duration.  
3.4.3. Reproducibility on healthy vs. clinical conditions 
Frimodt-Moller (2008) studied the intra-rater and inter-rater reproducibility of 
pulse wave analysis on a limited number of 19 patients with chronic kidney 
disease and found high reproducibility with day-to-day measurements. Savage 
et al (2002) also found a high reproducibility on 188 patients with chronic renal 
failure (intra-observer difference of 0 ± 4% and inter-observer difference of 0 ± 
3% and –1 ± 9% for augmentation index). Papaioannou et al (2004) found a 
high reproducibility of pulse wave analysis on patients with low blood pressures 
due to cardiogenic shock and who had received a stent for recent myocardial 
infarction (intra-observer difference was 0.10 ± 5.82% for aortic augmentation 
index and 0.14 ± 1.2% for reflection time index). Wilkinson et al  (1998) also 
studied a mixed clinical group (eight hypertensives and six 
hypercholesterolaemics) and similarly found a high reproducibility (inter-
observer difference was 0.23 ± 0.66% and intra-observer difference was 0.49 ± 
0.93% for augmentation index). Studies on healthy subjects have also used 
86 
 
similar sample size and reproducibility on inter-rater measurements and time-to-
time measurements. Filipovsky et al  (2000) studied 88 healthy subjects 
measured by different raters (inter-observer differences  was 0.4 ± 6.4 % for 
augmentation index,  between visits 1 ± 0.9%). Papaioannou et al (2007) 
studied 22 healthy subjects on various occasions (hour-to-hour differences  
coefficient of variation = -7.1 ± 165% and ICC = 0.86 ±0.11, week-to-week 
differences coefficient of variation = 290.9 ± 466.6%, ICC = 0.72 ± 0.19). 
However, the reproducibility of pulse wave analysis was lower with time in 
healthy populations compared with studies on clinical population. It may be due 
to the lack of control on factors influencing haemodynamic changes such as 
age, physical activities and food intake.    
3.5. Conclusions 
In a healthy Indian population, the variables of pulse wave analysis are highly 
reproducible. The reproducibility slightly reduces with time. These reproducibility 
values are important and should be considered when designing interventional 
studies to reduce errors. More studies are needed to investigate reproducibility 
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CHAPTER 4. ACUTE CHANGES IN ARTERIAL STIFFNESS FOLLOWING 
EXERCISE IN HEALTHY CAUCASIANS AND SOUTH ASIANS 
Abstract 
Introduction: Arterial stiffness and exercise capacity are independent 
predictors of cardiovascular diseases. This study aims to find the acute changes 
in arterial stiffness using applanation tonometry following sub-maximal exercise 
in Caucasians and South Asians. This study also aims to establish the 
relationship between exercise capacity and arterial stiffness. Methods: In total, 
69 participants including 32 Caucasians and 37 South Asians were assessed 
for arterial stiffness non-invasively using SpygmoCor (SCOR-PVx, Version 8.0, 
Atcor Medical Private Ltd, USA) before and after an exercise test using the 
Bruce protocol on a treadmill and by measuring aerobic capacity using a 
metabolic analyser (Medical Graphics, Cardio Control, Minnesota, USA). 
Results: Significant increases in arterial stiffness variables were observed 
including augmentation pressure, subendocardial viability ratio, ejection 
duration, pulse pressure, augmentation index and mean arterial pressure 
following exercise in both ethnic groups (P<0.05). There were no significant 
differences in these increases between the ethnic groups (p>0.05). There was 
no change in pulse wave velocity (p>0.05). Exercise capacity was inversely 
related to arterial stiffness (P<0.05). Conclusion: There are no differences in 
arterial stiffness at the baseline and following acute exercise between 
Caucasians and South Asians. There was significant increase in arterial 
stiffness following exercise in both groups. Exercise capacity is inversely related 
to arterial stiffness. The results suggest that non invasive arterial stiffness could 
be used as a tool to measure acute changes following exercise.  
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4.1. Introduction  
4.1.1. Arterial stiffness 
Changes in arterial distensibility occur with aging and arterial stiffness 
increases. These biophysical signs are elevated in cardiovascular conditions 
such as diabetes and hypertension (Boutouyrie et al. 2002; Cruickshank et al. 
2002). Measurement of central aortic pressures has an important clinical value 
in the early diagnosis of cardiovascular risk. Central aortic pressures are often 
different from peripheral pressures and they have more diagnostic value than 
peripheral pressures because they are pathophysiologically more relevant  
(Smulyan et al. 2003). Recently a ‘Generalized Transfer Function’ (GTF) 
technique has been developed and widely used to measure the central aortic 
pressures non-invasively using peripheral pulse wave analysis. Different types 
of equipment are available on the market to measure arterial stiffness using 
pulse wave analysis non-invasively. There are some differences between the 
measured values from those different systems (Millasseau et al. 2005), yet non-
invasive measurements provide important diagnostic and prognostic values. 
Studies show that non invasive assessment of pulse wave and arterial stiffness 
can be an independent predictor for cardiovascular mortality in healthy people 
(Benetos et al. 1997; Willum-Hansen et al. 2006).  
The SphygmoCor is one of the recently developed, computerized, portable and 
simple to use devices to assess pulse waveforms, and one of the common 
systems in use for measuring arterial stiffness (Yasmin et al., 1999). It uses an 
arterial applanation tonometer for recording pressure waveforms. The 
advantage of this technique is the ease of performing applanation tonometry at 
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the artery sites. Arterial stiffness varies with age, sex and ethnicity (Hlaing et al. 
2006; Heffernan et al. 2008). However, the non-invasive arterial stiffness 
measures are less frequently studied and reference values are not established 
for South Asian populations such as in India.  
4.1.2. Exercise capacity 
Measurement of exercise capacity using metabolic analysers is a standard 
method to predict or diagnose cardiovascular disease. Exercise capacity is 
inversely related to arterial stiffness in healthy people as well as those with 
cardiovascular conditions (Vaitkevicius et al. 1993; Kingwell 2002). For example 
pulse wave velocity, one of the arterial stiffness variables derived from pulse 
wave analysis, has been shown to have an inverse correlation with exercise 
capacity in people with coronary artery disease (Enko et al. 2008). 
Ethnic differences in exercise capacity have been observed and well 
established (Wyndham et al. 1963). However, the ethnic differences in the 
relationship between exercise capacity and arterial stiffness have been studied 
infrequently, especially between Caucasians and South Asians. The changes in 
arterial distensibility immediately following exercise may have important clinical 
importance. However, these are scarcely reported using maximum oxygen 
uptake (VO2) and non-invasive carotid-radial pulse wave analysis.   
The current study was carried out to explore the acute changes in arterial 
stiffness using applanation tonometry following a sub-maximal exercise in 
Caucasians and South Asians. This study also aims to find the relationships 




H1 - There will be significant changes in arterial stiffness immediately after 
sub- maximal exercise. 
H2 - There will be significant relationships between exercise capacity 
variables using metabolic analysis and arterial stiffness variables using pulse 
wave analysis. 
H3 - There will be a significant difference between Caucasians and South 




Following institutional ethical approval, the study was advertised to staff and 
students at Bucks New University through posters on notice boards and through 
emails. Sixty nine volunteers aged 20-63 (mean 33.09 ± 11.94) participated. 
Healthy Caucasians (37) and South Asians (32) were included. Subjects were 
excluded who had known cardiovascular conditions and any orthopaedic 
conditions which could limit exercise testing on treadmill.  
4.2.2. Procedures and protocol 
Participants who showed interest were given a detailed information sheet with 
the entire requirement to be undertaken before the study. Participants were 
asked (i) not to smoke or have caffeinated drinks for three hours before the 
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study, (ii) not to drink alcohol or participate in unusually heavy activity for a day 
before the test. They were also advised not to take heavy meals immediately 
before the test. Upon arrival at the Research Lab, Bucks New University, 
Uxbridge, the participants were measured for weight using a floor scale (Seca 
model 761, Vogel ad Halke, Germany) and height using a free standing 
stadiometer (Leicester Height Measure, Invicta Plastics, Oadby, Leicester, UK). 
The treadmill exercise testing was explained to the participants and a 
familiarisation session on treadmill walking was performed if necessary. They 
then sat in a chair and rested for 10 min. During this time they completed a 
Physical Activity Readiness Questionnaire (PARQ), a detailed demographic 
information sheet and the consent forms.  
4.2.2.1. Measurement of arterial stiffness 
The procedures for measuring arterial stiffness are given in detail in Chapter 
3.2.2. The measurements were repeated within 5-10 min after completing a 
submaximal exercise testing.  
4.2.2.2. Measurement of exercise capacity 
After arterial stiffness measurement, ECG electrodes and leads were connected 
to the participants according to the instruction manual and the participants were 
connected to the metabolic analyzer (Medical Graphics, Cardio Control, 
Minnesota, USA) via a disposable pneumotach and facemask. Resting 
measurements were taken for five minutes for oxygen consumption (VO2), 
carbon dioxide production (VCO2) and minute ventilation (VE). Then, the 
participants performed a Bruce protocol (Bruce et al. 1973) on treadmill with the 
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continuous breath-by-breath measurement of respiratory gases. The protocol 
consists of seven stages having three min each. It starts with 2.7 kmph with 
10% gradient. The speed increased by 1.3 kmph every stage until the treadmill 
reaches 18% grade and 8 kmph. After this, the speed is increased by 1.8 kmph 
at every stage. All the participants were instructed to walk or run as long as they 
could endure. Handrail support was discouraged, however hand rail (on the 
front) support was allowed if necessary to maintain balance. Blood pressure 
was measured at the last minute of each stage of the Bruce protocol. The 
ACSM guidelines were followed for any early termination of exercise testing 
(ACSM 2000). The criteria are as follows: 
 Onset of angina or angina like symptoms 
 Significant drop (20 mmHg) in systolic blood pressure or a failure of the 
systolic blood pressure to rise with an increase in exercise intensity 
 Excessive rise in blood pressure: systolic >260 mmHg or diastolic 
pressure >115 mmHg 
 Signs of poor perfusion: light headedness, confusion, ataxia, pallor, 
cyanosis, nausea or cold and clammy skin 
 Failure of heart rate to increase with increased exercise intensity 
 Noticeable change in heart rhythm 
 Subject requests to stop 
 Physical or verbal manifestations of severe fatigue 
96 
 
 Failure of testing equipment 
The exercise was stopped on achieving of 90% of the maximum heart rate or if 
the participant was not able to continue. The subjective feeling of high intensity 
work was monitored using the Borg scale. A printed scale was placed in front of 
the participant at a reachable distance to point to the exact levels. The exercise 
was normally stopped when reaching 17 on the Borg scale; however some 
participants were allowed to exercise up to 19 on Borg scale if they were willing 
to continue.  The participants were asked every minute of the test “are you 
feeling ok?” and before the end of each stage “are you ok to continue for the 
next stage?”. The participants responded for the questions with thumb signals. 
At the termination of test, the subjects undertook active recovery and the ECG 
and gas exchange were monitored and measured for five minutes. The arterial 
stiffness measurements were taken immediately and always within 5-10 min 
after exercise testing.  
4.2.3. Statistical analysis 
All statistical analysis was carried out using SPSS version 18.0 (IBM 
Corporation, New York, USA). Normality of distribution was assessed using a 
Kolmogorov-Smirnov test. Levene’s test was used to confirm the homogeneity 
of the variances. Difference between ethnicity, gender and age were assessed 
using analysis of covariance (ANCOVA). Paired t test was used to compare the 
changes in arterial stiffness before and after exercise in each group. An 
independent t test was used to compare the difference between groups before 
the exercise and after the exercise separately. The correlations between 
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exercise capacity variables and arterial stiffness variables were performed using 
a Pearson’s correlations test. A ‘p’ value of < 0.05 (95% confidence interval) 
was considered as statistical significance for all the statistical tests.  
4.3. Results 
4.3.1. Demography 
The participants’ demographic details are given in table 4.1. There was a 
significant difference in age between the ethnic groups (p=0.001), but not in 
BMI (p=0.87). To reduce the age related effects on the results, statistical 
analysis was carried out with the data controlled for age up to 40 years.  
Table 4.1 Demographic details of the participants 
Characteristics Caucasian n=37 
Asian 
n=32 Male Female 
Age (years) 
(Mean ± SD) 39.0 ± 13.2 26.2 ± 4.4 33.0± 12.9 33.2± 11.2 
Height (cm) 
(Mean ± SD) 170.1± 10.1 167.1± 7.1 174.8± 7.6 162.8± 5.5 
Weight (kg) 
(Mean ± SD) 74.4±15.8 64.4± 11.0 76.1± 11.9 63.6± 14.4 
Body Mass Index 
(Mean ± SD) 25.6± 0.7 26.1±16.1 27.6± 15.3 24.1± 4.7 
Physical activity was higher in South Asians with 65.7% of South Asians and 
42.8% of Caucasians regularly involved in physical activities of more than 30 
min at least three days a week. 
4.3.2. Ethnic differences 
The ethnic differences in metabolic measures during sub-maximal exercise are 
listed in table 4.2 at VO2 max and table 4.3 at the time of anaerobic threshold 
(AT). There were significant differences between the groups at VO2 max for 
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VCO2, respiratory rate (RR), tidal Volume (Vt), expiratory volume (VE),  
breathing reserve (BR)¸VO2/HR and at AT for RR and VE.  
There was no difference in maximal treadmill exercise time between the groups. 
VCO2 peak was significantly lower in the South Asian group. After controlling the 
data for age, there were significant differences in the exercise capacity values. 
After controlling the data for age the significance increased including VO2 Peak 




Table 4.2 Difference in exercise variables between groups 
Variables Group Mean ± SD Sig 
Exercise Time (min) Caucasian 13.8 ± 2.5 NS 
South Asian 13.9 ± 2.5 
VO2 Peak mL.kg-1.min-1 
Caucasian 28.71 ± 6.24  
NS South Asian 26.66 ± 5.41 
VCO2 Peak mL.kg-1.min-1 
Caucasian 22.85 ±7.98 ** 
South Asian 17.54 ±5.57 
RER 
 
Caucasian 1.06 ± 0.11  
NS South Asian 1.03 ± 0.09 
METs Caucasian 8.15 ± 1.78  NS South Asian 7.50 ± 1.66 
RR (br/min) Caucasian 31.88 ± 5.96  * South Asian 36.00 ± 6.54 
Vt BTPS (L) 
Caucasian 1.90 ± 0.61 ** 
South Asian 1.31 ± 0.29 
VE BTPS (L/min) 
Caucasian 59.73 ±19.42 ** 
South Asian 46.36 ± 13.64 
BR (%) Caucasian 57.35 ± 9.71 ** 
South Asian 67.71 ± 8.23 
VE/VO2 
Caucasian 27.85 ± 2.88 NS 
South Asian 28.03 ± 3.69 
VE/VCO2 
Caucasian 26.42 ± 2.59 NS 
South Asian 27.13 ± 3.35 
VO2/HR 
Caucasian 13.55 ± 3.97 ** 
South Asian 10.03 ± 3.17 
PETO2 (kpa) 
Caucasian 13.81 ± 0.60 NS 
South Asian 13.75 ± 0.80 
PETCO2 (kpa) 
Caucasian 5.52 ± 0.57 NS 
South Asian 5.56 ± 0.67 
BORG RPE 
Caucasian 14.88 ± 2.56 
NS 
South Asian 13.89 ± 3.86 
 n= 37 Caucasians and 32 South Asians, NS – No significance          
*Statistically significant at p<0.05 **Statistically significant at p<0.01 
VO2- oxygen uptake, VCO2- carbon dioxide production, RER- respiratory exchange ratio, 
METs- metabolic equivalents, Vt- ,tidal volume VE- minute ventilation, BTPS- body 
temperature and pressure saturated , BR- breathing reserve, HR- heart rate, PETO2- end 






Table 4.3 Difference between groups in exercise gas changes at anaerobic threshold 
Variables Group Mean ± SD Sig 
Speed at VO2 max (kmph) 
Caucasian 2.70 ± 0.85 
NS 
South Asian 2.33 ± 0.64 
Speed at AT (kmph) 
Caucasian 3.52 ± 1.06 
NS 
South Asian 3.51 ± 0.78 
VO2 at AT mL.kg-1.min-1 
Caucasian 16.26 ± 3.78 
NS 
South Asian 14.32 ± 3.53 
RER at AT 
Caucasian 0.86 ± 0.05 
NS 
South Asian 0.87 ± 0.09 
METs at AT 
Caucasian 4.45 ± 1.35 
NS 
South Asian 4.09 ± 1.02 
RR at AT (br/min) 
Caucasian 20.73 ± 4.86 
** 
South Asian 24.84 ± 6.61 
VE at AT (L/min) 
Caucasian 26.20 ± 8.23 
* 
South Asian 21.97 ± 4.97 
n= 37 Caucasians and 32 South Asians,  NS – No significance  
 *Statistically significant at p<0.05 **Statistically significant at p<0.01 
AT – anaerobic threshold, VO2- oxygen uptake, RER- respiratory exchange ratio, METs- 
metabolic equivalents, RR- respiratory rate, VE- minute ventilation 
The differences in arterial stiffness variabl es between the groups are listed 
table 4.5. There was no significant difference between the groups before 
exercise except in aortic pulse pressure, aortic systolic pressure and pulse 
wave velocity. After controlling the data for age there was no change in the 
significance in the resting values (table 4.6). 
The acute changes in arterial stiffness in relation to ethnicity, gender and age 
are illustrated in table 4.7. The ANCOVA analysis did not show any significant 
influences of these factors on the changes in arterial stiffness except mean 
pressure with ethnicity.  
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Table 4.4 Difference in exercise variables between groups for reduced data for age 
Variables Group Mean ±SD Sig Variables Mean ±SD Sig 
Exercise Time (min) 




South Asian 14.02 ±2.38 10.03 ±3.17 
VO2 Peak (mL.kg-1.min-1) 
Caucasian 30.43 ±5.12 
* PETO2 (kpa) 
13.86 ±0.66 
NS 
South Asian 26.87 ±5.38 13.74 ±0.82 
VCO2 Peak (mL.kg-1.min-1) 
Caucasian 24.61 ±7.23 
** PETCO2 (kpa) 
5.71 ±0.47 
NS 
South Asian 17.54 ±5.66 5.58 ±0.67 
RER 
Caucasian 1.11 ±0.10 
* BORG RPE 
15.06 ±2.56 
NS 
South Asian 1.03 ±0.09 13.76 ±3.84 
METs 
Caucasian 8.69 ±1.45 
* Speed at VO2 max (KMPH) 
2.69 ±0.83 
NS 
South Asian 7.55 ±1.66 2.33 ±0.65 
RR (br/min) 
Caucasian 33.25 ±5.80 
NS Speed at AT (KMPH) 
3.99 ±1.10 
NS 
South Asian 36.10 ±6.62 3.57 ±0.72 
Vt (L) 
Caucasian 1.92 ±0.69 
** VO2 at AT (mL.kg-1.min-1) 
16.96 ±4.22 
* 
South Asian 1.30 ±0.29 14.53 ±3.38 
VE (L/min) 
Caucasian 61.84 ±16.81 
** RER at AT 
0.85 ±0.05 
NS 
South Asian 46.09 ±13.78 0.87 ±0.09 
BR (%) 
Caucasian 59.62 ±9.11 
** METs at AT 
4.48 ±1.69 
NS 
South Asian 67.83 ±8.34 4.15 ±0.97 
VE/VO2 
Caucasian 27.94 ±3.26 
NS RR at AT  (br/min) 
19.88 ±4.04 
** 
South Asian 27.87 ±3.64 24.77 ±6.71 
VE/VCO2 
Caucasian 25.25 ±2.32 
NS VE at AT (L/min) 
24.61 ±8.97 
NS 
South Asian 27.00 ±3.33 22.06 ±5.02 
(n= 17 Caucasians, 30 South Asians)  NS – No significance *Significant at p<0.05  **Significant at p<0.01 
VO2- oxygen uptake, VCO2- carbon dioxide production, RER- respiratory exchange ratio, METs- metabolic equivalents, Vt- ,tidal volume VE- 
minute ventilation, BTPS- body temperature and pressure saturated , BR- breathing reserve, HR- heart rate, PETO2- end tidal oxygen tension, 
PETCO2- end tidal carbon dioxide tension, RPE- rate of perceived exertion, AT – anaerobic threshold, RR- respiratory rate 
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Table 4.5 Difference in arterial stiffness before exercise 
Variables Group Mean ±SD Sig 
Pulse Wave Velocity (m/s) 
Caucasian 8.37 ± 1.50 
* 
South Asian 7.72 ± 1.03 
Aug  Pressure (mmHg) 
Caucasian 4.00 ± 4.62 
NS 
South Asian 2.08 ± 3.07 
Aug Index  
Caucasian 11.56 ± 14.30 
NS 
South Asian 8.03 ± 10.78 
Aortic Pulse Pressure (mmHg) 
Caucasian 31.55 ± 7.40 
** 
South Asian 26.05 ± 4.47 
Aortic Systolic  Pressure (mmHg) 
Caucasian 109.70 ± 14.26 
* 
South Asian 102.25 ± 9.53 
Aortic Diastolic  Pressure (mmHg) 
Caucasian 78.14 ± 10.61 
NS 
South Asian 76.10 ± 8.23 
Mean Pressure (mmHg) 
Caucasian 92.38 ± 12.44 
NS 
South Asian 88.60 ± 9.03 
Ejection Duration (ms) 
Caucasian 37.06 ± 9.30 
NS 
South Asian 36.66 ± 5.19 
SEVR  
Caucasian 156.72 ± 45.86 
NS 
South Asian 158.26 ± 34.47 
HR (bpm) 
Caucasian 69.48 ± 17.13 
NS 
South Asian 70.92 ± 12.01 
NS – No significance,  *Significant at p<0.05 **Significant at p<0.01 
(n= 36 Caucasians, 32 South Asians), SEVR – Subendocardial Viability Ratio, Aug – 
Augmentation, HR- Heart Rate 
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Table 4.6 Difference in baseline arterial stiffness values at rest between groups, for data 
controlled for age 
Variables Group Mean ± SD Sig 
Pulse Wave Velocity (m/s) 
Caucasian 7.99 ±1.30 
NS 
South Asian 7.71 ±1.04 
Aug Pressure (mmHg) 
Caucasian 1.91 ±3.98 
NS 
South Asian 2.01 ±3.09 
Augmentation Index 
Caucasian 7.53 ±13.98 
NS 
South Asian 9.41 ±10.75 
Augmentation Index@75HR 
Caucasian 5.04 ±14.47 
NS 
South Asian 7.86 ±10.92 
Aortic Pulse Pressure (mmHg) 
Caucasian 27.29 ±5.54 
NS 
South Asian 25.68 ±4.04 
Aortic Systolic Pressure (mmHg) 
Caucasian 102.62 ±11.20 
NS 
South Asian 102.02 ±9.60 
Aortic Diastolic Pressure (mmHg) 
Caucasian 75.39 ±9.11 
NS 
South Asian 76.24 ±8.33 
Mean Pressure (mmHg) 
Caucasian 87.68 ±10.29 
NS 
South Asian 88.58 ±9.18 
Ejection Duration (ms) 
Caucasian 38.16 ±9.51 
NS 
South Asian 36.93 ±5.04 
Subendocardial Viability Ratio 
Caucasian 151.56 ±49.93 
NS 
South Asian 156.08 ±32.71 
Heart Rate (bpm) 
Caucasian 72.95 ±15.85 
NS 
South Asian 71.49 ±11.76 
NS – No significance  (n= 17 Caucasians, 30 South Asians) 
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Table 4.7 Significance in Analysis of Covariance in arterial stiffness variables 
Variables Ethnicity Gender Gender within Ethnicity 
Age within 
Ethnicity 
Pulse Wave Velocity NS NS NS NS 
Aug Pressure NS NS NS NS 
Aug Index NS NS NS NS 
Pulse pressure NS NS NS NS 
Mean Pressure * NS NS NS 
Ejection Duration NS NS NS NS 
SEVR NS NS NS NS 
NS – No significance  *Statistically significant at p<0.05 
SEVR – Subendocardial Viability Ratio, Aug – Augmentation, HR- Heart Rate 
 
4.3.3. Acute changes following exercise 
Table 4.8 lists the changes in arterial stiffness variables before and after 
exercise within Caucasian and South Asian groups. Most of the variables 
(15/20) had significant changes following exercise in both the groups. The only 
non-significant changes were in pulse wave velocity in both groups, in 
augmentation index in Caucasians, and in augmentation pressure and aortic 




Table 4.8 Changes in arterial stiffness after exercise in Caucasians and South Asians 
  Caucasians South Asians 
















After Exercise 6.22 ±6.29 3.13 ±3.74 
Aug Index  




After Exercise 12.81 ±13.05 4.48 ±11.93 
Aortic PP 
(mmHg) 




After Exercise 38.34 ±10.98 28.70 ±7.70 
Aortic SP 
(mmHg) 




After Exercise 123.80 ±16.28 111.20 ±11.80 
Aortic 
DP(mmHg) 




After Exercise 85.55 ±10.52 82.51 ±7.41 
Mean P 
(mmHg) 












After Exercise 42.55 ±4.89 43.40 ±3.61 
SEVR  




After Exercise 116.35 ±23.74 114.71 ±20.59 
HR (bpm) 




After Exercise 80.20 ±11.80 87.75 ±10.16 
NS – No significance  *Significant at p<0.05  **Significant at p<0.01  
Caucasians (n=32) and South Asians (n=29)  
SEVR – Subendocardial Viability Ratio, Aug – Augmentation, HR- Heart Rate, SP- 
Systolic Pressure, DP- Diastolic Pressure 
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4.3.4. Relationship between variables 
There was a significant inverse relationship between exercise capacity variables 
and arterial stiffness variables in both Caucasians and South Asians (Table 4.9 
& 4.10). The patterns of relationship between VO2 peak and augmentation 
pressure before and after exercise for both groups are exemplified in figures 
4.1- 4.4. More figures on the relationship between VO2 peak and arterial stiffness 
variables are given in appendix.2.  
Table 4.9 Relationship between the variables of exercise capacity and arterial stiffness among 
Caucasians at peak value (correlation coefficeints) 







Pulse Wave Velocity 
(m/s) 0.01 0.09 0.03 0.12 0.10 
Augmentation 
Pressure (mmHg) -0.41* -0.17 -0.37** 0.04 -0.08 
Augmentation Index -0.35* -0.06 -0.30* 0.17 0.04 
Aortic Pulse pressure 
mmHg 0.00 0.20 -0.03 0.39** 0.26* 
Ejection Duration 
(ms) -0.19 -0.34* -0.18 -0.37** -0.31* 
SEVR 0.18 0.37** 0.19 0.42** 0.34* 
n=37 NS – No significance  *Significant at p<0.05    **Significant at p<0.01 
 
Table 4.10 Relationship between the variables of exercise capacity and arterial stiffness among 
South Asians 







Pulse Wave Velocity 
(m/s) .213 .281 .254 .059 .144 
Augmentation Pressure 
(mmHg) -.261 -.221 -.240 -.135 -.100 
Augmentation Index -.294 -.183 -.227 .007 -.001 
Aortic Pulse Pressure 
(mmHg) -.050 -.018 -.171 .112 .013 
Ejection Duration 
(ms) -.106 -.268 -.120 -.457* -.216 
SEVR .055 .270 .109 .462* .243 
n=32 NS – No significance  *Significant at p<0.05  **Significant at p<0.01 




Figure 4.1 VO2 peak vs. Augmentation pressure before exercise in Caucasians 
 




Figure 4.3 VO2 peak vs. Augmentation pressure after exercise in South Asians 
 




Pulse wave analysis using generalized transfer function with applanation 
tonometry is used in many studies to determine central blood pressures non-
invasively at rest and exercise (Naka et al. 2003; Munir et al. 2008; Dawson et 
al. 2009; Campbell et al. 2011). The accuracy of the transfer function is 
debatable. Sharman et al (2006) found that the values obtained from the 
measurements from the non-invasive technique are reliable and similar to 
invasive techniques.  Hickson et al (2009) claim that the peripheral waveforms 
approximate the central waveforms in various age groups. However, it was also 
claimed that the accuracy of this technique altered with the inaccuracy of the 
brachial pressure measured using oscillometric devices (Smulyan et al. 2003; 
Zuo et al. 2010). In the current study, extra care was taken to measure 
oscillometric brachial pressures. SphygmoCor measurements were taken with 
precision, considering the same side and site of the radial and carotid arteries 
and the position of the participants. This is the first to study the changes in 
arterial stiffness and its relationship with cardiac exercise capacity within two 
ethnic groups, Caucasians and South Asians.  
4.4.1. Changes in arterial stiffness 
Most of the arterial stiffness variables showed an increase following acute 
exercise. The increase in arterial stiffness may be due to an increase in blood 
viscosity immediately following the exercise. Blood viscosity is inversely 
proportional to arterial distensibility (Kingwell et al. 1997).  Naka et al (2003) 
studied the changes in pulse wave velocity along with plasma viscosity and 
found that there was an increase in pulse wave velocity (~35%) three min after 
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exercise, then a decline in pulse wave velocity lower than baseline (~6%) after 
10 min and further lowered (~10%) after 60 min. Plasma viscosity also 
increased three min after exercise and resumed to normal after 20 min. They 
suggest that the immediate increase in pulse wave velocity may be influenced 
by reduced vascular distensibility by neurohumoral and endothelial influence on 
vascular tone. Dulai et al (2011) studied changes in arterial stiffness three, 15 
and 30 minutes after moderate intensity exercise. They found a significant 
increase in pulse wave velocity after three minutes and a complete recovery in 
15 minutes. In contrast to these findings, pulse wave velocity did not change 
significantly after exercise in the current study. It was not possible to take 
arterial stiffness measures immediately after the completion of exercise as the 
participants were still connected to the metabolic analyser to monitor recovery 
for any adverse changes. The current measurements were taken 5-10 min after 
exercise where the pulse wave velocity could have been shown substantial 
recovery. However, Munir et al (2008) found pulse wave velocity unchanged up 
to an hour after exercise, though there was a reduction in augmentation Index. 
Their results are similar to the current findings.  
Augmentation index is a reflection of aortic pulse wave and it is influenced by 
wave velocity. Thus, it is a measure of arterial stiffness. Dawson et al (2009) 
define augmentation index as a representation of the difference in amplitude 
between incident and reflected pulse wave as a percentage of pulse pressure. 
They found significant increase in mean arterial pressure and augmentation 
index with increasing workload. However, in the current study, augmentation 
index reduced after exercise which is not clear. Similar to the current results, 
Sharman et al (2006) observed an increase in pulse pressure, mean arterial 
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pressure and a decrease in SEVR after exercise.  In contrast, the ejection 
duration increased after exercise in the current study, the reason for which is 
not clear.  
High mean pressure during exercise is associated with decreased endothelial 
function (Gonzales et al. 2011). This may be due to the oxidation stress 
produced by the increase in oxygen uptake during acute exercise (Harris et al. 
2008) 
There was no significant difference between Caucasians and South Asians on 
arterial stiffness variables at rest (table 4.4). In previous studies, the South 
Asians seem to have more endothelial dysfunction than the Caucasians. 
Murphy et al (2007) studied the resistance vessel endothelial function by 
forearm blood flow (FBF) and the number of circulating endothelial progenitor 
cells (EPC) which are responsible for nitric oxide production and endothelial 
repair. They found lower levels of EPC and FBF in South Asians compared with 
Caucasians. This may be the reason for the higher pulse wave velocity in South 
Asians in the current study. However, South Asians had comparatively lower 
aortic systolic pressure and pulse pressure. These variables need to be 
investigated more to validate these differences. 
4.4.2. Exercise capacity and its relationship with arterial stiffness 
There was a significant difference in exercise capacity between groups. The 
Caucasians had a higher exercise capacity in the age controlled results. The 
differences may not be due to variations in height or weight as there was no 
significant difference in body mass index between the groups. The difference in 
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the exercise capacity may be due to nutritional and socio-cultural factors 
(Swaminathan et al. 1997), but this would need to be studied specifically to 
confirm such speculations. There was also a significant difference in VO2/HR. 
The VO2 and HR increase linearly with exercise intensity and the relationship 
between them is important for the assessment and prescription of exercise 
(ACSM 2000; Skinner et al. 2003). Studies show that comparatively low levels 
of physical activity were observed in South Asians living in the UK (Fischbacher 
et al. 2004). However, the South Asian participants in the current study reported 
higher levels of physical activity in terms of duration, but the intensity of physical 
activities was not defined. 
The current study finds that arterial stiffness has an inverse relationship with 
exercise capacity. In Caucasians, augmentation pressure and augmentation 
index had significant inverse relationship with VO2. These agree with the 
findings of previous studies (Vaitkevicius et al. 1993; Kingwell 2002). In South 
Asians, there was also an inverse relationship between these variables but it 
was not found be statistically significant in the current study. Binder et al (2006) 
also found a similar inverse relation between VO2 max and augmentation index. 
Kingswell (2002) suggested that people with high resting aortic pulse pressure 
might experience higher aortic pulse pressure at maximal exercise. This was 
corroborated in the current study (table 4.4).  
4.4.3. Limitations 
Due to the lack of availability of the participants, it was not possible to take 
serial measurement of arterial stiffness. The SphygmoCor technique does not 
allow measurement during exercise on the treadmill.   A greater number of 
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participants would improve the power of the results and allow for matched 
subgroup analysis. One of the major limitations was the age difference between 
the groups. The ANCOVA results could have been strengthened if there were a 
greater number of age matched participants. Previous studies suggest that 
there are variations in the immediate change in arterial stiffness between the 
exercising limb and the other regions of the body (Sugawara et al. 2003). It 
would require more studies to clarify the regional differences in arterial stiffness 
due to acute exercise. In the current study, it was not possible to measure the 
arterial stiffness immediately at the end of exercise session due to metabolic 
monitoring and no further measurements were carried out after 10 minutes due 
to unavailability of the participants. More sequential measurements for a longer 
duration could be more informative in the arterial stiffness changes following 
acute exercise.  
4.5. Conclusions 
There are no differences in arterial stiffness variables at rest between 
Caucasians and South Asians. There was significant increase in central aortic 
pressures and reduction in augmentation index within 5-10 min following acute 
exercise in both groups. However, there was no difference in these increases 
due to ethnicity, gender or age. There were differences between these ethnic 
groups in exercise capacity and gas exchange variables during sub-maximal 
exercise. This may be due to the difference in adhering to a healthy lifestyle and 
needs to be investigated. There were strong inverse correlations between 
exercise capacity and arterial stiffness. Non-invasive carotid-radial arterial 
stiffness measurements could be used in exercise-based interventional studies.  
The findings of this study advance the understanding of the clinical evaluation in 
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difference ethnic groups who are in higher risk. More studies need to be carried 
out on clinical populations with cardiovascular risks to enable appropriate 
preventive measures. Larger scale studies need to establish the validity of the 
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CHAPTER 5. RELATIONSHIP BETWEEN BODY ADIPOSITY AND 
ARTERIAL STIFFNESS IN YOUNG INDIAN ADULTS 
Abstract 
Background: Obesity is one of the major cardiovascular risk factors and is 
linked with arterial stiffness. This study has been undertaken to establish the 
relationship between regional adiposity and arterial stiffness using simple non-
invasive techniques. Methods: In total, 181 young Asian-Indian adults aged 18-
28 years (mean age 21.9 ± 2.2) were measured for adiposity and arterial 
stiffness. Total body fat percentage was derived from skinfold thickness of 
various body sites. Body mass index (BMI) and waist-hip-ratio (WHR) were also 
measured. Arterial stiffness was measured using a SphygmoCor with a carotid-
radial pulse wave analysis technique Results: Significant gender differences 
were observed on anthropometric variables including skinfold thickness 
(p<0.05) and all the arterial stiffness variables (p<0.05) except pulse wave 
velocity. Systolic pressure, augmentation pressure, augmentation index, 
augmentation index at 75% heart rate, aortic systolic pressure had statistically 
significant correlations with all three adiposity variables (p<0.05). Significant 
correlations were found in a higher number of variables in the females.  
Physical activity had negative correlations with arterial stiffness and adiposity 
variables (p<0.05). Conclusion: Arterial stiffness measured by carotid radial 
pulse wave analysis is strongly related to adiposity measured from skinfold 
thickness in females. Females had higher arterial stiffness and adiposity 
compared with men. These findings could be helpful in future research using 




5.1.1. Obesity prevalence 
Obesity is one of the important risk factors for diabetes and other cardiovascular 
disease. The World Health Organisation has declared that ischaemic heart 
disease will be ranked first and diabetes will move from 11th place to sixth place 
for the global burden of diseases and mortality by 2030 (2006). In 2005, it was 
estimated that 33% of the world’s adult population were overweight or obese. 
Further it is projected that there will be up to 57% overweight or obesity levels 
by 2030 (Kelly et al. 2008). Obesity prevalence is observed in developed as well 
as developing counties such as India. In India, it is projected that there will be 
an increase of the prevalence of overweight or obesity from 16.9% (as in 2005) 
to 32.8% by 2030 (Kelly et al. 2008). In India, obesity was observed even in 
school age pre-adolescents and adolescents in both males and females. There 
was higher a prevalence in high socio-economic children and females 
(Chhatwal et al. 2004).  
5.1.2. Arterial stiffness and obesity 
Arterial stiffness is one of the key tools in the measurement of cardiovascular 
risk. Many studies have confirmed the relationship between arterial stiffness 
and adiposity in different age groups (Acree et al. 2007; Ferreira et al. 2004; 
Sakuragi et al. 2009; Whincup et al. 2005). A strong relationship between 
adiposity and arterial distensibility using ultrasound imaging was found in British 
adolescents (Whincup et al. 2005). In addition to adiposity, physical fitness and 
lifestyle also influence arterial stiffness (Sakuragi et al. 2009). Physical activities 
have a strong correlation with the incidence of obesity in adolescents and young 
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adults (Kemper et al. 1999).  Body mass index is a standard method of 
assessing overall obesity. Skinfold thickness and waist/hip circumferences are 
used to measure adiposity in specific parts of the human body. Acree et al 
(2007) found obesity was associated with decrease in large and small artery 
compliance. In their study, large arterial compliance had significant correlations 
with the skinfold thickness and small arterial compliance with the waist/hip 
circumferences and the ratios. Total adiposity and truncal subcutaneous fat 
accumulation at the age of adolescence had positive correlations with the 
carotid intima-media thickness at the age of 36 in a longitudinal study (Ferreira 
et al. 2004). Juonala et al. (2005) also found childhood obesity  was related to 
the development of carotid stiffness in adulthood. Interestingly, Zebekakis et al 
(2005) found that carotid distensibility decreased with higher BMI. They state 
that the arterial stiffness was modulated with age i.e. the negative effects of 
obesity on arterial stiffness were higher in younger age groups.  They also 
suggest studying whether obesity in young adults has a higher risk of arterial 
stiffness and cardiovascular disease. It could help to find the potential of 
preventing obesity at younger age (Zebekakis et al. 2005) .  Most of the studies 
using non-invasive pulse wave analysis have measured carotid-femoral pulse 
wave velocity. The current study aims to use and establish the importance of 
carotid radial pulse wave velocity, which is less intrusive.  
To the investigators’ knowledge, no study has been carried out to find the 
relationship between adiposity and arterial stiffness in young and healthy Indian 
adults. The current study aims to study the relationship between adiposity using 
skinfold thickness and arterial stiffness using pulse wave analysis in young 




In young healthy Indian adults: 
H1 - There will be a significant positive relationship between body fat 
percentage measured by skinfold thickness and arterial stiffness measured by a 
non-invasive pulse wave analysis. 
H2 - There will be significant differences between males and females in the 
above said relationship. 
H3 – There will be a significant relationship between abdominal obesity and 
arterial stiffness. 
5.2. Methods 
The participants were same as in chapter 3 who were aged 18-28 years (mean 
age 21.9 ± 2.2) were recruited and 181 participants volunteered for the study.  
5.2.1. Skinfold thickness 
The skinfold thickness was measured using a Harpenden skinfold calliper 
(Quality Measurement Limited, UK). Measurements were taken according to the 
manufacturer’s guidelines.  
Measurement was taken on healthy, undamaged and uninfected dry skin. The 
participants were instructed to keep the muscles relaxed during the test. All the 
measurements were taken on the right side of the body. An exception was 
made in case of a deformity in the right limb. The skinfold site was marked 
using a water-soluble ink marker. A tape measure was used to find the accurate 
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mid-points. Each skinfold was firmly grasped by the thumb and index finger, 
using the pads at the tip of the thumb and finger. Then skinfold was gently 
pulled away from the body; the calliper was placed with its dial facing up; 
perpendicular to the true double fold of skin thickness; on the site marked the 
calliper was applied at approximately 1cm below the finger and thumb. While 
maintaining the grasp of the skinfold, the calliper was allowed to release so that 
full tension was placed on the skinfold. After the grip was fully released for one 
to two seconds, the dial was read to the nearest 0.50mm. Two measurements 
were taken at each site and averaged. The measurements were repeated if the 
two measurements varied by more than 1 mm. The skinfold measurement was 
taken from seven sites as follows. Chest measurements were taken only on 
male participants.  
Site 1 Biceps - The anterior surface of the biceps midway between the anterior 
fold and the antecubital fossa. 
Site 2 Triceps - A vertical fold on the posterior midline of the upper arm, over 
the triceps muscle, halfway between the acromion process (bony process on 
top of the shoulder) and olecranon process (bony process on elbow). The elbow 
should be extended and the arm relaxed. 
Site 3 Subscapular - The fold is taken on the diagonal line coming from the 
vertebral border to between 1 and 2cm from the inferior angle of the scapula. (A 
diagonal fold about 1 to 2cm below the point of the shoulder blade and 1-2cm 
toward the arm). 
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Site 4 Supra-iliac - A diagonal fold above the crest of the ilium at the spot where 
an imaginary line would come down from the anterior auxiliary line, just above 
the hipbone and 2-3cm forward. 
Site 5 Chest (Juxta-nipples) - A diagonal fold taken one half of the distance 
between the anterior auxiliary line and the nipple. (The anterior auxiliary line is 
the crease where the top of the arm, when hanging down, meets the chest). 
Site 6 Abdominal - The vertical fold taken at the lateral distance of 
approximately 2cm from the umbilicus (2cm to the side of the umbilicus). 
Site 7 Thigh - A vertical fold on the anterior aspect of the thigh, midway between 
the hip and knee joints (on the front of the thigh halfway between the hip joint, 
where the leg bends when the knee is lifted, and the middle of the knee cap). 
The leg should be straight and relaxed. 
The body fat percentage was calculated using the linear regression equations of 
Durnin & Wormersley and Siri’s equation (Durnin and Womersley 1974) (Table 
5.1). The four skinfolds that includes biceps, triceps, subscapular and supra-




Body density = C [M (log 10 sum of all four skinfolds)] 
(C, M = Constant values) 
Table 5.1 Body density constants 







C 1.162 11631 1.1422 1.162 1.1715 
M 0.063 0.0632 0.0544 0.07 0.0779 







C 1.1549 1.1599 1.1423 1.1333 1.1339 
M 0.0678 0.0717 0.0632 0.0612 0.0645 
The Siri’s equation fat percentage = [(4.95/Body Density) -4.5] x100 
5.2.2. Arterial stiffness measurement 
The procedures for measuring arterial stiffness are given in detail in Chapter 
3.2.2. 
5.2.3. Calculations and statistical analysis 
Abdominal obesity was determined using the International Federation of 
Diabetes’s guidelines (waist circumference ≥ 90 cm in men and ≥80 cm in 
women). 
Data were analysed using a software package, SPSS 18 (IBM Limited, USA). A 
Kolmogorov-Smirnov test was applied to test the normality of the data. A 
Pearson correlation test was used to analyse the relationship between the 
adiposity and arterial stiffness variables. The meaningfulness of the correlation 
coefficient was evaluated by calculating the coefficient of determination (r2).  An 
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independent t test was used to find the difference in the measured values 
between males and females. Statistical significance was indicated if p<0.05.  
5.3. Results 
5.3.1. Gender Differences 
In total, 124 females and 57 males participated.  The physical characteristics of 
the participants were (Mean ± SD): Height (cm) -162.3±11.0, Weight (kg) - 
58.8±10.9 and Body Mass Index - 22.1±3.0 kg/m2. More than half of the 
participants engaged in no physical activity. The duration of their physical 
activity per day was categorized as follows; >60 min-15.4%, 30-60 min -15.4%, 
< 30 min - 9.4% and none - 59.1%. 
The differences in the variables between males and females are listed in table 
5.2. There were significant differences in height and weight between males and 
females, but there was no difference in their body mass index. There were 
significant differences in the anthropometric variables between males and 
females except abdomen skinfold thickness. Abdominal obesity was found in 
11.9% males and 15.9% females. There were significant differences in all the 
arterial stiffness variables except pulse wave velocity. This was especially the 




Table 5.2 Differences in arterial stiffness variables and skin fold thickness between sexes 
Variables Sex Mean ± SD Sig Variables Sex Mean ± SD Sig 
Height 
(cm) 
Male 169.5 ±14.9 
** SEVR 
Male 158.26 ±26.1 
** 
Female 159.0 ±6.3 Female 126.36 ±22.7 
Weight 
(kg) 
Male 66.9 ±10.4 
** BP (mmHg) 
Male Systolic 121.1±9.9 ** 
Female 55.1 ±9.0 Female Systolic 110.5±0.9 
BMI 
(kg/m2) 
Male 22.7 ±2.6 
NS HR (bpm) 
Male 69.05 ±8.9 
** 
Female 21.8 ±3.1 Female 77.85 ±9.8 
Fat % 
Male 20.89 ±4.5 
** Waist (cm) 
Male 80.4 ±8.1 
** 
Female 31.31 ±3.8 Female 72.1 ±8.2 
PWV 
(m/s) 
Male 8.00 ±1.1 
NS Hip (cm) 
Male 95.3 ±7.4 
* 
Female 7.96 ±1.0 Female 92.15 ±6.4 
Aug P 
(mmHg) 
Male 1.23 ±2.4 
** Waist/Hip 
Male 0.84 ±0.1 
** 
Female 4.36 ±2.8 Female 0.77 ±0.1 
Aug Index 





Male 13.99 ±6.2 
 Female 15.88 ±8.7 Female Not measured 
Aug Index 
@75 





Male 9.77 ±10.5 
** 
Female 17.23 ±8.3 Female 16.84 ±8.8 
Aortic PP 
(mmHg) 





Male 14.30 ±4.8 
** 
Female 23.98 ±6.3 Female 20.73 ±9.4 
Aortic SP 
(mmHg) 





Male 22.79 ±8.8 
** 
Female 100.17 ±9.6 Female 34.57 ±8.0 
Aortic DP 
(mmHg) 





Male 17.18 ±7.2 
* 
Female 76.23 ±8.9 Female 14.77 ±4.8 
Mean P 
(mmHg) 





Male 26.34 ±10.7 
NS 









Male 21.47 ±9.9 
* 
Female 41.66 ±4.2 Female 18.70 ±5.9 
**Significant at p< 0.01  *Significant at p<0.05 NS- Not significant 
(BMI- Body Mass Index, PWV – Pulse Wave Velocity, SP- Systolic Pressure, DP- 
Diastolic Pressure, SEVR– Subendocardial Viability Ratio, HR- Heart Rate, Aug – 




The relationship between the adiposity and arterial stiffness variables are listed 
in table 5.3. Systolic pressure, augmentation pressure, augmentation index, 
augmentation index at 75% heart rate, aortic systolic pressure had statistically 
significant correlations with all three adiposity variables. There was no 
significant relationship found between fat percentage and body mass index with 
gender combined (table 5.3), but a significant relationship was established 
when the data were analysed separately (Table 5.4). Augmentation index had a 
significant negative correlation with height (r = -0.329, p= 0.0001). 
Table 5.3 Relationship between arterial stiffness measures and body fat percentage 
(correlations coefficients) 
Variables Fat Percentage Body Mass Index Waist Hip Ratio 
Pulse Wave Velocity .042 .025 .021 
Aug Pressure .306** .224** .325** 
Aug Index .210* .264** .274** 
Aug Index @75 .413** .217** .340** 
Aortic PP .274** .046 .055 
Aortic Systolic Pressure .256** .294** .269** 
Aortic Diastolic Pressure .095 .349** .270** 
Mean Pressure .167 .333** .271** 
Ejection Duration .540** .058 .203* 
SEVR -.514** -.031 .173 
Systolic Pressure .330** .309** .309** 
Diastolic Pressure .104 .345** .276** 
Heart Rate .461** .048 .152 
**Significant at p< 0.01   *Significant at p<0.05  
(SP- Systolic Pressure, DP- Diastolic Pressure, SEVR– Subendocardial Viability Ratio, 
Aug - Augmentation) 
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There were no significant correlations between fat percentage derived from 
skinfold thickness and any of the arterial stiffness variables in males.  Mean 
pressure and aortic systolic pressure had a significant correlation with waist hip 
ratio (WHR). The females’ adiposity variables had significant correlations with a 
greater number of arterial stiffness variables, including augmentation pressure, 
augmentation index and mean pressure. 














Fat Percentage  .607** .327*  .556** .250* 
Body Mass Index   .183   .382** 
Pulse Wave 
Velocity .160 .154 .054 .106 .100 .036 
Augmentation 
Pressure .001 .083 .241 .279** .214* .284** 
Aug Index .159 .222 .001 .320** .231* .165 
AugIndex@75 .011 .092 .239 .264 .202 .254* 
Aortic Pulse 
Pressure .088 .001 .182 .183 .094 .227* 
Aortic SP .019 .153 .349* .168 .302** .014 
Aortic DP .025 .147 .251 .315** .389** .135 
Mean Pressure .019 .158 .341* .254* .361** .069 
Ejection Duration .216 .203 .364* .193 .140 .090 
SEVR -.191 -.208 -.427** -.148 -.089 .119 
SP .002 .202 .352* .178 .308** -.013 
DP .023 .154 .234 .320** .378** .144 
Heart Rate .291* .206 .432** .156 .081 .114 
**Significant at p< 0.01        *Significant at p<0.05  
(SP- Systolic Pressure, DP- Diastolic Pressure, SEVR– Subendocardial Viability Ratio, 
Aug - Augmentation) 
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The participants who had higher physical activity scores had significantly less 
fat percentage.  However, the BMI had non-significant correlations and WHR 
had a positive correlation with physical activity (table 5.5). Most of the arterial 
stiffness variables had negative correlations with physical activity (table 5.5).  












0.123 -0.306** -0.375** 0.336** -0.309** -0.335** 0.126 
Aug Index 





-0.438** 0.242** 0.183* 0.211 0.093 -0.502** 0.207* 
Correlation coefficients **Significant at p< 0.01  *Significant at p<0.05 
(SEVR– Subendocardial Viability Ratio, Aug – Augmentation, BMI- Body Mass Index, 
WHR- Waist Hip Ratio) 
5.4. Discussion 
5.4.1. Influence of gender and physical characteristics 
Any discussion of correlation must take into account the contribution to the total 
variance. This study showed a number of significant correlations within the 
range of 0.3-0.5. it is recognised that the contribution to the total variance is low 
(9-25%), still leaving a large unaccounted variance. The following discussion 
recognise this limitation. 
The results show a strong relationship between adiposity derived from skinfold 
thickness and arterial stiffness derived from a less invasive carotid-radial pulse 
wave analysis. These results are similar to previous studies, which used similar 
and alternative methods. De Jongh et al (2006)  studied the relationship 
between visceral adiposity using magnetic resonance imaging, skinfold 
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thickness and post occlusive skin capillary recruitment using a vascular 
microscope. They found that vascular recruitment was inversely related to 
inflammation score, visceral adiposity and truncal/extremities skinfold thickness. 
Whincup et al (2005) studied the relationship between adiposity and arterial 
distensibility in adolescents. They measured the arterial distensibility using 
ultrasound and body fat using skinfold thickness, similar to the current study. 
They found a significant relationship between them in both sexes. There was a 
lower arterial distensibility in females in their study. Similarly, the females in the 
current study had higher arterial stiffness that includes ejection duration, pulse 
pressure and augmentation index. In agreement with these results, Yasmin and 
Brown (1999) also found higher augmentation index in females using a similar 
radial pulse wave analysis. These findings clearly show a need to have 
separate reference values for males and female. Yasmin and Brown (1999) also 
found a similar negative correlation between augmentation index and height. It 
confirms that there could be an earlier reflection of pulse waves in shorter 
people, which results in a lower augmentation index. It is also important to note 
that females also had a higher fat percentage as estimated by the measurement 
of the individual skinfold thickness of the biceps, triceps and thigh. The current 
study showed significant relationships between obesity (BMI and WHR) and 
arterial stiffness similar to Whincup et al’s (2005) study. However, the 
relationships were more significant in a number of variables in females (Table 
5.4). This may be due to the higher number of female participants. 
Nevertheless, the females had lower BMI compared with males yet their fat 
percentage was significantly higher. Several studies have found that Asians 
have higher fat percentage and in general, females have higher fat percentage 
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compared with their body mass index (Deurenberg-Yap et al. 2000; Wang et al. 
1994). It was suggested that it might be due to the difference in body type such 
as trunk/leg length in different ethnics and lifestyle factors (Deurenberg-Yap et 
al. 2000; Dudeja et al. 2001; Novotny et al. 2006; Wang et al. 1994). Thus, in 
the current study, the higher fat percentage may be the reason for the 
significant correlations found between more arterial stiffness variables and fat 
percentage in females. These findings suggest that fat percentage measured by 
skinfold thickness has more clinical importance than simple BMI measurements. 
5.4.2. Relationship between adiposity, insulin resistance/hyperinsulinaemia and 
arterial stiffness 
A possible mechanism for the positive relationship between adiposity and 
arterial stiffness is the increase in insulin resistance due to adiposity (Garg 
2004; Ross et al. 2002). Banerji et al (1999) found a strong correlation between 
insulin resistance and total body fat as well as regional and subcutaneous fat in 
Asian Indians. They state that visceral fat increases with total body fat and this 
results in increased insulin resistance. Urakawa et al (2003) observed a direct 
correlation between adiposity and oxidative stress. They state that adiposity 
increases the release of reactive oxygen species from leukocytes and thus 
increases the oxidative stress and leads to an increase in insulin resistance. 
Insulin resistance results in hyperinsulinaemia. Hyperinsulineamia leads to 
many following physiological reactions: (1) sodium retention due to increased 
sodium absorption in the renal circulation (DeFronzo et al. 1976; ter Maaten et 
al. 1999) (2) Previous studies have found that body fat is associated with over 
activity of autonomic nervous system especially sympathetic system at rest 
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(Chen et al. 2008; Scherrer et al. 1994). Hyperinsulinaemia is the main 
mechanism that triggers sympathetic activity (Vollenweider et al. 1993). This 
results in an increase in resting heart rate and blood pressure (Baba et al. 
2007). The positive relationship between heart rate, systolic blood pressure and 
fat percentage in the current results (table 5.4) confirms these findings. (3) 
Hyperinsulinaemia increases the mitogenic activities that lead to vascular 
smooth muscle proliferation, increased collagen synthesis in the vascular wall 
and vascular hypertrophy (DeFronzo and Ferrannini 1991; Draznin 2011; 
Zimlichman et al. 1995). In addition, adiponectin, a protein derived from 
adipocyte, act as a modulator for vascular smooth muscle proliferation (Arita et 
al. 2002). An increase in other inflammatory adipocytokines such as tumor 
necrosis factor-α, interlekin-6, leptin, plasminogen activator inhibitor-1, 
angiotensinogen, resistin and C-reactive protein (CRP)  also have negative 
impacts on vascular structure (Lau et al. 2005). All these mechanisms ultimately 
affect the endothelium dependant vasodilatation and increase vascular stiffness 
(DeFronzo and Ferrannini 1991; Kotchen 1999). 
Leptin was not measured in this study. Leptin is a protein, which regulates 
adiposity and increases in concentration when body fat percentage increases 
(Considine et al. 1996). Leptin is also found to be an important factor that 
increases sympathetic activity (Haynes et al. 1997). Singhal et al (2002) studied 
the relationship between leptin, body fat mass and arterial distensibility. They 
found the arterial distensibility had a negative relationship with leptin 
concentration in blood and body fat mass derived from skinfold thickness. This 
negative relationship was irrespective of other inflammatory markers such as C-
reactive protein, insulin and lipids.  
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Pulse wave velocity had significant positive relationship with body adiposity 
variables in many previous studies. Sutton-Tyrrell et al (2001) found a strong 
relationship between visceral adiposity measured by computed tomography and 
pulse wave velocity measure using Doppler flow signals on 2488 older adults 
with a mean age of 74 years. However, they found a weak correlation between 
pulse wave velocity and the subcutaneous fat (p=0.026). Wildman et al 
(Wildman et al. 2003) also found a strong positive relationship between Doppler 
measures carotid-femoral pulse wave velocity and BMI. However, the current 
study results did not show any significant relationship of pulse wave velocity 
with any adiposity variables.  Carotid-radial pulse wave velocity may therefore 
not be an early indicator of arterial stiffness in young Indian adults. This needs 
to be studied more to be confirmed.  
5.4.3. Physical activity 
The negative correlations between physical activity and fat percentage have 
been demonstrated in previous studies. Sakuragi et al (2009) found a negative 
relationship between cardiac fitness and arterial stiffness (using carotid-femoral 
pulse wave analysis) as well as adiposity. However, there was no correlation 
between physical activity and BMI in the current study. Controversially, there 
was positive correlation between physical activity and WHR. This may be due to 
the differences in the other lifestyle factors among the participants. Thus, 
skinfold thickness may be a more valid method to measure body fat. However, it 
is also important to consider the factors other than physical activity that 
influence obesity such as ethnicity, parental obesity, dietary pattern and 
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sedentary behaviours such as watching television (Gordon-Larsen et al. 2002; 
Maffeis et al. 1998; Salmon et al. 2000) 
To the investigators’ knowledge, this is the first study in India to establish the 
relationship between adiposity and non-invasive brachial-radial arterial stiffness. 
The agreement between the current findings and previous studies confirms that 
the non-invasive arterial stiffness could be a marker for cardiovascular risks in 
young adults. The increase in the prevalence of obesity is seen in all the age 
groups and continuously developing globally. The current findings could be 
helpful for future studies and for developing diagnostic and preventive 
measures for cardiovascular risk at younger age groups.  
5.4.4. Limitations 
A larger number of participants could improve the significance of the results. It 
was not possible to control the dietary pattern and physical activities in the 
participants and they had a wide range of these values. Measurement of blood 
lipids and inflammatory biomarkers such as leptin and C-reactive protein would 
have improved the correlations of arterial stiffness. It was not possible in this 
study due to limited availability of funds. 
5.5. Conclusions 
Arterial stiffness measured by carotid radial pulse wave analysis is strongly 
related to adiposity measured from skinfold thickness in young South Asian 
females. There are gender differences in arterial stiffness variables derived from 
pulse wave analysis. More controlled studies are necessary to improve the 
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quality of the results using this less intrusive technique, the carotid-radial pulse 
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CHAPTER 6.  REVIEW OF LITERATURE- ERECTILE DYSFUNCTION AND 
CARDIAC REHABILITATION 
Abstract 
Erectile dysfunction (ED) is identified as one of the markers of coronary artery 
disease (CAD) and is highly prevalent and increasing all over the world. There 
are strong physiological and pathophysiological relationships between 
cardiovascular and erectile functions. The prevalence of ED increases with age 
and is mainly caused by endothelial dysfunction that develops arterial stiffness. 
The treatment for ED is based on the level of cardiovascular risk. Medical 
therapy is available and oral phosphodiestrase-5 is one of the successful drugs 
in treating ED with a vascular cause. In addition to medical therapy, invasive 
therapies such as Intra-cavernosal/urethral injection therapy or 
vacuum/constrictive devices can be used. 
Modern cardiac rehabilitation/secondary prevention programmes (CR) are 
recognized as integral to the comprehensive care of patients with 
cardiovascular disease. CR programmes are known for reducing all cause 
mortality, hospital readmissions and recurrence of cardic events. Restoring 
complete sexual functions is one of the major goals for CR programmes. 
However, this part is not undertaken very often. The regular exercise in CR can 
reduce the cardiac work required for sexual activity. The cardiac rehabilitation 
programmes in the UK are infrequently studied for their effects on sexual 
functions. The improvement in the exercise capacity and its relationship with 
arterial stiffness and erectile functions need to be studied to establish effective 
treatment options.  
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6.1. Erectile dysfunction 
Erectile dysfunction (ED) is defined as an inability to attain or maintain erection 
sufficient for satisfactory sexual performance [National Institute of Health 
Consensus Development Programme (NIHCDP 1992) & The National Health 
and Social Life Survey (1992) (Laumann et al. 1999)]. These programmes 
addressed erectile dysfunction as the leading complaint and primary source of 
the patients attending sex clinics. Generally ED has a multifactorial 
pathophysiology that includes arterial, neurogenic, hormonal, cavernosal, 
iatrogenic and psychogenic aspects (Billups 2005b). This chapter discusses 
erectile function, its relationship with cardiovascular pathology and 
management. 
6.1.1. Erection and the heart 
There is a strong physiological and pathophysiological relationship between the 
heart and penis. Rajfer et al (2004) describe the penis as a specialised 
extension of the vascular system. Both heart and penis are midline structures 
having an intimate relationship with the peripheral vascular system. Vascular 
smooth muscles at the corpora of the penis have two cylinders of a syncytium, 
which look similar to myocardium. They both are regulated by the 
parasympathetic system, specifically the non-adrenergic, non-cholinergic 
system that uses nitric oxide as its neurotransmitter (Rajfer 2004). The 
regulation of blood flow through the peripheral vascular system is mainly 
influenced by the endothelium. This includes the cavernous arteries, which 
supply blood to the penis. This regulation is achieved by changing the arterial 




6.1.2. Erection physiology 
The penis is a richly vascularised organ (Billups 2005a), which consists of two 
corpus cavernosae and a ventral corpus spongiosum that surrounds the 
urethra. These are expandable tissues, composed of a meshwork of 
endothelium lined, interconnected smooth muscle cells (Bivalacqua et al. 2003). 
They are expanded with an influx of blood in the penile chambers. The dorsal 
and cavernosal artery supplies the corpus cavernosae. The venous blood 
returns in the subtunincal venular plexus, the deep dorsal vein and others. It 
needs a simultaneous action of psychological, hormonal, vascular and 
neurological agents to optimize male sexual function (Schwarz and Rodriguez 
2005). However, erection is considered primarily a vascular function. Following 
sexual stimulation the NO pathway is activated and NO is released in the penile 
smooth muscle from i) enzyme endothelial nitric oxide synthase (eNOS) from 
endothelial cells lining the cavernosal smooth muscle cells and resistance 
helican arteries in response to sheer stress, ii) agonist induced activation by 
acetylcholine release from cholinergic nerves and iii) neuronal NOS (nNOS) 
activity in non adrenergic non cholinergic (NANC) neurons. NO diffuses to the 
adjacent smooth muscle cells and activates guanylyl cyclise. This converts 
guanosine triphosphate into a second messenger, cyclic guanosine 
monophosphate (cGMP) and induces substantial intracellular cGMP (Schwarz 
and Rodriguez 2005). It results in smooth muscle relaxation and increased 
blood flow in the penile arteries. The cGMP induced trabecular smooth muscle 
relaxation facilitates the engorgement of the sinusoidal spaces, lengthening and 
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enlargement of the penis and compression of subtunical venules (Billups 
2005b). Eventually it results in complete occlusion of penile venous outflow and 
trapping of blood within the corpus cavernosae. It leads to the stasis of more 
blood in the penis and a harder erection. Erection is enhanced by various 
factors like vasodilatation due to nitric acid, radiation of blood flow from the 
internal pudental artery into penile chambers, physical senses and psychogenic 
factors. Importantly, the continuous activation and production of eNOS 
maintains the tumescence phase of penile erection (Bivalacqua et al. 2003; 
Billups 2005b; Billups 2005a; Schwarz and Rodriguez 2005). 
6.1.3. Prevalence of erectile dysfunction 
Erectile dysfunction is highly prevalent worldwide. It was estimated that 100 
million men were affected world wide by 1993 (NIHCDH 1993) and 140 million 
by 2006 [The second Princeton Consensus (Jackson 2006)].  Further it is 
expected that this condition will more than double in the next 25 years, 
ultimately affecting more than 330 million men worldwide (Goldstein 2000). 
A number of studies have been carried out and the prevalence of ED has been 
stated in various populations. An estimation of the prevalence is presented in fig 
6.2 (Goldstein 2000). A community based multidisciplinary study on 
Massachusetts males showed that the combined prevalence of minimal, 
moderate and complete erectile dysfunction. There were 52% of men with ED in 
the age group of 40 to 70. Moreover the prevalence of complete erectile 





Figure 6.1 Impact of age on erectile dysfucntion 
Age shows a strong impact on erectile dysfunction (1.0 = 100% probability). Goldstein 
(2000) estimated in his study that ED affects about 40% of men over age 40 and up to 
70% of men over 70 years old (Scientific American, 2000). 
Laumann et al (1999) analysed the data of 1410 men aged between 18 to 59 
years from the National Health and Social Life Survey in the United States. 
They found that the prevalence of sexual dysfunction was 31% in men and the 
ages 52-59 years were likely to experience ED more than three times greater in 
comparison to men aged 18-29 years. Bacon et al (2003) reviewed 
observational studies and found a strong relationship between erectile 
dysfunction and aging. They carried out the largest study to date which 
observed 31,742 various health professional men between 53 and 90 years. 
They found that the relative risk for erectile dysfunction increased up to 10-fold 
with age, regardless of health status or previous erectile function. There was 
32% prevalence of ED among men older than 50 years of age. The co-morbid 
conditions increased the absolute risk for erectile dysfunction, approximately 
10% higher at all ages for co-morbid men compared with healthy men. Lewis et 
al (2004) reviewed 24 studies undertaken from 1993 to 2003 around the world 
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and listed the prevalence of ED. The prevalence of ED was 1-9 % for those 
below 40 years, 2-30% for those aged 40-59 years, 20-40% for those aged 60-
69 years and 50-75% for those aged above 70 years. Gazzaruso et al (2004) 
found in their study that ED had increased fourfold in men aged 70 years 
compared with the men aged less than 50 years. These findings clearly show 
that age has strong associations with the prevalence of ED. The estimated 
prevalence of ED has a considerable variation because of various populations 
studied and the definition and methods used (Rosen et al. 1999).  
6.1.4. ED and coronary artery diseases (CAD) 
According to ‘the global burden of disease study’, ischemic heart disease was 
the fifth most common cause of disability in 1990 worldwide and by the year 
2020, it is expected to be the leading cause of global disability (Murray et al. 
1994; Lopez and Murray 1998; MacLean and Chockalingam 1999). The latest 
statistics shows that in the UK, heart and circulatory disease is the biggest killer 
and it claims 200,000 lives every year. Every year 146,000 people suffer a heart 
attack and every 6 min someone dies from a heart attack. There are 1.4 million 
people over 35 years in the UK who have survived a heart attack and there are 




Figure 6.2 The range of causes of erectile dysfunction 
Though ED is associated with various causes, mainly it is a vascular condition. The figure 
shows the various causes of ED and their percentage of incidence (Goldstein 2000). 
It has been widely accepted that ED is primarily caused by underlying vascular 
diseases especially atherosclerosis (Billups 2005b). The range of causes and 
percentage of incidence is shown in fig.6.2 .Vascular ED and coronary artery 
diseases share common risk factors such as a sedentary life style, obesity, 
heavy drinking, recreational drug use, high plasma cholesterol and triglycerides 
levels and smoking (Barrett-Connor 2005; Burnett 2006). These risk factors 
damage the endothelium and it affects the coronary arteries as well as the 
arteries throughout the body inclusive of the corpus cavernosum of the penis 
(Kaya et al. 2006).  
ED is strongly associated with micro albuminuria, which suggests that there is a 
strong link between ED, CAD and endothelial dysfunction (Gazzaruso et al. 
2004). Greenstein et al (1997) studied the relationship between the severity of 
coronary artery disease and erectile function on men who underwent an 
angiogram for cardiac disease. They evaluated the severity of the CAD by the 
number of occluded arteries, the level of anginal syndrome and whether or not 
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the patient had experienced an MI. The results showed that severity of the 
cardiac disease had worsened the erectile dysfunction. The associated risks 
like age, diabetes and hypertension also had further negative effects on the 
quality of an erection.  
6.1.5. Pathophysiology of ED with vascular cause 
For decades, the reduction in sexual function has been considered as a part of 
the natural aging process, it really involves a number of disease processes 
leading to abnormal erectile function with age (Bivalacqua et al. 2003). The 
ageing penile vascular artery undergoes characteristic changes involving the 
arterial and vascular beds. It includes endothelial dysfunction. Billups (2005b) 
strongly suggests to consider endothelial dysfunction as a central aetiological 
factor in systemic and peripheral vascular disease. 
6.1.5.1. Endothelial dysfunction 
Vascular endothelium serves as a barrier for the arterial and venous blood. It 
also plays a pivotal role in modulating vascular tone and blood flow as the 
response to humoral, neural and mechanical stimuli. These stimuli also play a 
role in the regulation of inflammation, platelet aggregation, vascular smooth 
muscle proliferation and thrombosis (Bivalacqua et al. 2003). 
Endothelial dysfunction is defined as a functional deterioration of endothelium 
characterized by vasospasm, vasoconstriction, alteration in coagulation 
mechanisms and fibrinolysis, and increased vascular proliferation (Kaya et al. 
2006). The primary underlying mechanisms are elevated vasoconstrictor tone 
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and decreased endothelial and neurogenic endothelial relaxation of the penile 
vascular artery. These are considered to be due to the reduced NO 
biosynthesis and reduced enzyme activity of eNOS in the aged penile 
vasculature. There is also a lack of substrate or co factors for eNOS. There is 
an alteration in intra cellular signalling such that eNOS is not appropriately 
activated or uncoupled or accelerated degradation of NO by reactine oxygen 
species (ROS). Oxidation stress in particular, the reaction of NO and a 
superoxide anion is an important pathogenic element in the development of 
endothelial dysfunction in vascular diseases such as diabetes mellitus (DM), 
hypertension, atherosclerosis and hypercholesterolaemia. These vascular 
disorders are highly prevalent in patients with ED and have been identified as 
independent risk factors for ED in large population based studies (Bivalacqua et 
al. 2003). The prevalence of ED in DM is three times higher in men, occurs at 
an earlier age and increase with disease duration (De Tejada et al. 2005). The 
enhancement of oxygen free radicals including advanced glycosylatin end 
products (AGE) in diabetes impairs the endothelium dependent relaxation in the 
aorta and corpus cavernosae. There is a diminished effect of released NO. In 
diabetes, there is a significant reduction of endothelial dependant vascular 
relaxation in the penile resistant arteries which is mediated by the endothelium 
derived hyperpolarizing factor (EDHF) (De Tejada et al. 2005). The changes in 
the neural integrity of the cavernosal nerve and pelvic plexus also play a role in 
the overall reduction of endothelial cell function (Bivalacqua et al. 2003). 
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6.1.5.2. Drug induced ED  
A medical treatment or examination that unintentionally results in an illness as a 
complication is called an iatrogenic cause. There are iatrogenic causes of ED 
from some common drugs used to treat cardiac diseases. In fact, drugs are one 
of the major causes of ED in up to 25% of patients attending an ED clinic 
(Eardley and Sethia, 2003). Some antihypertensive drugs, like diuretics and β 
blockers are highly associated with ED. Collectively, an antihypertensive agent 
that reduces the systemic pressure results in a reduction in pelvic pressure 
gradient. Eventually it worsens the vascular function and exacerbates erectile 
dysfunction (De Tejada et al. 2005; Burnett 2006). A list of drugs and their 
effects on sexual function are given in table 6.1.  
Table 6.1 Drugs that may cause ED 























Beta  blockers 






















ED, loss of libido, ejaculatory disfunction 
ED 
Retrograde ejaculation and priapism 
 
ejaculatory disfunction 
ED, loss of libido, ejaculatory disfunction 
and priapism 
ED and painful ejaculation 
 
ED and loss of libido 
ED and loss of libido 





ED and loss of libido 
ED 
ED and loss of libido 
ED and loss of libido 
(Eardley and Sethia 2003) 
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6.1.6. ED as a predictor of CAD 
It has been found that endothelial dysfunction precedes the development of 
atherosclerotic changes in the arteries. The small vessels of the penis are very 
sensitive to functional and structural changes (Kaya et al. 2006) and they are 
more prone to develop atherosclerotic occlusion compared with the larger 
vessels of the other parts of the body (Kirby et al. 2001). 
Recent studies demonstrated that damage to the penile vascular beds occurs 
earlier than systemic vascular illness. Sixty seven percent of patients, having 
CAD with ED reported that symptoms of ED began before CAD symptoms in a 
mean time interval of at least three years. The severity of ED correlates with the 
severity of CAD and thus may be a useful indicator CAD (Kaya et al. 2006). 
In the presence of ED with other cardiovascular risk factors, the prevalence of 
coronary artery diseases is higher. Gazzaruso et al (2004) found a strong and 
independent association between ED and silent CAD. They studied diabetic 
men with and without ED and found that ED was the most efficient predictor of 
coronary vascular disease. The presence of ED was as high as eight fold in the 
patients with silent CAD compared with the others. Even the uncomplicated 
diabetic patients, with no silent CAD, also had a similar presence of ED.  
Bluementals et al (2003) studied 25,650 males with and without ED. They found 
ED as a marker for peripheral vascular disease and the risk became more 
pronounced with increase in age. Hodges et al (2007) found in their study 
population that 43% of healthy subjects had ED. Sixty six percent of subjects 
had ED prior to CVD and 79% of subjects had ED after CVD. 
155 
 
C-reactive protein (CRP) is a marker for endothelial function. Billups et al., 
(2003) studied the relationship between C-reactive protein and cardiovascular 
risks in men with ED but not clinically established coronary artery disease. They 
found that CRP was significantly associated with increase in severity of ED. 
Inman et al (2009) studied biennially 1400 community dwelling men who had 
regular sex partners and without known CAD for the presence of ED. The 
results showed that the younger men (50-59 years) with ED had marked 
increase in the risk of future cardiac events than the older men (60-69 years). In 
older men, ED appears to be of little prognostic importance.  
6.1.7. ED and Quality of Life (QoL) 
QoL is defined as “individuals’ perception of their position in life in the context of 
the culture and value systems in which they live in relation to their goals, 
expectations, standards and concerns”. It is a broad ranging concept affected in 
a complex way by the person’s physical health, psychological state, level of 
independence, social relationships and their relationships to salient features of 
their environment (WHO 1996). The relevance of its dimensions on a person’s 
life depends on how the individual perceives them (Mallis et al. 2006). 
Sexual dysfunction is an important component of a patient’s QoL and subjective 
wellbeing. Studies have shown that ED has a significant negative effect on QoL 
of not only the person with ED but also his partner and family (Mallis et al. 
2006). Men with ED showed lower satisfaction with sexual life as well as their 
overall life compared with healthy individuals. In addition, severity of ED had a 
stronger negative effect on patients’ satisfaction with sexual life (Mallis et al. 
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2006). Litwin et al (1998) studied the effect of ED on health related QOL using 
the SF-36 questionnaire. The results showed that the emotional domains were 
associated with more profound impairment than physical domains. Many other 
studies also accepted that ED affects the psychological aspects of the patient 
more.  Laumann et al (1999) stated that ED affects individuals’ mood and 
interpersonal functioning. Hatzichristtou et al (2005) stated that the association 
of ED and CAD was mediated by the psychological impact of both disorders. It 
commonly leads to a depressive status and clinical depression. 
6.1.8. Management of ED 
The second Princeton Consensus (Kostis et al. 2005) divided patients with ED 
according to their level of cardiac risks.  
Low risk: 
 Asymptomatic, less than three cardiovascular risk factors 
 Controlled hypertension 
 Mild, stable angina pectoris 
 Post revascularisation 
 Post myocardial infarction (MI) (6 to 8 weeks) 
 Mild vascular disease 





 Unstable or refractory angina 
 Uncontrolled hypertension 
 Congestive heart failure (NYHA class III or IV) 
 Recent MI (2 weeks) 
 High-risk arrhythmia 
 Obstructive hypertrophic cardiomyopathy 
 Moderate to severe valvular disease 
Intermediate risk factors: 
 Asymptomatic, >3 risk factors 
 Moderate, stable angina pectoris 
 History of MI ( 2 weeks,  6 weeks) 
 Left ventricular dysfunction (or) congestive cardiac failure  
 (NYHA class II) 
 Non-cardiac sequel of atherosclerotic disease 
Further, the consensus has derived an algorithm for risk stratification and 
patient management in three steps. 
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Step 1: Sexual function should be assessed at the initial level of cardiovascular 
evaluation. Based on the initial evaluation, the patients are assigned a level of 
risk following specialised tests if necessary. 
Step 2: Low risk patients may safely engage in sexual activity with or without 
treatment for ED. High risk patients should be stabilised by specific 
cardiovascular interventions before engaging in sexual activity is considered, or 
specific interventions of ED is recommended. The patients should be regularly 
followed up and reassessed.  
Step 3: The patients with ED should be routinely evaluated for cardiovascular 
risks. The patients should be discussed on monitoring, evaluating and 
improving the risk and subclinical cardiovascular disease risks 
Various treatment options are available for erectile dysfunction. The second 
international consultation on erectile dysfunction (Wyllie 2003) recommends 
letting the patient decide the most appropriate treatment.  
6.1.8.1. Medical therapy 
Reversible conditions that cause erectile dysfunction are considered for medical 
therapy (NIHCDP 1992). Amongst oral therapy, phosphodiesterase-5 (PDE) 
inhibitors have been proven effective in the treatment of ED with minimal or no 
side effects for people with cardiac disease. The cyclic guanosine 
monophosphate (cGMP) enzyme levels are regulated by cGMP specific 
phasphodiestrase. The inhibitors of these enzymes increase cGMP 
concentrations at the level of the endothelium. It enhances the smooth muscle 
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relaxation and the inflow of arterial blood into the corpus cavernosum. Sildenefil 
was the first oral phosphodiestrase-5 (PDE-5) inhibitor for the treatment of men 
with ED. Originally it was developed and studied as an anti-anginal agent. Very 
positive clinical results on erectile function were due to the effects on cGMP 
levels and increased intracavernosal smooth muscle relaxation. Sildenefil is the 
most thoroughly studied PDE-5 agent in the class and has been proven safe for 
men with cardiovascular risk. It has been successful even in patients taking 
diuretics and beta-blockers. However, a pre evaluation is necessary for any 
additional risk such as the use of nitrates (Billups 2005a; Shigemura et al. 
2006). A marked hypotension results from the usage of nitrates and sildenafil 
also has a hypotensive effect (Mahmud et al. 2001). Vardanafil is a highly 
selective PDE-5 inhibitor, which has been another effective oral treatment for 
ED. Vardanafil increased the ischemic threshold during exercise and increased 
the ability to undergo exercise for a longer period. This increased exercise 
tolerance level was more than the normal required level to complete sexual 
activity (Thadani et al. 2002). The alpha-adrenergic receptor antagonist also 
facilitates erection when administered orally. These alpha-blockers antagonize 
the activity of nor-epinephrine and attenuate the contractile response opposing 
the NO mediated smooth muscle relaxation. An important fundamental issue in 
these orally administered PDE-5 inhibitors is that the efficacy of these agents 
depends on the associated sexual stimulation (Lue and Lee 2000). 
If a trial of oral therapy fails, then it is usual to proceed to invasive therapies. 
Intra-cavernosal and intra-urethral injection therapy are available such as 
papavarine hydrochloride and alpha-adrenergic receptor antagonist. These 
agents are effective in increasing the intra cavernosal blood flow and activation 
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of veno-occlusive mechanism (Lue and Lee 2000). These are successful for 
many patients and careful consideration for contraindication and effectiveness 
with individuals is recommended. Alternatively, vacuum/constrictive devices are 
effective at generating and maintaining an erection with low incidence of side 
effects. However, there is a significant rate of patient drop out for many reasons 
including a lack of spontaneity between partners, general discomfort and 
impaired ejaculation. There are surgical treatments also available. Patients with 
venous leakage have been treated effectively with venous legation surgery. 
There are three forms of penile prosthesis available, which could be used when 
other forms of therapy failed or were refused by the patients. They are semi 
rigid, malleable and inflatable. Their effectiveness, complication and 
acceptability vary and the main problems identified are mechanical failure 
requiring reoperation and infection (NIHCDP 1992). Many of the patients are 
reluctant to take any further specific treatment of ED due to several reasons 
such as advanced age, organic and psychological diseases, problems in the 
relationships, lack of information and the fear of complications (Maroto-Montero 
et al. 2008).  
A multidisciplinary approach may be of great benefit in defining the problem and 
arriving at a solution (NIHCDP 1992). Cardiac rehabilitation (CR) is one such 
programme that is a well established for cardiovascular risk patients. 
6.2. Cardiac Rehabilitation (CR) 
Among surviving patients after a myocardial infarction (MI), only a quarter of 
them experience improvements, another quarter experience deterioration and 
the remaining half experience no change in their life (Thompson and Bowman 
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1998). A structured care for chronic cardiac disease management can improve 
the outcome for people with risk factors (Dalal et al. 2004). CR programmes 
were developed in 1960 as an exercise-based therapeutic management. 
Despite the effectiveness of them, the evaluations of the programme required 
attention to various components other than exercise (Jones and West 1995). 
Balady et al (2007) suggest cardiac rehabilitation programmes do not consist of 
exercise training alone, but they are actually a multifaceted and multidisciplinary 
approach to overall cardiovascular risk reduction. The National Service 
Framework for Coronary Heart Disease (NSF 2000) recognized CR as an 
effective multidisciplinary approach with a combination of exercise, medical, 
psychological and educational interventions (Lau-Walker 2004). 
Modern cardiac rehabilitation/secondary prevention programmes are 
recognized as integral to the comprehensive care of patients with 
cardiovascular disease (Balady et al. 2007). The World Health Organization 
defines CR as “the sum of activities required to influence favourably the 
underlying cause of the disease as well as the best possible physical, mental 
and social conditions, so that they may, by their own efforts preserve or resume 
when lost, as normal a place as possible in the community” (Coats et al. 1995). 
According to the American Heart Association, the core components of cardiac 
rehabilitation/secondary prevention programmes are patient assessment, 
nutritional counselling, blood pressure management, lipid management, 
diabetes management, tobacco cessation, psychosocial management, physical 
activity counselling, and exercise training (Balady et al. 2007).  
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The target groups for CR are acute coronary syndromes, post 
revascularizations, stable angina, chronic heart failure, cardiac transplantations, 
valve surgeries, congenital heart diseases, implanted cardioverter defibrillators 
(Coats et al. 1995; Thow 2006) 
6.2.1. Phase of cardiac rehabilitation 
In the UK, cardiac rehabilitation is divided into four phases, progressing from 
the acute hospital admission stage to long-term maintenance of lifestyle 
changes, as follows (Thow 2006): 
 Phase I – in-patient period or after a ‘step change’ in cardiac condition 
 Phase II – early post-discharge 
 Phase III – supervised out-patient programme including structured 
exercise 
 Phase IV – long-term maintenance of exercise and other lifestyle 
changes 
The British Association of Cardiac Rehabilitation (BACR) and Scottish 
Intercollegiate Guidelines Network (SIGN) have published guidelines for cardiac 
rehabilitation programmes (Coats et al. 1995; SIGN 2002). 
Phase I 
It is the first stage of the patient’s cardiac rehabilitation pathway. It either starts 
as an in-patient stage, or after a ‘step change’ in the patient’s cardiac condition. 
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These step changes include myocardial infarction, onset of angina, any 
emergency hospital admission for coronary heart disease, cardiac surgery or 
angioplasty and/or stent, and first diagnosis of heart failure. Patients with any 
age are included and there is no specific exclusion to phase I. The participants 
are visited in the coronary care unit or ward by the CR team members.  The 
partner or family are also included in this phase. Reassurance, 
information/education, mobilization and discharge planning are included in the 
phase I.  
The education component adhering to adult education principles including: 
 Relevance (tailored to patients’ knowledge, beliefs and circumstances) 
 Feedback (informed regarding progress with learning or change) 
 Individualisation (tailored to personal needs) 
 Facilitation (provided with means to take action and/or reduce barriers) 
 Reinforcement (reward for progress).  
 
Phase I CR includes educational advice regarding: 
 Risk factors (modifiable and non-modifiable) 
 Living with CHD 
 Anatomy and physiology of the heart 
 Clinical management of CHD 
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 Cardio-protective diet 
 Sensible alcohol use 
 The benefits of exercise 
 Cardiac misconceptions 
 Return to driving, employment and hobbies 
 Holiday advice 
 Medications 
 Psychological aspects of CHD and stress management 
 Sexual activity 
 Sleep 
To achieve these needs, an individual assessment is carried out by considering 
the patients personal requirements and risk factors. The assessment includes 
family/personal history, risk factor assessment, prognostic evaluation, risk 
stratification, psychosocial status, socio-economic status, vocational/leisure 
activities. Then, a tailored plan is produced for every individual to achieve the 
above goals. On average, the patients stay 5-7 days in the hospital, but that 
varies with the diagnosis and the treatment. On discharge, patients are offered 
the following as an integral part of acute care: 
 Assessment of physical, psychological and social needs for future CR 
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 Negotiation of a written individual plan for meeting these needs 
 Prescription of effective medication, and education about its use, benefits 
and side effects 
 Involvement of relevant informal carer(s) 
 Provision of information about cardiac support groups 
 Provision of locally relevant, written information about CR 
(Coats et al. 1995; SIGN 2002) 
The BACR guidelines (Coats et al. 1995) recommend that patients receive a 
programme of graduated mobilisation and exercises, so that by discharge time 
the patient is ambulant, able to climb stairs and attend to his or her own 
activities of daily living. 
Phase II 
This is the initial post-discharge stage and is of low intensity. After discharge, 
the patient may feel isolated, insecure, and anxious. Access to appropriate 
health care professionals is important in this period. With an involvement of 
primary care, the CR team may give care through phone or by home visits, 
depending on the available service. The modification of risk factors start at this 






Phase III is a well recognised, hospital based, outpatient education programme 
including structured exercise training sessions. Structured community 
programmes are also delivered safely and successfully.  The risk factor 
modification and education are continued as established in phase I and II. The 
tailored approach for every individual is continued with monitoring and 
reassessing the identified risk factors and lifestyle. A multi-factorial risk factor 
modification as appropriate to each patient is emphasised. The outcomes are 
continuously reviewed, audited and modified appropriately. The involvements of 
partner/family/friends are important also in this phase. The patients are 
examined for risk stratification prior to exercise classes. Generally group 
exercises with aerobic circuit interval training are found effective and used in the 
CR programmes in the UK (SIGN 2002). Resistance exercises are also used 
depending on the patients’ fitness and improvement. Patients are taught home-
based exercises and self-monitoring skills to continue the rehabilitation at home. 
Every exercise training session consists of a warm-up, an aerobic conditioning 
phase and a cool-down period. It is important that the exercise programmes is 
tailored for each patient’s needs and circumstances to encourage adherence to 
exercise (Thow 2006). 
Phase IV 
Phase IV focuses on the long-term goals of risk factor modification, with long-
term follow-up in primary care. These are important for the sustained benefits 
achieved from the previous phases (SIGN 2002). It is an informal stage of CR 
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and primary health care teams take care of the individual goals that are set in 
the previous phases, outside the hospital setting (Coats et al. 1995). Patients 
are informed of the exact nature of the follow-up systems available. Patients are 
encouraged, on a formal or informal basis, to continue and progress appropriate 
physical activities. It is to ensure that the patients have appreciated their 
exercise abilities and learnt appropriate self monitoring techniques (Thow 
2006). 
6.2.2. Benefits of cardiac rehabilitation 
There is an increasing appreciation of the value of a rehabilitation programme in 
helping patients back to normal or near normal life after a cardiac event (Song 
and Lee 2001). After myocardial infarction, approximately one-third of the 
patients undergoing cardiac rehabilitation have regained their quality of life in 
100 days. Cardiac rehabilitation programmes reduces the readmissions to 
hospital and recurrence of cardiac events (Thompson and Bowman 1998).  
6.2.2.1. Effects of exercise in cardiac rehabilitation 
There have been several studies that revealed the physiological effects of 
exercise within cardiac rehabilitation. CR improves haemostasis, endothelial 
function and arterial blood pressure in patients with CAD (Lee et al. 2006). 
Exercise training has been shown to modify the sympathovagal control of the 
heart towards an increase in parasympathetic tone. It is considered that the rise 
in heart rate during exercise is related to the combination of parasympathetic 
withdrawal and sympathetic activation. The fall in heart rate immediately after 
exercise might result from reactivation of the parasympathetic nervous system. 
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Increased vagal activity, on the other hand, is associated with reduced risk of 
death from cardiac-related causes (Tiukinhoy et al. 2003). Dalal et al (2004) 
also stated that exercise-based cardiac rehabilitation after myocardial infarction 
has been shown to reduce all cause mortality. Moreover, findings from the 
previous meta-analysis show that rehabilitation with exercise after MI 
significantly reduced the total and cardiac mortality at various follow up 
durations from one to three years (Thompson and Bowman 1998).  
6.2.2.1.1. Duration of CR 
Different durations have been observed in various CR programmes. Hevey et al 
(2003) conducted a study to evaluate the effectiveness of a 4-week 
multifactorial CR programme compared with a standard 10-week CR 
programme on quality of life and exercise capacity. He found that exercise 
capacity, general health and quality of life dimensions (e.g., energy, pain, 
emotional well-being, social wellbeing, and general health) were significantly 
improved, irrespective of the duration of the cardiac rehabilitation programmes. 
Systematic reviews have suggested that longer programmes are associated 
with better outcomes. However, shorter programmes may still represent a 
valuable CR service option. 
6.2.2.1.2. Age and CR 
Marchionni et al (2003) found that the extent of the improvement by cardiac 
rehabilitation was independent of age. They studied the effects of a cardiac 
rehabilitation programme on different age groups varying from 45 to above 75 
years. They found that the total work capacity and the health related quality of 
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life improved in all the age groups. They also compared the hospital based CR 
with home-based CR and found both of them similarly effective in the short 
term. Rajeski et al (2002) studied the effects of CR in elderly patients. They 
compared the effects of two different approaches to cardiac rehabilitation on 
performance-related and self-reported measures of physical function on three 
months of treatment. The interventions compared were a group-mediated 
cognitive-behavioural intervention for physical activity and a traditional exercise 
therapy programme. Overall, both treatment groups experienced statistically 
significant improvements in performance-related and self-reported physical 
function. However, the organized physical activity, coupled with group-mediated 
cognitive behavioural counselling achieved a better short-term benefit in older 
patients with lower physical function and the greatest risk for subsequent 
morbidity and mortality. 
Lavie and Milani (2000) compared the effects of CR in the elderly with young 
people and demonstrated the disparate effects on improvements in aerobic 
exercise capacity and QoL. They found that the elderly had significant 
improvements with relatively smaller improvements in measures of aerobic 
exercise capacity including estimated metabolic equivalents, anaerobic 
threshold and peak VO2. However, they had greater improvements in both total 
function scores and QoL scores after cardiac rehabilitation programmes, 
compared with younger patients.  
170 
 
6.2.2.2. Effects of cardiac rehabilitation on sexual function 
The peripheral effects are improvement in muscle structure and function. These 
central and peripheral effects together improve the functional capacity and 
quality of life (Mustata et al. 2004). The energy expenditure in men for sexual 
activity that includes stimulation and orgasm is 2-METs (metabolic equivalents) 
for woman-on-top coitus and 3.5-METs for men-on-top coitus. There are 
significant individual variations that range from 2-METs to 5.4-METs. This 
energy expenditure is equivalent to the intensity of walking a kilometre in 15 
minutes or to climbing up a flight of stairs in 10 seconds. Based on these, a 
functional capacity of 6-METs attained on exercise stress testing provides 
sufficient margin of safety (Sainz et al. 2004). Exercise training in cardiac 
rehabilitation could achieve this required functional capacity for sexual 
intercourse. Mickley et al (2000) also suggest that the improvement in the 
physical activity and self confidence following cardiac rehabilitation could help 
the patients to resume sexual activity. The performance of an exercise test at 
the time of discharge should be mandatory for risk stratification. The patients 
who can manage a work capacity of at least 100 watt without evidence of 
myocardial ischaemia or arrhythmia may take part in an active sexual life 
without concerns. Muller et al (1996) suggest that physicians should strongly 
encourage patients with known coronary artery disease to participate in a CR 
programme and perform regular exercise. Such exercise can reduce the cardiac 
work required for sexual activity and reduce the risk of triggering the onset of an 
MI.   
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Successful risk factor modification and the maintenance of a healthy lifestyle 
with regular physical activities is a lifelong process (Balady et al. 2007). Chronic 
heart diseases are attributable to unhealthy life styles and the psychological 
effect of coping with and recovering fully from myocardial infarction is great. 
Lifestyles have received increasing attention because many health conditions 
and premature deaths are preventable through modification in lifestyles (Song 
and Lee 2001). As a part of a Massachusetts male aging study, Derby et al 
(2000) studied 593 men without ED at baseline and followed them up for 8.8 
years. They found the lowest risk for ED was among individuals who had a 
sedentary lifestyle at baseline and then became physically active during the 
course of the study. The highest risk for ED was among men who were 
sedentary at both the baseline visit and at follow-up. It was also found that 
physical activity, increased physical activity, leanness, moderate alcohol 
consumption and not smoking were associated with decreased risk of ED 
(Bacon et al. 2003). 
6.2.2.3. Quality of life and sexual function 
Sexual problems are widespread and adversely affect mood, well-being and 
interpersonal function. It is an important component of quality of life in cardiac 
patients (Tuniz et al. 2004). Improvement in the quality of life (QoL) is one of the 
potential major goals of CR programmes. These programmes not only aim to 
increase the life span but also try to help the patients to live better. Song and 
Lee (2001) examined the relationship between exercise and a healthy lifestyle 
by focusing on the role of motivation as an intervening factor. They examined 
the effects of a 12-week exercise programme on the motivation and 
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performance of a healthy lifestyle among persons who were recovering from 
coronary artery disease and confirmed that motivational variables were 
modifiable. The findings of the study partially support the positive effects of a 
12-week exercise programme on the performance of a healthy lifestyle. It 
significantly supported the effects on motivation after controlling for income, 
education, and pre-test scores. Thus, when developing health promotion 
programmes for initiating and maintaining a healthy lifestyle, the relative 
importance of different motivational variables should be considered. To the 
investigators’ knowledge, there have been no studies carried out to see 
changes in erectile dysfunction related quality of life in cardiac rehabilitation. 
6.2.2.4. Family and Cardiac Rehabilitation 
Comprehensive cardiac rehabilitation programmes tend to provide a range of 
services to support family members. Possibly the most compelling reason for 
cardiac rehabilitation is the prospect of improving health-related quality of life, 
not only for the patient, but also for the family (Thompson and Bowman 1998). 
The cardiologists and the team members could help almost all the patients in 
enhancing emotional well being and overall quality of life including sexual 
function as there are only a few patients have specific cardiac reasons that limit 
their sexual activity  (Taylor 1999).   
Sexual activity that was affected by a myocardial infarction can be a source of 
anxiety and fear. There is usually a temporary reduction in sexual activity and 
satisfaction but a substantial minority seem to experience a long-term 
deleterious effect on their sexual relationship. The reduction in sexual activity 
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and consequent dissatisfaction is mostly as a consequence of the spouses’ or 
the patients’ fear of a recurrent myocardial infarction. The relative risk of an MI 
in the two hours following sexual activity is 0.9% in patients with prior cardiac 
disease. Regular exercise can reduce and possibly eliminate the small risk of 
recurrence of MI associated with sexual activity. The annual risk of MI due to 
sexual activity is very low compared with the other potential risks such as anger 
and exertion. The frequency of sexual activity is less than the frequency of the 
other risks in patients with MI (Muller et al. 1996). 
Gunzler et al (2007) found a significantly decreased partnership quality in 
patients with sexual dysfunction in cardiac rehabilitation programme. Concern 
about the return to sexual activity and the impact of the illness upon spouse and 
other members are some of the major issues that need discussion and 
counselling (Song and Lee 2001). Restoring normal sexual function is one of 
the primary goals of cardiac rehabilitation.  Hood and Robertson (2004) state 
that cardiac rehabilitation programmes are ideally placed to enquire about 
symptoms of ED and to initiate treatment. Tuniz et al (2004) suggest that it is 
extremely important to face the problem of resuming the sexual activity 
systematically within the cardiac rehabilitation programme, with educational 
sessions, individual or couple conversations and with the aid of information 
pamphlets.  
Very few studies have been carried out with a focus on sexual function in 
patients with cardiac rehabilitation. Klein et al (2007) added a sexual therapy 
that included patient education, cognitive restructuring, emotional support, 
guided imaginary and specific medication with regular cardiac rehabilitation in 
174 
 
Israel. The sexual therapy patients improved more than controls in quality of 
sexual function in (Klein et al. 2007) terms of libido, confidence to attain 
erection, satisfaction with sexual relationship, frequency of erection and 
enjoyment of sex. The sexual therapy patients were highly satisfied with cardiac 
rehabilitation and sexual therapy. The study group suggest that sexual therapy 
should be an integral part of cardiac rehabilitation. Maroto-Mantero et al (2008) 
studied the effects of cardiac rehabilitation on erectile dysfunction in Spain. 
They found a majority of participants refused any specific treatment for ED for 
various reasons such as advancing age, partnership problems and the fear of 
complication. They suggest that it is essential for the health care professionals 
to provide sufficient and good quality information to patients. They found 
excellent results when the patients are specifically treated with PDE-5 inhibitors, 
when there was no contraindication. However, none of the studies examined 
the diagnostic or prognostic values of arterial stiffness of the patients 
undergoing cardiac rehabilitation. 
6.2.3. Uptake and participation 
The participation was influenced by the provider, patient’s choice, 
accountability, accessibility, improved health and protection/security. The 
patients’ likelihood to participate in CR and undertake exercise were influenced 
by the following themes; improve health, feel better, enjoy being active, self 
motivation, companionship, setting/surroundings, habit and get back to previous 
activities. Though a great number of people suffer from cardiac events, only few 
survivors are offered comprehensive cardiac rehabilitation (Dalal et al. 2004). A 
significant number of that minority of patients who attend CR fail to complete it  
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(Turner et al. 2002). More research is needed to minimize these limitation and 
to establish more convenient alternate programmes.  
6.3. Conclusions 
Erectile dysfunction has strong associations with arterial stiffness and is a 
marker of cardiovascular disease. Regular exercise can reduce the cardiac 
work required for sexual activity and improve erectile dysfunction. Further 
medical therapy and invasive interventions are also available. Cardiac 
rehabilitation is an effective exercise-based programme for the reduction of 
cardiovascular risk. Restoring sexual function is also an important goal of 
cardiac rehabilitation. However, the effects of cardiac rehabilitation on sexual 
functions are infrequently studied in the UK. The improvement in the exercise 
capacity and its relationship with arterial stiffness and erectile functions need to 
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CHAPTER 7. CHANGES IN ERECTILE DYSFUNCTION AND ARTERIAL 
STIFFNESS FOLLOWING CARDIAC REHABILITATION 
Abstract 
Background: Modern cardiac rehabilitation (CR) programmes provide 
comprehensive care for patients with CVD. Resuming sexual function is one of 
its goals yet is often omitted. This study establishes the effects of CR on erectile 
dysfunction (ED) and arterial stiffness. Methods: 157 men with CVD, 
undergoing phase III CR participated and 61 of them completed all phases of 
the study. Before and after CR, they were assessed for arterial stiffness using 
carotid-radial applanation tonometry and completed four questionnaires: (i) a full 
medical history including erectile function details, (ii) the 5-item international 
index of erectile function questionnaire (IIEF-5), (iii) the erectile dysfunction 
related quality of life questionnaire (ED-EQOL), (iv) the erection hardness scale 
(EHS). Results: 63% of the participants had ED based on their IIEF- 5 scores. 
There was significant improvement in arterial stiffness following CR (p<0.05). 
Those who had mild erectile dysfunction before CR had a significant 
improvement in IIEF score (p<0.05) and those who had  moderate to severe ED 
showed no significant change (p>0.05). There was no significant improvement 
on EHS and ED-QoL following CR (p>0.05). Those participants, who were 
treated medically for ED, had significant improvement in IIEF, erection hardness 
score and ED-QOL (p<0.05) Conclusion: CR programmes are effective in 
improving cardiovascular risk by reducing arterial stiffness. In general, the CR 
programmes do not improve erectile function to a clinically satisfactory level 
unless the condition is treated medically. Specific attention and motivation is 




7.1.1. Pathology of erectile dysfunction 
Endothelial dysfunction is the central etiologic factor for systemic and peripheral 
cardiac disease (Billups 2005). It is defined as a functional deterioration of 
endothelium characterized by vasospasm, vasoconstriction, alteration in 
coagulation mechanisms and fibrinolysis and increased vascular proliferation 
(Kaya et al. 2006).  These are considered to be due to the reduced NO release 
in the vascular system. It has been found that endothelial dysfunction precedes 
the development of atherosclerotic lesions. The small vessels of the penis are 
very sensitive to functional and structural changes (Kaya et al. 2006) and they 
are more susceptible to atherosclerotic occlusion than the larger vessels of the 
heart and limbs (Kirby et al. 2001). So the ED is now considered as a marker of 
cardiovascular diseases and the arterial stiffness plays a major role in the 
development of ED and cardiovascular disease. 
7.1.2. Management of ED and cardiac rehabilitation 
The second Princeton Consensus (Jackson 2006) divides patients with ED 
according to their cardiac condition as low risk, high risk and intermediate risk. 
The intermediate and low risk patients may safely engage in sex with or without 
treatment. The high-risk patients should be treated and their cardiovascular 
system should be stabilized before the resumption of sexual activity. Treatment 
for ED also recommended for them. Various treatment techniques are available 
for ED. Among them, the PDE-5 inhibitors are widely used and successful in 
treating the vascular ED.  
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Modern cardiac rehabilitation (CR) programmes are recognized as integral to 
the comprehensive care of patients with cardiovascular disease. The 
programmes aim to resume the best possible physical, mental and social 
function of cardiac patients. Resuming the sexual function is also one of the 
goals of CR. However, it is often omitted. The current study has been carried 
out to see the effects of cardiac rehabilitation exclusively on sexual function and 
sex related quality of life in relation to arterial stiffness. 
7.1.3. Research Hypotheses 
H1 – There will be significant improvement in erectile function and arterial 
stiffness following phase III cardiac rehabilitation in participants with erectile 
dysfunction 
H2 – There will be a significant improvement in erectile function related quality 
of life (ED-QOL) following phase III cardiac rehabilitation in participants with 
erectile dysfunction 
7.2. Methods 
7.2.1. Recruitment of subjects 
Following national ethics committee’s approval, all the cardiac rehabilitation 
programmes in the list available from British Heart Foundation, were contacted 
through telephone and emails. Meetings were arranged with interested cardiac 
rehabilitation teams and 16 programmes offered to be involved. The project was 
approved by their research and development departments once all the 




The study involved 157 participants undergoing phase III cardiac rehabilitation 
who had at least one of the following conditions: myocardial infarction (MI), 
transient ischemic attack, attended rapid chest pain clinic, angina or a positive 
diagnosis for cardiovascular disease (e.g. cardiac failure). The predominant 
condition was MI, which presented in 78% of the participants.  Individuals were 
excluded from the study if they had conditions affecting the brain, spinal cord, or 
pelvic nerves (e.g. multiple sclerosis, multi system atrophy, spinal cord injury 
and tumours), conditions affecting the cauda equine such as prolapsed 
intervertebral disc or tumours), disease to the asympathetic nerves within the 
pelvis that affecting the functions of prostate, seminal vesicle, external genitalia 
and blood vessels of pelvic organs received extensive surgery to the pelvis or 
abdomen chronic renal failure, hyperprolactinaemia, hypergonadism and 
hypogonadism.  
7.2.3. Study Design 
The study involved both the two stage (pre and post) CR longitudinal design 
and a cross sectional correlational analysis of measures at each stage.  
7.2.4. Organizational procedure 
Each participant was contacted on the pre-assessment day before starting the 
phase III cardiac rehabilitation. Participants were given a coded invitation pack 
that contained an invitation letter from the cardiac rehabilitation programme, a 
invitation letter from Buckinghamshire New University, a patient information 
sheet, three informed consent forms, a leaflet providing information on Medical 
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Research & Governance, a patient education booklet ‘Sex and the heart’ from 
Pfizer Ltd and four questionnaires: erectile dysfunction details; International 
Index of erectile function – 5 (IIEF-5); Erectile dysfunction related effects on 
quality of life (ED-EQOL); erection hardness scale (EHS) and a prepaid 
envelope. The questionnaires were completed privately by self-administration 
and returned to the Research Centre at Buckinghamshire New University. The 
participants were measured for arterial stiffness using a SphygmoCor as 
detailed below. The participants were reassessed on the post assessment day 
after completing cardiac rehabilitation and measured for arterial stiffness. They 
were given a pack of three questionnaires IIEF-5, ED-EQOL, EHS and following 
completion they were returned in a prepaid envelope.  
7.2.4.1. Questionnaires 
7.2.4.1.1. International index of erectile function – 5 
IIEF has been adopted as the ‘gold standard’ treatment outcome measure for 
clinical trials in ED, regardless of the type of treatment intervention or study 
population under investigation. Since its introduction in 1997, more than 50 
clinical trials have been conducted using this instrument with a broad range of 
treatment agents. It is approved by national institute of health (Rosen et al., 
2002). The IIEF-5 questionnaire is an abbreviated form of the original IIEF. Four 
items were selected from the erectile domain portion of the IIEF-15 plus the 
item addressing sexual satisfaction (Hodges et al. 2007). The IIEF-5 fulfils the 
need for a simple patient administered diagnostic tool of ED for easy use in 
clinical settings. It could aid in decreasing the incorrect diagnosis of ED and 
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decreasing the number of undiagnosed cases worldwide. It provides accurate 
and reliable information as a quantitative index of ED severity. Many studies 
have used this short version of IIEF and reported that sensitivity and specificity 
of the questionnaire were high (Rosen et al. 1999). It consists of five questions 
and in each of them, patients make a self evaluation on a scale ranging from 
zero to five points. The sum of the scores of each question in the IIEF-5 was 
calculated and the degree of erectile dysfunction was derived as complete (≤ 4), 
severe (5-7), moderate (8-11), mild to moderate (12-16) mild (17-21) or none 
(22-25). 
7.2.4.1.2. Erectile dysfunction related effects on quality of life (ED-QOL) 
The ED-EQOL questionnaire is a robust instrument measuring the impact of ED 
on quality of life (QoL). It is simple to use and fulfils the usual psychometric 
properties of reliability, validity and responsiveness (MacDonagh et al. 2004). 
The latest version ED-EQOL has 15 questions and each question has five 
possible responses scored from 0 to 4. The sum of the scores was calculated 
from the 15 questions. A score of less than 15 was considered that the 
individuals’ QoL was not or only mildly affected by ED. A score of 15 to 29 
indicated that QoL was moderately affected and a score of above 30 was 
considered that the individual is severely affected. 
7.2.4.1.3. Erection hardness score 
Erection hardness score (EHS) is a single item scale and a patient-reported 
outcome for scoring erection hardness on a scale ranging from one to four. EHS 
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demonstrates a high reliability and is highly responsive to treatment (Mulhall et 
al. 2007). It shows a close correspondence with the erectile function (IIEF) and 
ED related psychosocial factors in men (Cappelleri et al. 2009). The relationship 
between EHS and other erectile function questionnaires are strong and it is 
recommended for clinical practice (Goldstein et al. 2008). 
The participants, who reported that they had used specific medicines for ED, 
were asked to complete two sets of the questionnaires according to their 
experience with and without the medications.  
7.2.4.2. Arterial stiffness using SphygmoCor 
The procedures for measuring arterial stiffness are given in detail in Chapter 
3.2.2. 
7.2.5. Statistical analysis 
Statistical analysis was undertaken using the statistical software, SPSS for 
windows (version 14.0). Paired-samples t test was used to compare the results 
pre and post cardiac rehabilitation. The Pearson correlation test was used to 
find the relationship between erectile function scores and the SphygmoCor 
measurements. The scores and age were recorded to find the prevalence and 






In total, all the male patients who were attending the cardiac rehabilitation 
programmes in 16 various hospitals were invited to participate in the study 
regardless of their sexual function. In total, 157 patients volunteered to 
participate in the study. Among them 130 participants underwent baseline 
SphygmoCor measurements and 61 completed post intervention 
measurements. Initially 114 participants filled the baseline questionnaires and 
nearly half of them completed post intervention questionnaires (Table 7.3). The 
participants’ physical characteristics were as follows (Mean ± SD): age- 60.8 ± 
11.0 years, height- 174.1 ± 7.5 cm, weight  84.8 ± 15.5 kg and body mass 
index- 27.9 ± 0.5. There were 9.5% current smokers and 14.6% ex-smokers. 
Fifty one percent of them were alcohol drinkers and >90% of them were within 
the recommended limit for a normal adult. The participants’ cardiovascular 
comorbidities are listed in Table.7.1. About 40% of participants had more than 
one comorbid medical conditions, cardiovascular procedures or surgeries. 
Table 7.1 Comorbid cardiovascular conditions of the participants 
Comorbid conditions % in total participants (n= 105) 
% in participants with ED 
 (n= 66) 
Diabetic 13.5 20.7 
Angioplasty 39 44.8 
CABG 28.4 34.5 
Stent 41.9 44.8 
Thrombolysis 6.8 13.8 
Symtomatic Angina 29.7 41.4 
PVD 0 0 
(CABG- Coronary artery bypass surgery, PVD- Peripheral vascular disease) 
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The medications administered to the participants with cardiac diseases are 
listed in Table 7.2.  Beta blockers and ACE inhibitors were administered to a 
high number of participants. This could be a definite cause for the high number 
of ED prevalence in the study group.  
Table 7.2 Drug administration in the participants 
Drugs % in total subjects (n=105) 
% in Subjects with ED 
(n=66) 
Aspirin 93.1 67.4 
Beta Blockers 77.8 86.2 
ACE Inhibitors 65.3 65.5 
Calcium Channel Blockers 18.1 17.2 
Alpha Blockers 1.4 0 
Angiotension Receptor 
Antagonist 6.9 10.3 
Diuretics 8.3 6.9 
Nitrates 12.5 10.3 
Potassium Channel Blockers 2.8 6.9 
Chlestrol Lowering agents 90.3 93.1 
PDE Inhibitors 4.2 6.9 
 
7.3.1. Erectile dysfunction 
Sixty three percent of the participants who were undergoing cardiac 
rehabilitation had ED based on their IIEF- 5 scores. They were divided in to five 
categories according to the severity of ED as complete (≤ 4), severe (5-7), 










The duration of ED varied from one month to 20 years with a mean of 3.6 years. 
There was a strong positive correlation between ED duration and the severity of 
ED (p<0.05). 
Age had a strong positive correlation with the IIEF scores (P<0.01). Age also 
had a strong positive correlation with the severity of ED (p<0.01) and the 
participants above 70 years had an increased prevalence of ED and it was 
twice as severe as the other age groups.   
7.3.1.1. International Index of Erectile dysfunction 5 
In general, there was no significant change between the baseline measures 
(pre CR) and the final measure (post CR) for any of the domains of the IIEF 
scores in all the patients with ED (Table 7.3). Those who had mild erectile 
dysfunction before CR had a statistically significant improvement in IIEF score 














Figure 7.1 Severity of erectile dysfunction in the participants 
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change the category of their ED severity. There was no significant change in 
IIEF-5 scores in participants who had mild to moderate, moderate or severe ED. 
Table 7.3 Changes in erectile function questionnaires following CR 
Questionnaires Pre CR ± SD Post CR ± SD Significance 
IIEF-5 Score 
(n=61) 14.83 ± 8.47 15.23 ± 9.1 Non-significant 
ED-QOL Score 
(n=34) 15.93 ± 17.58 13.93 ±16.33 Non-significant 
EH Score1 
(n=59) 2.65  ± 1.14 2.72 ±1.28 Non-significant 
 
7.3.1.2. Erectile function related effects on Quality of Life 
Among the participants who had ED, 48.6% were considered as they were 
mildly or not affected in their erectile dysfunction related quality of life (ED-QoL 
score <15). There were 25.7% of moderately affected (ED-QoL score 15 to 30) 
and 22.9 % severely affected participants (ED-QoL score >30). The 
improvement in the ED-QoL following CR was not statistically significant.  There 
was no significant correlation between ED-Qol score, IIEF score, IIEF score 
based severity of ED and age (p>0.05) 
7.3.1.3. Erection Hardness Score 
Though there was a mild improvement in the participants in EHS score, it was 
not statistically significant. However there was a strong positive correlation 




7.3.2. Medication for ED in CR 
7.3.2.1. PDE-5 Inhibitors 
There were only four participants who used sildenafil citrate during the CR and 
there was a statistically significant change in erectile function. They could 
achieve normal erectile function (IIEF score >21, EHS score ≥ 3) every time 
they used sildenafil citrate.  
7.3.3. Pulse wave reflections 
Over half of the arterial stiffness measures were reduced following CR with all 
others showing a non-significant change (Table 7.4 and fig 7.3). There was a 
significant reduction in peripheral and aortic systolic pressure. Though there 
was no significant change in diastolic pressure and mean arterial pressure, 
there was a significant reduction in aortic pulse pressure. The augmentation 
pressure was significantly reduced after CR as was the augmentation index and 
augmentation index at 75%. The pulse wave velocity was significantly reduced. 
There was no significant change in subendocardial viability ratio, ejection 
duration and heart rate. The changes in the pulse wave reflections were visible 
in the shape of pulse wave following CR. A sample  from a participants pre and 
post intervention pulse wave shapes are illustrated in Fig 7.4. The peak of late 
systolic peak and the augmentation pressure were markedly reduced. There 
was a significant negative correlation between IIEF scores and pulse wave 
velocity and pulse pressure (Table 7.5). There was also a negative correlation 
between erection hardness scores and pulse wave velocity.  
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Table 7.4 The pulse wave analysis results following CR 




Participants with ED 
(n=25) 
Pre CR Post CR Significance Pre CR Post CR Significance 
Pulse wave velocity (m/s) 7.32 ± 1.40 6.35 ± 0.96 * 7.56 ±1.37 6.69 ±1.26 * 
Augmentation pressure (mmHg) 6.81 ± 5.24 3.22 ± 6.38 * 7.92 ±5.04 6.28 ±5.22 NS 
Augmentation Index 24.64 ± 12.00 13.33 ± 20.23 * 22.36 ±11.38 18.96 ±14.67 NS 
Augmentation Index@75 19.56 ± 10.78 9.22 ± 20.50 * 16.46 ±8.77 16.58 ±12.59 NS 
Aortic pulse pressure (mmHg) 34.47 ± 9.50 29.03 ± 7.81 * 33.36 ±9.10 28.76 ±7.86 * 
Aortic systolic pressure (mmHg) 116.00 ± 11.38 111.44 ± 8.78 * 114.36 ±10.46 111.28 ±8.45 * 
Aortic diastolic pressure (mmHg) 81.58 ± 6.29 82.36 ± 3.17 NS 80.96 ±4.43 82.40 ±1.83 * 
Mean arterial pressure (mmHg) 95.89 ± 8.29 94.89 ± 5.33 NS 94.32 ±6.07 95.76 ±4.65 NS 
Ejection Duration (ms) 33.25 ± 3.61 33.56 ± 3.42 NS 32.48 ±3.54 35.16 ±3.72 * 
Subendocardial viability ratio 174.14 ± 30.59 177.17 ± 27.72 NS 179.48 ±28.61 165.64 ±28.20 * 
Systolic pressure (mmHg) 125.44 ± 11.42 122.83 ± 9.62 * 123.60 ±10.42 121.80 ±7.32 NS 
Diastolic pressure (mmHg) 80.78 ± 6.23 81.44 ± 3.14 NS 80.44 ±4.41 81.04 ±1.51 NS 
Heart rate 64.25 ± 10.26 66.78 ± 9.01 NS 63.52 ±10.26 71.16 ±10.79 * 
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7.5 Correlations between erectitile dysfunction scores and arterial stiffness variables 
Variables IIEF-5 Score ED-QOL Score EH Score 
Pulse wave velocity  -.443* -.026 -.212* 
Augmentation pressure  -.101 .235 -.074 
Augmentation index  -.051 .140 .013 
Augmentation index @75%HR  -.010 .009 .086 
Aortic pulse pressure  -.282* .398 -.231 
Aortic systolic pressure  -.077 .276 -.151 
Aortic diastolic pressure  .175 -.256 .122 
Aortic Mean Pressure  .094 .088 .015 
Ejection Duration pre  .017 -.053 .039 
Subendocardial Viability Ratio .030 .143 -.014 
Systolic pressure  -.087 .040 -.151 
Diastolic pressure  .137 -.258 .075 
Heart rate  -.038 -.188 -.045 
n=105 *Statistically significant at p< 0.05 level, NS – Not significant 
IIEF- International index of Erectile Function, ED-QOL- Erectile Dysfunction related 
Quality of Life, EH- Erection Hardness 
 
7.3.4. Duration of CR 
There was no significant difference in erectile function scores and pulse wave 
reflections between the CR programmes which ran for six weeks or 12 weeks 
(p>0.05).  
7.4. Discussion 
Among the 16 CR programmes, which agreed to participate in the study, three 
hospitals were regularly visited by the investigator to measure arterial stiffness 
and conduct the questionnaires. Four programmes only actively participated in 
the use of questionnaires. Other programmes had not delivered any 
questionnaires due to lack of staff. This is one of the major factors, which 
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affected the number of participants in the study. All the patients who were 
attending CR were invited for the study, yet 65% of the patients refused to 
participate in the study. Various reasons were acknowledged for this refusal or 
withdrawal of consent to participate in the study. They were shyness, age, 
associated diseases, inactive sexual life, no partners and partners’ 
disagreement to involvement in the study. These factors also influenced the 
60% withdrawal of consent to participate in the study. In addition, many of them 
reported to their cardiac rehabilitation nurse that the questionnaires were too 
invasive.  
The prevalence of ED in cardiac patients who were attending CR was >50% 
(64%) in the current study which agrees with the previous studies on cardiac 
patients [54% in Maroto-motero et al (2008), 66% in Hodges et al, (2007)]. The 
participants were from different CR programmes, and the total number of 
exercise sessions varied in those programmes from six to 12 and the duration 
of CR varied from six to 12 weeks. Some of the programmes run the exercise 
sessions twice a week and others once a week. However, findings of this study 
showed that there was no difference between these alternative programme 
lengths. 
Smoking has been shown to be a strong risk in causing ED.  There was no 
significant correlation between severity of ED and smoking history in the current 
study. This may be due to the large number of missing values in the recorded 
smoking history. Drinking alcohol also had no correlation with the ED. It may be 
because of the alcohol consumption of more than 90% of participants who were 
consuming alcohol were within the limit recommended for an adult during the 
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CR. However, the recommendations for alcohol limit vary with the severity and 
the combination of the diseases. The previous history of the participants’ 
alcohol intake was not completely known. The high use of drugs such as beta-
blockers and ACE inhibitors must also have a positive influence in the 
prevalence ED in cardiac patients (Maroto-Montero et al. 2008). 
7.4.1. Pulse wave reflections 
The major original finding of this study is that cardiac rehabilitation improves 
arterial stiffness.  
7.4.1.1. Pulse wave velocity (PWV) 
The brachial artery PWV was significantly improved following cardiac 
rehabilitation in this study. PWV has been identified for its extensive prognostic 
significance (Baulmann et al. 2006). This improvement may be due to the 
decreased left ventricular afterload and hypertrophy, an increased 
subendocardial perfusion and an improvement in the mechanical stress of the 
larger arteries (Mustata et al. 2004). The strong positive correlation between 
PWV and augmentation pressures assures the reduction of arterial stiffness in 
patients undergoing CR. Three of the participants’ PWV were increased post 
CR and one of them had coronary artery bypass graft and continued with CR. 
The increase in PWV may be due to the other risk factors such as life style and 
associated cardiac risk factors, which were not studied.  
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7.4.1.2. Augmentation Index (AIx) 
The AIx was markedly reduced at the end of the CR. Mahmed et al (2001) 
suggest that the reduction may be due to the delaying of the wave reflections by 
decreasing pulse wave velocity, shorter left ventricular ejection duration or 
reducing the intensity of pulse wave reflection. The results from the current 
study are similar to their findings.  However, their study did not measure the 
pulse wave velocity. The pulse wave intensity was reduced which is visible in 
the pulse waveforms and the reduction in the ejection duration was not 
significant.  AIx also depends on other variables such as heart rate and the 
vasomotor tone of the arterial system, which can result in considerable 
variability and thus may limit its use as a surrogate measure of arterial stiffness 
(Wang et al. 2008). However, the strong correlation of the AIx with the pulse 
wave velocity in this study suggests that AIx can be an individual marker for 
arterial stiffness. 
The improvement in the arterial stiffness and blood pressures correlates with 
the findings of Mustata et al (2004) who speculated that the improvement might 
be due to the effects of exercise training on the improvement of endothelial and 
smooth muscle function. The exercise training in CR is likely to have improved 
the exercise tolerance and VO2 of the patients. Aortic stiffness is inversly 
related to VO2 and exercise tolerance in cardiac patients suggesting that it is an 
independent predictor for them. The less compliant aorta influences the function 
of the left ventricular systolic energetics and mechanics. It also affects the left 
ventricular relaxation and filling pattern. These result in the impairment of the 
normal increase in cardiac output in response to exercise (Bonapace et al. 
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2003; Enko et al. 2008). Peripheral vascular abnormality may also be 
responsible for low VO2 as flow-dependant, endothelial mediated vasodilatation 
is important for the skeletal blood flow, which defines exercise capacity (Enko et 
al. 2008).  Therefore, the reduction in the arterial stiffness suggests that CR 
improves vascular endothelial function and aortic compliance and thus the 
exercise capacity.  
7.4.1.3. Pulse Pressure (PP) 
The faster the blood pressure changes within the artery, the lower the wall 
distensibility.  Increased pulse pressure is one of the principal arterial alterations 
that results from arterial stiffness in coronary artery diseases. PP has been 
identified as an independent marker for cardiac events and mortality. Pulse 
pressure is modified predominantly by two mechanisms: (i) ventricular ejection 
intersecting with viscoelastic properties of the arterial bed and (ii) pressure 
wave deflections. The increase of both stroke volume and arterial stiffness led 
to an increase in PP (Papaioannou et al. 2004). The distensibility of arteries 
changes with age. In people <50 years of age, diastolic pressure is a strong 
predictor of coronary heart disease. In the transition period of 50-59 years, 
systolic, diastolic and pulse pressure are similar predictors of cardiovascular 
risk. Above 60 years, diastolic pressure is negatively related to the risk of 
coronary artery events and therefore, the pulse pressure is a better predictor 
than systolic pressure (Willum-Hansen et al. 2006). In the current study, 
diastolic pressure did not change significantly and there was a significant 
reduction in PP in all age groups. This means that the CR programmes are 
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effective in improving the arterial function. It is notable that it was reduction in 
systolic pressure after CR which helped in the reduction the pulse pressure.  
7.4.1.4. Aortic blood pressure 
Aortic blood pressures are most physiologically relevant to ventricular-vascular 
coupling. Systolic pressure at the ascending aorta is the pressure that the left 
ventricle has to confront and thus it is related to cardiac energy consumption 
and load. Central diastolic pressure determines the coronary blood flow. 
Increased systolic pressure, low diastolic pressure and wider pulse pressure are 
the common clinical findings in cardiovascular risk patients. There was a higher 
baseline systolic pressure than normal in the participants. The reduction in the 
aortic systolic pressure has a significant effect on reducing the pulse pressure. 
Generally, the current study participants had no abnormal mean diastolic 
pressure at baseline and this was maintained at the end of CR.   
7.4.2. Erectile function  
Fifty two percent of the participants with ED in the current study experienced ED 
after the cardiac event. Forty-eight percent participants experienced ED before 
the cardiac events, which ranged from a month to 10 years. Eighteen percent of 
the participants had not identified their erectile dysfunction, yet they were falling 
in the mild ED category. These results clearly show that ED is a strong 
comorbid condition and a marker of coronary artery disease. 
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7.4.2.1. International index of erectile dysfunction- 5 
IIEF is a specific, treatment oriented and a well-documented diagnostic as well 
as prognostic tool. The five domains of IIEF are erectile function, orgasmic 
function, intercourse satisfaction and overall satisfaction. In this study, the 
subjects who had no erectile dysfunction before the cardiac rehabilitation had 
no significant change in their erectile function after CR. The CR might have 
helped them to maintain their erectile function for a longer period, but this was 
not studied and requires further research. In general, the participants with 
moderate to complete ED had no improvement in their erectile function 
following CR. No domains in IIEF-5 had changed following a six week or 12 
week CR programme. 
Interestingly, the subjects who had mild erectile dysfunction had an appreciable 
benefit from cardiac rehabilitation. The participants who had their IIEF-5 scores 
between 17-21 had a significant improvement in their erectile function. Their 
confidence on gaining an erection, i.e. one of the domains of IIEF, was 
improved significantly. This shows that CR improves the psychological 
wellbeing of the participants. However, the improvement was not clinically 
significant as they were not able to complete full sexual activity.  
7.4.2.2. Effects on erectile dysfunction related quality of Life (ED-QOL) 
The Ed-QOL shows a large number of participants who had ED were affected 
moderately (Score 30-50) or severely (Score >50) in their erectile dysfunction 
related quality of life (>50) irrespective of their IIEF scores and age. It is clear 
that the influence of erectile dysfunction on the quality of life varies between 
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individuals irrespective of the severity of their erectile dysfunction. It suggests 
that every individual with ED should be considered equally and carefully for the 
treatment options. ED should not be considered as just an epiphenomenon of 
age or underlying cardiovascular disease. It requires more attention and 
evaluation (Schwarz and Rodriguez 2005). 
7.4.2.3. Erection hardness score (EHS) 
Though there was a mild improvement in mean value of EHS score it was not 
statistically significant. The study findings show a direct relationship between 
IIEF and EHS scores. The positive correlation between the IIEF scores and 
EHS scores at the baseline (pre CR) as well as at the end of CR shows that 
EHS can be an effective assessment tool to measure erectile dysfunction 
quickly. As a single item scale, it is easy to complete, specific to understand and 
has a highly relevant outcome. It can be used as a proxy assessment for other 
detailed assessment tools (Goldstein et al. 2008). 
There are the possibilities of a few major limitations in these questionnaires: (i) 
in spite of using the shortened versions, respondents are burdened with multiple 
detailed queries on sensitive topic, (ii) the items omitted in the questionnaires 
resulted in a difficult calculation of the total score and (iii) participants’ 
misinterpretations of the lengthy questions (McKinlay 2000).  
7.4.3. Erectile function and arterial stiffness 
In this study, erectile function was not improved significantly in association with 
the improvement in arterial stiffness. Penile arteries are relatively small, with the 
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average cavernosal artery being 0.5 mm in diameter. The helican arteries, 
which run between the cavernosal artery and the sinusoids, are much smaller. 
These smaller arteries need to dilate up to 80% to provide the blood flow 
necessary to produce enough venous compression to sustain an erection 
(Carson et al. 2008). The findings of the study suggest that the improvement in 
the major arterial stiffness is not sufficient to produce a significant influence in 
the smaller arteries. It is also important to consider the negative effects of drugs 
such as beta-blockers and ACE inhibitors. It is possible that the improvement in 
the physical function following CR is not sufficient to overcome the effects of 
these drugs on erectile function. It is also not clear what is the required amount 
of improvement in carotid-radial pulse wave velocity to produce a relatively 
satisfactory level of improvement in penile arteries and erectile function.  
7.4.4. Effects of specific treatment for ED 
There were two participants already consuming PDE-5 inhibitors before joining 
the phase III CR. During the CR, among the participants who showed interest to 
know about the treatment options for ED, only six participants followed up with 
their consultants. Two of them agreed to take oral PDE-5 inhibitors and they 
were prescribed flexible doses of sildenafil citrate. However, none of the other 
participants was interested to take any further specific treatment of ED. This 
may be due to several reasons such as advanced age, organic and 
psychological diseases, problems in the relationships, lack of information and 
the fear of complications (Maroto-Montero et al. 2008). 
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Sildenafil accounted for a successful erection and hardness every time after 
consumption for the four participants. These stimulated erections lasted long 
enough for successful sexual intercourse. Their improvement in arterial stiffness 
was not significantly different from the improvement of the other participants 
who did not use a PDE-5 inhibitor. Though the number of consumers is small, 
the results could be supported by previous studies. Sildenafil increases cGMP 
levels in coronary vascular smooth muscles, enhancing the effects of NO and 
increasing coronary blood flow at rest and exercise. This may be due to the 
dilatation of coronary resistance vessels which results in increased blood flow in 
the ischemic blood supply. The current findings confirm that PDE-5 inhibitors do 
not worsen the ischaemia. The PDE-5 inhibitors are likely to improve anginal 
threshold and the exercise threshold after use. After consuming sildenafil, the 
workload achieved could be up to 8-METs, which is considerably greater than 
the energy expended during even vigorous sexual activity, i.e. five to six METs 
(Fox et al. 2003).  However, the participants reported that there was no 
significant change in erectile function in those participants when the medicine 
was not consumed. 
It was very clear that most of the participants in the current study were very 
apprehensive about re-engaging in sexual activity and seeking treatment of ED 
after experiencing a cardiac event. This may be due to the development of lack 
of concern about sexual life with age (Lowy et al. 2007). It may also be due to 
the fear of the risk of cardiac event during sexual activity. The incidence rate of 
death or infarction in cardiac patients during sexual intercourse is negligible i.e. 
one in million (Muller et al. 1996).  The second Princeton Consensus (Jackson 
2006) divides patients with ED as high risk, low risk and intermediate risk 
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according to their level of risks. The low risk category are asymptomatic, with 
less than three cardiovascular risk factors, controlled hypertension, mild, stable 
angina pectoris, post revascularization, post myocardial infarction (MI) (6 to 8 
weeks), mild vascular disease, left ventricular dysfunction class I (NYHA). 
These patients can be safely encouraged to resume sexual activity. If required, 
the safe treatment options should be discussed and encouraged. 
7.4.5. Limitations  
Larger studies with a greater number of patients would be statistically more 
powerful. The long-term effects of the cardiac rehabilitation on arterial stiffness 
also need to be studied. The exercise tolerance level was not measured in the 
participants either at baseline or at post CR. A treadmill exercise test has been 
established as a reliable tool for determining the tolerance of sexual activity in 
MI.  
The relationship between the changes in exercise tolerance levels, erectile 
function and arterial stiffness would have been a valuable finding, but it was not 
possible to arrange an exercise test with these participants.  
The duration of CR was not similar for all the participants. Though there was no 
significant difference on the effects, previous studies suggest a longer duration 
of exercise programmes is necessary to cause substantial effects (Mustata et 
al. 2004).  
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The study was not designed to identify specifically how many participants really 
would have specifically wished to improve their sexual function and whether 
personal and social factors had influenced their sexual activity.  
To secure the maximum validity of the data, the same equipment were used by 
a single operator for all the participants throughout the study. Although the 
transfer function has been validated, the accuracy of central aortic PP obtained 
with the SphygmoCor has been widely debated. The debate focused mainly on 
the validity of the transfer function but ignored a second possible source of error 
in the prescribed SphygmoCor procedure: calibration of the RA wave with 
brachial instead of radial blood pressure values (Verbeke et al. 2005). 
7.5. Conclusions 
The incidence of erectile dysfunction is very high and is also an early sign in 
patients with cardiac diseases. Both the patients and clinical care providers 
should give more attention to this serious problem. In general the CR 
programmes do not improve the erectile function to a clinically satisfactory level 
unless the condition is treated with specific treatment options. The CR 
programmes are effective in improving cardiovascular risk by reducing arterial 
stiffness. The improvement in arterial stiffness is not enough to produce a 
satisfactory erectile function. It is understood that the complex treatment of 
cardiac rehabilitation improves larger artery mechanism but not the smaller 
cavernosal arteries. Specific attention and motivation is needed for patients with 
ED in CR to utilize the available treatment options when not contraindicated. 
Larger, more controlled and stratified groups should be studied further to 
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CHAPTER 8. METABOLIC SYNDROME – A LITERATURE REVIEW 
Abstract 
Incidence: Metabolic syndrome is a cluster of various cardiovascular risk 
factors such as obesity, dyslipidaemia, hyperinsulinemia and high blood 
pressure. Various definitions have been developed specific to ethnicity and 
countries. The prevalence of metabolic syndrome has been increasing all over 
the world. Women and the elderly are more prone to developing metabolic 
syndrome. The primary cause of metabolic syndrome varies due to different 
epidemiological factors such as nutrient levels, ethnicity, genetic and 
socioeconomic status etc. Physiologically, excessive fat is the primary cause of 
metabolic syndrome that contributes to other components such as 
dyslipidaemia, hyperinsulinemia and high blood pressure. Sedentary lifestyle 
and low cardiorespiratory fitness are largely associated with the prevalence of 
metabolic syndrome.  Management: There is no specific treatment protocol 
available. Treating individual components of metabolic syndrome has been 
established as an effective strategy. A change in lifestyle with regular physical 
activities and a healthy diet is recommended. Conclusion: The prevalence of 
metabolic syndrome is continuously escalating worldwide. Early identification of 
metabolic syndrome could help to reduce the risks of cardiovascular disease. 
Lifestyle change is the key factor for the prevention and management of 
metabolic syndrome. Specific modes of treatment with more emphasis on 





8.1.1. Development of definitions 
Cardiovascular disease (CVD) is the main cause of mortality and morbidity 
throughout the world. Several risk factors for CVD have been identified. In 
recent decades, it is developing into a trend of studying the clustering of 
cardiovascular risks. Camus (1966) was the first one to introduce ‘trisyndrome 
metabolique’ which is a combination of gout, diabetes and dyslipidaemia.   
Later, the Framingham study (Kannel and McGee 1979) discussed the 
possibilities of the associations among diabetes, dyslipidaemia, hypertension 
and obesity. Orchard et al (1983) discussed the associations of 
hyperinsulinemia and blood lipids as an atherogenic risk. Modan et al (1985) 
found the link between hypertension, obesity and hyperinsulinemia. Stern and 
Haffner (1986) discussed the associations between the pattern of body fat 
distribution and hyperinsulinemia as the causes of diabetes. Later, Reaven 
(1988) noted that hypertension, glucose intolerance and altered lipid levels were 
commonly clustering together. He introduced this cluster of risk factors as 
‘Syndrome X’ at the annual meeting of the American Diabetes Association 
(1988). Ten years later he restructured the definition including more factors 
such as altered haemodynamics, haemostatics and uric acid metabolism 
(Reaven 1999). In the mid-1990s it was termed as insulin resistance syndrome 
(DeFronzo and Ferrannini 1991). In that time, insulin resistance was considered 
as a major cause of metabolic syndrome until many epidemiological studies 
established that insulin resistance was not the sole cause of the condition 
(Saylor 2005).   
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The World Health Organisation (WHO) introduced the term ‘metabolic 
syndrome’ (1999) which is widely used internationally and a definition was 
derived by a  WHO consultation (WHO 1999). The criteria are the presence of 
diabetes mellitus or glucose intolerance with any two of the other factors: 
obesity, high blood pressure, dyslipidaemia and microalbuminuria. The 
reference values for the various definitions are listed in table 8.1. 
Later, the National Cholesterol Education Programme (NCEP) (2002) expert 
panel on detection, evaluation and treatment of high blood cholesterol in adults 
(Adult treatment panel III) (ATP III) introduced another definition. It gives equal 
weight to all the criterion factors. The National Heart, Lung and Blood Institute 
(NHLBI) and the American Heart Association (AHA) have released a report on 
criteria for diagnosing metabolic syndrome using the same ATP III’s definition 
(Grundy 2005; Grundy et al. 2005b).  The panels describe metabolic syndrome 
as the presence of any three of the following: abdominal obesity, dyslipidaemia 
(high levels of triglycerides, low HDL), increased blood pressure and increased 
fasting glucose. The ATP III criterion does not include microalbuminuria despite 
the strong associations with metabolic syndrome (Palaniappan et al. 2003). 
In 2003, the American College of Clinical Endocrinologists (AACE) developed a 
new definition for insulin resistance syndrome which is a combination of the 
previous WHO and ATP III definitions (Einhorn et al. 2003). There was no 
specific number of risk factors for the diagnosis of the syndrome and it was left 
to clinical judgement. 
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The International Diabetes Federation (IDF 2006) has developed a new 
definition. The IDF takes central obesity as a pre-requisite for the diagnosis of 
metabolic syndrome in addition to any two of the following: raised triglycerides, 
reduced HDL cholesterol, raised blood pressure, raised fasting plasma glucose. 
An advantage in IDF is that it has derived ethnic specific abdominal obesity 
values for the criteria.  
The Chinese Diabetes Society (CDS) has developed a definition for metabolic 
syndrome within the Chinese population as the presence of three or more of the 
following components: (1) BMI ≥25 kg/m2; (2) blood pressure ≥140/90 mmHg or 
under antihypertensive medication; (3) serum triglyceride level ≥1.7 mmol.L-1 or 
HDL-C <0.91 mmol.L-1 in males and <1.0 mmol.L-1 in females; (4) FBG level 
≥6.1 mmol.L-1 or under antidiabetic medication (Li et al. 2006). 
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Table 8.1 Comparison of the criteria of metabolic syndrome 
Risk Factor WHO Metabolic syndrome 





Insulin resistance syndrome 
Obesity 
BMI ≥ 30 kg/m2 and/or WHR > 
0.90 in men and <0.85 in 
women 
Waist >102 cm (>40”) in 
men and >88 cm (>35”) in 
women 
Abdominal obesity with 
ethnic specific reference 
values 
BMI ≥ 25 kg/m2 
Fasting Glucose ≥ 6.1 mmol.L-1 (110 mg.dL-1) ≥100 mg.dL-1 
≥100 mg.dL-1 or 
previously diagnosed 
type 2 diabetes 
110 - 126 mg.dL-1 
Type II Diabetes Included Included but not compulsory 
Included but not 
compulsory Included but not compulsory 
Insulin resistance 
Impaired glucose tolerance (two-
hour glucose levels of 140 to 
199 mg.dL-1 [7.8 to 11.0 mmol.L-
1] on the 75g oral glucose 
tolerance test) 
Not included Not included Type II diabetes  or Postprandial glucose 140 to 200 mg.dL-1 
Triglycerides ≥1.7 mmol.L
-1  
(≥150 mg.dL-1)  ≥150 mg.dL
-1 ≥150 mg.dL-1 ≥150 mg.dL-1 
HDL Cholesterol 
<35 mg.dL-1 (<0.9 mmol.L-1) in 
men and <39 mg.dL-1 (>1.0 
mmol.L-1) in women 
<40 mg.dL-1  
(1.04 mmol.L-1) in men and 
<50 (1.29 mmol.L-1) mg.dL-1 
in women 
<40 mg.dL-1 in males 
and <50 mg.dL-1 in 
females 
<40 mg.dL-1 in males and <50 mg.dL-1 
in females 
Microalbuminuria 
Urine albumin excretion rate >20 
µg/min or albumin-to-creatinine 
ratio ≥ 30 mg.g-1 
Not used Not used Not used 
High blood pressure ≥140/90 mmHg or antihypertensive medicine ≥130/≥85 mmHg ≥130/≥85 mmHg ≥130/≥85 mmHg,  
Others None None None 
Family history of type II diabetes, 
hypertension or CVD, polycystic 
ovarian syndrome, sedentary lifestyle, 
advancing age, ethnic groups of 
having high risk for type II diabetes or 
CVD 
WHO- World Health Organization; NCEP ATP III- National Cholesterols Education Programme Adult treatment Panel III; IDF- International Diabetes 
Federation; AACE- American Association of Clinical Endocrinologists.  
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8.1.2. Controversies among definitions 
The prevalence of metabolic syndrome varies with the definitions used for 
diagnosis. Reinehr et al (2007) compared eight different criteria for metabolic 
syndrome and found a huge variation of prevalence from 2% to 39%. There are 
many controversies and questions developed from these ambiguous definitions 
(Benedict 2006; Kahn et al. 2005; Saylor 2005). The WHO definition is not clear 
about the inclusion of raised blood pressure when it is controlled by 
interventions. Moreover, there are extra laboratory tests for glucose tolerance 
and urine albumin-creatinine. It is also not clear that both systolic and diastolic 
pressures must be high or either one of them. WHO also considers body mass 
index as a tool for obesity, yet body mass index cannot provide a valid 
information on visceral obesity (Després 2006).  
There has been no justification why every new definition should include or 
exclude specific factors from the previous criteria. The current definitions have 
only outlined the values of individual risk factors just to identify their presence. 
However, highly altered values can lead to severe cardiac risk. As diabetes is 
already well known for its cardiovascular risk, it is questionable to include it in 
metabolic syndrome. The other lipids, low-density lipoproteins and total 
cholesterol are not included in the criteria though they are also important 
cardiovascular risks. Many other risk factors such as age, family history and 
lifestyle factors are not included in these definitions. The presence of more than 
the minimal number of criterion factors could be a higher CVD risk. This is not 
clear in any of the definitions. Solymoss et al (2004) divided 1108 patients with 
symptoms of coronary artery disease into six groups and scored them 
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according to the number of metabolic syndrome risk factors present, based on 
ATP III criteria. The metabolic syndrome score was significantly related to the 
severity of atherogenic changes in the angiogram. There is a need for a clear 
modified definition to clarify these disputes. Nevertheless, identification of 
metabolic syndrome using any definitions helps to warn of the risk of CVD. 
Huang et al (2008) found a weak association between metabolic syndrome and 
mortality using the IDF definition. However, Ko et al (2006) state that the WHO 
criterion has more predictive power for death than the other criteria.  
The ATP III criterion is considered inappropriate for Asian population, because 
Asians have higher body fat percentage and abdominal obesity and lower body 
mass index than Caucasians. A lowered abdominal obesity criterion will be 
more appropriate (Tan et al. 2004). So far, only IDF’s definition has ethnic 
specific abdominal obesity references to identify metabolic syndrome. 
Differences have been observed when using different definitions on Asian 
populations and higher prevalence observed when using the IDF criterion (He et 
al. 2006) 
8.2. Pathogenesis of the component factors 
Metabolic syndrome has a complex pathogenesis with various interlinked risk 
factors. Obesity and insulin resistance are described as the main components.  
8.2.1. Obesity 
The ATP III and IDF consider obesity as the main responsible pathogenic factor 
of metabolic syndrome. Overweight and obesity are common risk factors of 
many cardiovascular diseases. The findings from the third National Health and 
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Nutrition Survey, shows that 73.9% of the adolescents with metabolic syndrome 
were overweight (Ford et al. 2002).The association of android obesity with 
atherosclerosis and diabetes is long established (Vague 1956).  Visceral obesity 
is considered a major component of metabolic syndrome (Fan 2007). Després 
(2006) states that abdominal obesity has a strong genetic link, yet it will only 
develop with the presence of a positive energy balance. The increasing 
proportions of low physical activity with an energy-dense refined diet contribute 
to the development of abdominal obesity. The fat cells from visceral adipose 
tissue have a higher lipolytic activity compared with other regions (Fan 2007).  
Visceral adipose tissue releases pro-inflammatory adipokines such as tumour 
necrosis factor alpha (TNFα) and interleukin-6 (IL-6) (Després 2006). Excessive 
adipose tissue also releases non-essential fatty acids (NEFA), cytokines, leptin, 
resistin, plasminogen activator inhibitor (PAI)-1 and adiponectin (Fan 2007; 
Grundy et al. 2004). These products exacerbate the cardiac risk factors. When 
NEFA levels are high in the plasma, it overloads lipids in muscles and liver and 
that enhances insulin resistance. High C-reactive protein levels with obesity is a 
known proinflammatory state and is signified by the excessive release of 
cytokines. The increase in PAI-1 signifies the increase in fibrinogen and is 
known as a prothrombotic state (Grundy et al. 2004). In addition, adipose tissue 
releases various receptors such as insulin, glucagon, glucocorticosteroids, 
thyroid hormone and catecholamine in response to signals from hormones and 
the central nervous system (Fan 2007). All these factors, associated with 
abnormal body fat distribution, are also indirectly linked to metabolic syndrome.  
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8.2.2. Insulin resistance 
Insulin resistance is a marker of diabetes and cardiovascular disease. Many 
studies consider insulin resistance as a primary cause of metabolic syndrome 
due to its genetic origin and associations with other cardiac risk factors 
(Borgman and McErlean 2006; Ferrannini et al. 1991; Reaven 1988). Presence 
of insulin resistance will lead to the development of type 2 diabetes within 10 
years (Borgman and McErlean 2006). Insulin resistance subsequently leads to 
hyperinsulinemia with hypertension. These may be due to increased 
sympathetic tone, endothelial proliferation and increased sodium retention 
(DeFronzo and Ferrannini 1991). The influence between insulin resistance and 
obesity is not clear. Insulin resistance increases with body fat levels and most 
obese people (BMI≥30 kg/m2) have a low insulin sensitivity and postprandial 
hyperinsulinemia (Abbasi et al. 2002). However, a spectrum of insulin 
resistance has been identified in overweight individuals (BMI=25-30 kg/m2) and 
also in normal weighed people (BMI <25 kg/m2) (Grundy et al. 2004).  
8.2.3. Dyslipidaemia 
Insulin resistance or hyperinsulinemia plays a major role in resulting 
dyslipidaemia. There is an increased release of free fatty acids from fat lipolysis 
and decreased uptake in the periphery. It causes an increased level of free fatty 
acids in the liver that results in the release of very low-density lipoprotein 
(VLDL), triglycerides and apolipoprotein-B. Cholesterol ester transfer protein 
(CETP) is a plasma protein that facilitates the transport of cholesteryl esters and 
triglycerides between lipoproteins. It collects triglycerides from VLDL or low-
density lipoproteins (LDL) and exchanges them for cholesteryl esters from high-
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density lipoproteins (HDL), and vice versa. The removal of cholesteryl esters 
from LDL and HDL results in an increased small dense LDL and a decreased 
HDL. Thus, there is a decreased availability of HDL for reversed cholesterol 
transport (Bhatheja and Bhatt 2006). The association of dyslipidaemia with 
obesity and insulin resistance varies considerably due to a high modulation of 
lipid metabolism by genetic variation (Grundy et al. 2004). However, obesity and 
insulin resistance themselves have been established to be highly influenced by 
a latent genetic factor and other factors to a lesser degree (Hong et al. 1997). 
8.2.4. High blood pressure 
Every 20/10 mmHg increase in blood pressure doubles the risk of complications 
such as diabetes, renal insufficiency and heart failure. Hyperinsulinemia may 
lead to hypertension due to several mechanisms such as increased renal 
Na+/water reabsorption, sympathetic nervous system activation and decreased 
Na+-K+-ATPase activity,  increased Na+-H+ pump activity, increased cellular 
Ca2+ accumulation and stimulation of growth factors (DeFronzo and Ferrannini 
1991). 
8.2.5. Age 
The prevalence of metabolic syndrome increases with age. Ford et al (2002) 
found an increase in the prevalence of metabolic syndrome, increasing from 
6.7% among those aged 20 years to 43.5% among those aged 29 years and 
then to 42.0% among those aged ≥60 years in America. Recently, Lloyd-Jones 
et al (2010) reported the age-specific prevalence ranged from 20.3 % in age 
group 20 to 39 years, 40.8% in age group 40 to 59 and 51.5 % in age group 
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over 60 years  in American men. Among women, the age-specific prevalence 
ranged from 15.6% in age group 20 to 39, 37.2% in age group 40 to 59 years 
and 54.4% in age group over 60 years. Sharifi et al (2009) also found a huge 
increase from 7.5% in <30 years to 45.6% in >50 years. This may be due to the 
influence of advancing age on all the levels of pathogenesis (Grundy et al. 
2004).  Childhood overweight is also a cause for metabolic syndrome later 
(Carnethon et al. 2004). From the Princeton prevalence study and a 25 years 
follow up study, it is clear that childhood metabolic syndrome is a predictor of 
metabolic syndrome in adulthood and further cardiovascular risk (Morrison et al. 
2007). 
8.2.6. Gender 
Gender differences in the prevalence of metabolic syndrome have been 
observed in many studies. Ford et al (2002) found 57% higher prevalence in 
African-American women and 26% higher in Mexican-American women 
compared with men in the same population. Asian and African women also had 
higher prevalence compared with men (Table 8.2). this may be due to the 
relative high obesity prevalence in women (Agyemang et al. 2012). One 
possible explanation is that women frequently develop peripheral obesity at 
premenopausal stage and develop central obesity at (Regitz-Zagrosek et al. 
2006) postmenopausal stage. However, the mechanism of this physiological 
change is not clear. Lai (Lai et al. 2010) found increased CRP (C-reactive 
protein) levels with a stronger association with metabolic syndrome compared 
with men. It suggests that chronic inflammation could be the reason for higher 





Dietary habits play a major role in the prevalence of metabolic syndrome. 
Barnard et al  (1998) claim that diet is the primary cause of metabolic 
syndrome. They found a development of insulin resistance and 
hyperinsulinemia within two weeks of commencing a high fat diet on rats. The 
other manifestations of metabolic syndrome occurred later and the obesity was 
the last to develop in their study. Total fat intake in the diet is associated with 
the prevalence of metabolic syndrome (Freire et al. 2005). Damiao et al (2006) 
found eating red meat increases the chances of metabolic syndrome. Lack of 
fibre in dietary intake is associated with obesity, elevated plasma lipid levels 
and fasting glucose (Ludwig et al. 1999). High fat intake such as fried food  is 
associated with the risk of metabolic syndrome (Freire et al. 2005). The intake 
of calorically sweetened soft drinks especially high fructose corn syrup have 
strong association with excessive energy intake, weight gain and development 
of type 2 diabetes and metabolic syndrome (Allman-Farinelli 2009; Dhingra et 
al. 2007; Malik et al. 2010). 
8.2.7.2. Physical activity 
Low cardiorespiratory fitness levels are strongly associated with metabolic 
syndrome. Many studies have found an inverse relationship between 
cardiorespiratory fitness and the incidence of metabolic syndrome in various 
age groups and both sexes (Arat et al. 2008; Hassinen et al. 2008; LaMonte et 
al. 2005; Spies et al. 2005). Regular physical activity can maintain or improve 
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cardiorespiratory fitness and young adults with regular physical activity had a 
low risk of metabolic syndrome (Carnethon et al. 2004). Holme et al (2007) 
studied the leisure time physical activity of men in their middle age (~50 years) 
and followed them up after 28 years. They found a strong inverse relationship 
between physical activity and prevalence of metabolic syndrome. Laaksonen et 
al (2002) measured leisure time physical activity and the physical fitness of high 
risk 612 middle aged men without metabolic syndrome and followed them up. 
After four years, metabolic syndrome was observed in 107 (17%) participants. 
They found strong negative correlations between intensity of leisure time 
activity, physical fitness and the risk of metabolic syndrome.  
8.2.7.3. Socioeconomic factors 
Dallongeville et al (2005) found that household income was inversely 
proportional to the prevalence of metabolic syndrome in women after controlling 
the data for lifestyle factors. They also found an association between metabolic 
syndrome and occupational category, working status and accommodation type 
in both men and women. Household wealth was also found to influence the 
prevalence of metabolic syndrome (Perel et al. 2006). In contrast, Ramsay et al 
(2008) found a weak influence of socioeconomic status on metabolic syndrome. 
However, they found strong association between socioeconomic status and 
social behaviours that cause metabolic syndrome.  Mental status is also 
associated with metabolic syndrome. Mentally depressed women were twice as 
likely to have metabolic syndrome compared with non-depressed women 




Education levels are associated with the prevalence of metabolic syndrome 
(Dallongeville et al. 2005). Obese people seem to consider that the cause of 
obesity is due to genetic factors rather than over eating or inadequate physical 
activities (Lichtman et al. 1992). Carnethon et al (2004) found higher prevalence 
of metabolic syndrome in people with lower education. This may be due to the 
limited health care and higher physical and personal stress. Findings from the 
SHIELD study (Lewis et al. 2008) reported a huge lack of knowledge about 
metabolic syndrome among people with metabolic syndrome (0.6% were aware 
of metabolic syndrome among 25.9% prevalence of the condition). 
8.2.8. Relationship between metabolic syndrome and cardiovascular disease 
Metabolic syndrome has a strong link to the risk of developing cardiovascular 
disease. The presence of metabolic syndrome showed an elevated odds ratio 
for coronary heart disease (1.66, 95% CI 1.31 to 2.10) in an elderly population 
(He et al. 2006). Lakka et al (2002) found 1-11% mortality due to CHD 
(coronary heart disease) and 1-6% due to CVD (cardiovascular disease) in 
patients with metabolic syndrome (data adjusted for age and all the risk factors). 
Grundy et al (2004) analysed the Framingham data to establish the risk for CHD 
due to metabolic syndrome. They found that men had a 10-20% increased risk 
on 10 years follow up and women had relatively less risk on eight years follow 
up. After adjusting for Framingham’s usual risk factors and age, there was not a 
significantly increased risk of CHD due to metabolic syndrome.  However, the 
risk of CHD in metabolic syndrome cannot be underestimated.  
228 
 
8.3. Prevalence of metabolic syndrome 
The prevalence of metabolic syndrome varies according to the populations 
studied and the definition used. The prevalence found in various studies all over 
the world is listed in Appendix III. The prevalence also varies with the age group 
and gender. Elderly and particularly women are mostly affected. It is also 
important to note that there were only 38% of people with none of the factors of 
metabolic syndrome in some prevalence studies (Ferrannini et al. 1991; Rupp 
1992).  
8.3.1. United States of America 
The prevalence of metabolic syndrome has been continuously escalating. The 
prevalence was 24% in men and 23.4% in women among adults in the USA 
(United States of America) from the Third National Health and Nutrition 
Examination Survey (NHANES) (1988-1994) (Ford et al. 2002). Later, the 
prevalence had increased to 29.3% in women and 25.2% in men from NHANES 
1999–2000 (Ford et al. 2004). The recent statistics by the American Heart 
Association (Lloyd-Jones et al. 2010) established a further increase. In total 
~34% of adults had metabolic syndrome and it was 35.1% in men and 32.6% in 
women. The ethnic specific prevalence of metabolic syndrome in men vs. 
women were 37.2% vs. 31.5% in non-Hispanic white, 25.3% vs. 38.8% in non-
Hispanic black and 33.2% vs. 40.6% in Mexican American. The Mexican 
American had a high prevalence of metabolic syndrome in other studies too 
(Ford et al. 2002).  Overweight and obesity in young age is the major cause of 
metabolic syndrome in America. Cook et al (2003) carried out an analysis from 
the Third National Health and Nutrition Examination Survey 1988-1994 
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(NHANES III) found that 4% of USA adolescents (12-19 years) had metabolic 
syndrome and 28.7% of the adolescents with metabolic syndrome were 
overweight.  In 2006, 30% of American adults were overweight (BMI 25-29.9 
kg/m2), 32% were obese (BMI ≥ 30 kg/m2) and 5% of them were extremely 
obese (BMI ≥ 40 kg/m2) (Ogden et al. 2006). 
8.3.2. Europe 
The prevalence of metabolic syndrome in Europe is similarly varying with 
different studies. Most of the studies show that the prevalence of metabolic 
syndrome is higher in men than in women (Appendix III). However, the 
immigrant Asians had a higher prevalence overall compared with Europeans 
and Asian women had a larger prevalence than men (Tillin et al. 2005).  
8.3.3. Asia 
Asians also have high prevelence of metabolic syndrome including immigrant 
Asians. Lloyd-Jones et al (2010) found a high prevalence ranging from 26.8% to 
38.2% in immigrant Asian Indians depending on the definitions used. The 
prevalence of metabolic syndrome varied with the criterion used and increased 
with age in both central (China) and South Asia (India) (Appendix III). Enas et al 
(2007) claim that South Asians have a high level of metabolic syndrome 
prevalence due to the following reasons: (1) epidemiological transition, (2) 
genetic predispositions or ethnic susceptibility, (3) nutritional transition and (4) 
low physical activity. South Asians have a high prevalence of metabolic 
syndrome compared with other populations due to the higher prevalence of 
obesity and insulin resistance. Moreover, diabetes and premature coronary 
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heart diseases occur more often and 10 years earlier than in the other 
populations in the world (Enas et al. 2007). Another report (Gupta 2007) claims 
that low birth weight could account for the increase in the prevalence of 
metabolic syndrome in India. The lack of islet cells due to low weight at birth 
results in low insulin levels which could develop to diabetes later. Secondly, the 
children with low birth weight are getting more attention with overfeeding and 
high caloric food that could result in obesity (Gupta 2007).  The patterns of 
infant BMI levels were also associated with the development of metabolic 
syndrome in a follow-up study from birth to 21 years on an Indian population 




8.4. Management of metabolic syndrome 
There is no special treatment for managing metabolic syndrome other than 
treating the involved individual factors (Benedict 2006). Controlling individual 
risk factors in metabolic syndrome can prevent CVD. Wong et al (2003) treated 
individual factors of metabolic syndrome using ATP III criteria. Treating all the 
risk factors prevented CVD events in 51.3% men and 42.6% in women and 
controlling these risk factors to optimal level prevented CVD events up to 85.5% 
in men and 82.1% in women.  
The InternationaI Diabetic Federation (2006) recommends uncompromising and 
aggressive management for metabolic syndrome. It considers lifestyle changes 
that includes moderate calorie restriction, moderate increase in physical activity 
and change in dietary composition as primary management. For those having a 
high risk of CVD and when lifestyle management is not enough, drug therapy is 
considered as secondary intervention to reduce the impact of all the risk factors: 
lowering triglycerides, raising HDL, reducing high blood pressure 
(antihypertensive therapy) and controlling insulin resistance/hyperglycaemia. 
The secondary interventions need to prioritize the care programme according to 
the primary risk (Benedict 2006). The interventions need to focus primarily on 
either stabilizing blood sugar or hypertension before controlling other factors.  
8.4.1. Management of hypertension 
The JNC 7 report suggests treating hypertension with antihypertensive drugs for 
those having blood pressure 140/90 or greater and 130/80 or greater with 
diabetes or kidney disease (Chobanian et al. 2003). However, no specific class 
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of antihypertensive drugs has been identified for patients with metabolic 
syndrome. Dumas (2003) suggests that use of drugs such as beta-blockers can 
reduce further endothelial damage.  Low salt diet should be encouraged  and 
weight loss of 4.5 kg could be effective in reducing 10 mmHg of blood pressure  
(Dumas 2003) 
8.4.2. Management of insulin resistance 
In case of hyperglycaemia, hypoglycaemic agents and lifestyle therapies should 
be used to maintain haemoglobin A1c levels (Grundy et al. 2004). Increased 
physical activity and weight reduction can reduce insulin resistance. Currently 
there are two classes of drugs available for insulin resistance: metformin and 
insulin sensitizers such as thiazolidinediones. Both of these drugs are currently 
used for type II diabetes or impaired glucose tolerance.  However, these drugs 
are not recommended for the reduction of CVD risk as there are no CVD end-
point studies available on people with metabolic syndrome (Grundy et al. 2004). 
Metformin is recommended for normalizing blood glucose level (Dumas 2003). 
Dietary supplements such as chromium are also effective to increase glucose 
utilization and decrease insulin resistance (Dumas 2003).  
8.4.3. Management of dyslipidaemia 
A healthy diet is an effective way to reduce lipid levels. Pharmacological 
management is also available. Statins and fibrates are cholesterol-lowering 
drugs commonly known for their effectiveness in the reduction of LDL 
cholesterol levels. Their effectiveness in the reduction of CVD risk has been 
established in patients with metabolic syndrome (Grundy et al. 2004). Evening 
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doses of statin are recommended to maximize the effect as the peak cholesterol 
synthesis occurs during the night (Dumas 2003). Ezetimibe is another lipid 
lowering drug which reduces the absorption of dietary cholesterol at small 
intestine level and thus lowers the amount of cholesterol delivered to the liver 
(Dumas 2003).  
8.4.4. Weight loss 
ATP III recommends obesity to be a primary target in the management of 
metabolic syndrome. Physical activity should be a first line therapy. Weight loss 
could help in achieving the following: reduction in serum levels of cholesterol, 
triglycerides, C-reactive protein, and PAI-1, reduction in blood pressure, glucose 
and insulin resistance, and increases in HDL cholesterol.  
A vigorous weight loss plan should be administered to reduce 7-10% of total 
body weight in the first year and then progressed slowly until reaching a BMI of 
about 20-25. Diet should be reduced by 500-1000 caloric intake per day rather 
than reducing it drastically (Grundy et al. 2005a). The use of exercise or diet 
alone is not enough to achieve a substantial weight loss but it is effective when 
they are combined (Wood 1993). The National Institute of Health (NIH) 
suggests that  a pharmacologic therapy could be used if only a patient is not 





Lifestyle change is the most important stratagy to manage metabolic syndrome. 
Rush et al  (2007) achieved a significant reduction in abdominal obesity and 
lipid levels with changes in lifestyle within five months in Asian Indian population 
who were older than 50 years. Enas et al (Enas et al. 2007) states that a 
healthy lifestyle should be adopted as early as from childhood or adolescence 
due to the genetic predisposition and epidemiological transition of components 
of metabolic syndrome. 
8.4.5.1. Exercise 
A combination of cardiorespiratory fitness, endurance and resisted muscle 
strength exercise is proposed as an optimal exercise programme for metabolic 
syndrome (Eriksson et al. 1997). A prior exercise testing and physical 
examination would help to prescribe optimal intensities of exercise. Petrella et al 
(2005) conducted a controlled cohort study on a 59-75 year old Canadian 
population. The subjects were administered supervised exercises regularly and 
followed up for 10 years. The exercised group had developed less metabolic 
abnormalities and higher physical fitness than the control group. This finding 
shows that regular exercise can help in preventing or delaying metabolic 
syndrome. Despite the success of regular exercise in the management of 
metabolic syndrome, there are no exercise programmes such as cardiac 





A lack of awareness of caloric intake exists among people with obesity. 
Lichtman et al (1992) found a significant discrepancy in calorie intake of obese 
participants. The actual calorie intake was substantially higher than the self-
reported values and their physical activity was overestimated in their reports. 
According to ATP III’s recommendations, everyday diet should be restricted as 
listed in table 8.3 (Grundy et al. 2005a). However, a balance on energy intake 
and expenditure on physical activities should be maintained (Anderson et al. 
2006). Therefore, health education on dietary intake and balancing it with 
physical activities needed to be improved.  
Table 8.2 Diet recommendations by ATP III 
Nutrient  ATP III Recommendations 
Total cholesterol <200 mg 
Total fat  25% -35% of total daily calories per day 
Saturated fat < 7% of total daily calories per day 
Polyunsaturated fat ≤ 10% of total daily calories per day 
Monosaturated fat ≤ 20% of total daily calories per day 
Soluble fibres 20-30 grams per day 
Carbohydrate 45%-50% of total daily calories 
Protein 15% of total daily calories per day  
Total energy intake Balanced (can be gradually reduced 500-1000 
calories per day) 
(Grundy et al. 2005a) 
8.4.6. Prevention 
Vigorous preventive measures should be taken for those having a family history 
of diabetes and CHD. Therapeutic lifestyle changes should be encouraged from 
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childhood. Healthy eating habits should be emphasized. Detection of one 
component of metabolic syndrome should lead to investigations for other 
components and further management. Adequate nutrition should be maintained 
during the intra uterine period in South Asian countries where malnutrition is 
one of the causes of metabolic syndrome (Misra et al. 2007). Adequate intake 
of dietary supplements should be encouraged such as folic acid and vitamin B6 
(decreases homocysteine which is related to heart disease), vitamin E (helps in 
breakdown of LDL while increasing HDL and also reduces the risk of thrombus 
formation), garlic (reduces the total cholesterol level) and omega-3 fatty acids 
(lowers total cholesterol and triglycerides levels) (Dumas 2003). Physical 
abuses such as smoking, heavy alcohol consumption and overeating need to 
be corrected. Regular exercise with optimum intensity and time should be 
encouraged as lifestyle behaviour.  
8.4.7. Future research 
A uniform definition for metabolic syndrome needs to be established. 
Theoretically, changing lifestyle is the most effective treatment for metabolic 
syndrome but it is practically difficult to achieve. Further studies using valid 
measures to minimize errors should be undertaken. Programmes will involve 
enhancing health education and developing more flexible exercise 
opportunities. New specific methods for encouraging lifestyle changes need to 
be developed and studied. Home-based exercise programmes could be an 
effective alternative for centre-based exercise programmes. Studies are needed 
on the effectiveness of home-based programmes on metabolic syndrome. 
Further, investigations are needed to validate home-based exercise 
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programmes, using recently developed communication technologies such as 
mobile phones and the internet.  
8.5. Conclusions 
The prevalence of metabolic syndrome is continuously escalating worldwide. A 
uniform, globally acceptable definition is necessary to establish the prevalence 
of metabolic syndrome and for the development of effective and unique 
treatment strategies. Early identification of metabolic syndrome could help to 
reduce the risks of cardiovascular disease. Monitoring the development of the 
risk factors from childhood or adolescence can help the early identification. A 
sedentary lifestyle is the major cause of metabolic syndrome. Lifestyle change 
is the key factor for the prevention and management of metabolic syndrome. 
More emphasis on changing to a healthy lifestyle with health education is 
necessary. More investigations are needed on alternative methods such as 
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CHAPTER 9. PREVALENCE OF HYPERTENSION, OBESITY, DIABETES 
AND METABOLIC SYNDROME IN NEPAL 
Abstract  
Background: Early detection of cardiovascular risk in underdeveloped 
countries in Asia, such as Nepal, is one method to control disease prevalence. 
This study was carried out to establish the prevalence of cardiovascular risks 
such as hypertension, obesity and diabetes in Eastern Nepal. This study also 
establishes the prevalence of metabolic syndrome (MS) and its relationships to 
those cardiovascular risk factors and lifestyle. Methods: 14,425 subjects aged 
20-100 (mean 41.4±15.1) were screened. Physical examination included blood 
pressure, weight, height, waist and hip circumferences. Blood test included 
fasting plasma glucose and lipids. Both the International Diabetic Federation 
(IDF) and National Cholesterol Education Programme’s (NCEP) definitions for 
MS were used and compared.  Results: According to the revised values for 
South Asians, 34% of the participants had hypertension and 6.3% were 
diabetic. 28% were overweight (BMI =22-24.9) and 32% were obese (BMI> 25). 
22.5% of the participants had metabolic syndrome based on IDF criteria and 
20.7% according to the NCEP definition. Prevalence was higher in the less 
educated, people working at home and females. There was no significant 
correlation between the participants’ lifestyle factors and the prevalence of MS. 
Conclusion: The prevalence of MS increased with age and females had higher 
prevalence of MS compared with men. The incidence of low levels of high-
density lipoprotein cholesterol and high levels if triglycerides, and abdominal 
obesity could be the major contributors to MS in Nepal. Education also appears 




According to the World Health Organization’s recent update (WHO 2009), 
diabetes, hypertension and obesity are one of the top five continuing risk factors 
for cardiovascular deaths in the world. Obesity is increasing substantially and is 
one of the major contributors of disease prevalence due to its 
pathophysiological link to other cardiovascular risks such as hypertension and 
diabetes. It is estimated that in 2010, 6.4% of adults would have diabetes 
mellitus affecting 285 million in the world and it will increase to 7.7% by 2030, 
affecting 439 million adults [2]. Of special note is that, there will be a 67% 
increase in the prevalence of diabetes in developing countries from 2010 to 
2030 (Shaw et al. 2010). 
Metabolic syndrome (MS) is a constellation of overweight/obesity, hypertension, 
and disturbances of lipid and carbohydrate metabolism. The definition of MS 
was debated for a long time to produce a standardized clinical criterion. The 
World Health Organisation describes MS as the presence of type II diabetes or 
impaired glucose tolerance with any two of the following characteristics; obesity, 
high levels of triglycerides, low levels of high-density lipoprotein and 
hypertension.  The International Diabetes Federation (IDF) takes central obesity 
as a pre-requisite for the diagnosis of MS with the association of any two of the 
other factors i.e. high blood pressure, abnormal blood glucose, high levels of 
triglycerides and low levels of high-density lipoprotein. In addition, the IDF has 
derived specific reference values for central obesity for different ethnicities. The 
National Cholesterol Education Programme (NCEP 2002) expert panel on 
detection, evaluation and treatment of high blood cholesterol in adults (Adult 
treatment panel, or ATP, III), the National Heart, Lung and Blood Institute and 
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the American Heart Association (Grundy et al. 2004) have released a report on 
the criteria for diagnosing and managing MS. The panel describes MS as the 
presence of any three of the following: abdominal obesity, dislipidaemia (high 
levels of triglycerides, low HDL), increased blood pressure and elevated fasting 
glucose. This definition has been extensively reviewed and accepted by the 
greatest number of researchers. For the purpose of this paper, the ATP III and 
IDF’s definitions are used and compared. 
Each component of MS is a known risk factor for the development of type 2 
diabetes, atherosclerosis and coronary artery disease (CAD). People with MS 
are 3-10 times more likely to develop cardiovascular disease commensurate 
with a high risk of morbidity and mortality (Eberly et al. 2006; Nestel et al. 2007). 
Central obesity, one of the components of MS, predicts the occurrence of 
diabetes and overall cardiovascular risk (Poirier and Despres 2003). The NCEP 
ATP III (NCEP 2002) states that MS is equal to cigarette smoking as a 
contributing factor for premature cardiovascular disease. 
The prevalence of metabolic syndrome is increasing all over the world with 
different regions having individual clusters of epidemic risk factors (Cheung and 
Thomas 2007; Eberly et al. 2006) and in particular there is evidence of a high 
prevalence of MS and diabetes in South Asians (Misra et al. 2009).  Substantial 
increase in the prevalence of type 2 diabetes in Asia in recent years has raised 
serious concerns about cardiovascular consequences for these populations 
(Nestel et al. 2007; Scott et al. 2008). However, in developing countries, many 
of these subclinical conditions are not diagnosed until the onset of 
complications such as myocardial infarction or stroke (Ringborg et al. 2009). It 
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is essential to initiate early detection of these chronic diseases in 
underdeveloped countries in Asia, such as Nepal, so that preventative action 
can minimize the consequences. 
This study aims to establish the prevalence of hypertension, diabetes, obesity 
and metabolic syndrome in the participants of a major health screening 
programme in Nepal. This study also aims to establish the relationship between 
the components of MS and lifestyle of the participants. 
9.2. Methods 
9.2.1. Subjects 
Nepal is one of the poorest countries of the world at the 136th position of 
human development index. The total population of Nepal is 27 million. The 
subjects were the participants of the ‘Programme for Detection and 
Management of Chronic Kidney Disease, Hypertension, Diabetes & 
Cardiovascular Disease,’ a community based screening programme in Eastern 
Nepal (Sharma et al. 2010) . A raw dataset was obtained with permission to use 
in the current study and published (Sharma et al. 2011). 
9.2.2. Research team and demographic data collection 
In this community-based programme a series of community awareness 
programmes were conducted in a specific locality with the help of local leaders, 
medical students and community volunteers. Various screening centres such as 
permanent centres (in health clinics, community centres, etc.) and temporary 
screening centres (in schools, clubs, houses of worship and private homes) 
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were used to screen the population. Each centre used a group of five to seven 
people as community volunteers and consisted of local leaders (priest, 
administrator, school teachers, and local political leaders), a laboratory 
technician, and nurse. Medical students (approximately 100 in number) and 
nursing students (around 25) assisted the community volunteers.  
Prior to screening, the community volunteers went from door-to-door to record 
the number of family members residing permanently and to inform the members 
of the family, about the need of the project.   All people of ≥20 years were 
invited to come to a predefined place in very close vicinity to their house.  They 
were requested to avoid food for the previous 12 hours. Pregnant or 
menstruating women at the time of analysis, people with a fever or acute illness, 
and those who had recently engaged in heavy exercise were excluded.  
The research team also collected general information on the participants’ 
demographic data, diet, smoking, alcohol consumption and physical activity. 
The data recorded included family and medical history for kidney disease, high 
blood pressure, diabetes, cardiovascular disease and any current medication or 
treatment.  
9.2.3. Physiological measurements 
Blood pressure was measured by the auscultatory method with a random zero 
mercury sphygmomanometer and standard cuff (12 x 34 cm). The blood 
pressure measurement was taken in the seated position, quietly in a chair with 




Hypertension was defined according to the guidelines of the Seventh Report of 
the Joint National Committee on Prevention, Detection, Evaluation and 
Treatment of High Blood Pressure (Chobanian et al. 2003), i.e. systolic blood 
pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg and/or 
concomitant use of antihypertensive medications. Body weight and height were 
assessed with all subjects standing without shoes and heavy outer garments to 
the nearest 0.1 kg and 1 cm, respectively.  Body mass index was estimated 
according to standard nomograms. Waist circumference was measured over 
light clothing at a level midway between the lower rib margin and the iliac crest 
in centimetres rounded up to nearest 0.5 cm. Abdominal obesity is defined as 
an abdominal circumference > 102 cm (40 in) in males and > 88 cm (35 in) in 
females for NCEP criteria and > 90 cm in males and >80 cm in females for IDF 
criteria for South Asians.  
Plasma glucose concentration was determined by the glucose oxidase-
peroxidase method (Vitalab Selectra-2, Merck, Germany). The diagnosis of 
diabetes was defined by either casual plasma glucose >200 mg.dL-1 
associated with symptoms of diabetes and on fasting samples, plasma glucose 
>126 mg.dL-1. Individuals with self-reported, prior physician-diagnosis of 
diabetes were classified as having previously diagnosed diabetes.  
Serum lipids that include total cholesterol, high-density lipoprotein (HDL), low-
density lipoprotein (LDL) and triglycerides (TG) were also measured (Vitalab 
Selectra-2, Merck, Germany). 
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9.2.4. Quality control 
The result from any person having a history of hypertension or found to have 
hypertension were verified by qualified doctors.  All biochemical abnormalities 
were reconfirmed. The biochemical tests were completed in semiautomatic 
analysers (Microlab 300, Vital Scientific, The Netherelands). The tests were 
undertaken in the same machine using standard biochemical reagents. Regular 
internal quality controls were undertaken and routinely crosschecked with other 
laboratories.  
9.2.5. Data Handling 
Data were stored in a central electronic database using ‘Epidata’ software. 
Epidata refers to a group of applications used in combination for creating 
documented data structures and analysis of quantitative data. In this study, 
Epidata was used for simple and programmed data entry and data 
documentation.  
9.2.6. Data analysis 
Data were extracted from ‘Epidata’ and imported to SPSS 18.0 software. The 
data were re-coded as necessary and frequencies were analysed. The IDF and 
NCEP ATP III’s criteria for metabolic syndrome were used to calculate and 
compare the frequency of metabolic syndrome. The NCEP criterion was used to 
find the correlations with other findings. The relationship between the 
prevalence of cardiovascular risk factors, demographic details, lifestyle and 
physiological test results were analysed using the Spearman correlation test. 
Further, the differences in the categorical variables were examined using chi-
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squared test. Odds Ratios (ORs) and their 95% confidence interval was 
calculated using logistic regression. 
9.3. Results 
In total, 14,425 people, aged 20-100 (Mean age 41.4±15.1) were included in the 
study. Among them, 99.9% were South Asians who were living in Nepal.  
The participants’ demographic and lifestyle details are listed in Table 9.1. The 
participants were a mixture of various levels of education. The percentage of 
education level is illustrated in accordance to the number of years in education 
(1-5 years – Primary, 6-10 years- Secondary, >10 years- Higher Secondary 
level). The participants were divided into four categories according to their work: 
labourer/farm, office, house and none/unknown. The age was divided into four 
categories. Participants’ physical activities were defined according to the time 
spent every day on physical activity as >60 min, 30-60 min and <30 min/day 





Table 9.1 Demographic and lifestyle details of the participants 
Demographic detail % in total participants 
Age 
(n= 14425) 
20-40 Years-     53.6% (n= 7729) 
41-60 Years-     33.8% (n=4880) 
61-80 Years-     11.9% (n= 1716) 
80-100 Years-    0.7% (n= 100) 
Gender (n= 14009) 
Male -                38% (n=5327) 
Female -            62% (n=8682) 
Level of education (n= 14009) 
Higher Secondary - 33.1% (n= 4635) 
Secondary -       22% (n= 3079) 
Primary -         14.9%  (n=2092) 
None-                30% (n= 4197) 
Work category (n= 13982) 
Labour -            12.9% (n= 1797) 
House -             57.1% (n=7977)  
Office -              14.9% (n=2090) 
None -             15.1% (n=2118) 
Physical activity (n= 14001) 
>60 min/day -    37.1% (n= 5190) 
30-60 min/day - 25.3% (n= 3543) 
<30 min/day  
or None -          37.6% (n= 5628) 
Fruits & vegetables in diet  
(n= 14009) 
Everyday -        31.4% (n= 4403) 
1-5 days -         56% (n=7842) 
Once/week  
or None -       12.6% (n= 1764) 
Smoking 
(n= 14004) 
Current – 11.9% 
(n=1673) 
>10 years –       8.5% 
1-10 years –     32.3% 
< 1 year –         59.2% 
Previous – 8.8% ((n= 1232) 
Alcohol consumption  
(n= 13998) Total -  24.8% 
Every day –        6% (n= 838) 
Once/week-       9.5% (n= 1189) 




9.3.1. Obesity, diabetes and hypertension 
Abdominal obesity was observed in 11.5% (n= 1607/14002) of the participants 
as per NCEP criteria (mean waist circumference: male-107.38 ± 6.19 cm, 
female - 94.84 ± 5.84 cm) and in 34.7% (n= 5006/14418) of the participants as 
per IDF criteria. According to the revised BMI values specifically for south 
Asians as outlined by Razak et al (2007), 10.6% (n= 1534/14423) were 
underweight (BMI< 18.5 kg/m2), 28.2% (n= 4065/14423) were overweight (BMI 
=22-24.9 kg/m2) and 32.5% (n= 4689/14423) were obese (BMI> 25 kg/m2).  
Diabetic prevalence was 6.3% (889/14008) of which 4.8% (n= 673/14008) were 
under treatment. A figure of 12.3% (n= 1718/14009) had a family history of 
diabetes. Hypertension was observed in 33.9 % (n= 4894/14422) of the 
participants (mean systolic 138.72 ± 18.03 mmHg and mean diastolic 93.09 ± 
8.45 mmHg). Only 12.9% (1812/14009) were previously diagnosed and 8.5% 
were receiving treatment for hypertension. A history of coronary artery disease 
was present in 1.6% (n = 218/14007) and 1% (n=142) were under treatment for 
ischemic heart disease or stroke. 
Table 9.2 shows the goodness of fit for the prevalence of obesity, hypertension 
and diabetes. The comparison was against the latest available prevalence data 
(IDF 2009; Vaidya et al. 2010; World-Hypertension-League 2008). Prevalence 
of hypertension showed no difference from these data and obesity showed only 
a small difference. Diabetes showed a large statistically significant difference 




Table 9.2 Chi-squared ‘goodness of fit’ for the prevalence of cardiac risk factors in participants 
Category  Observed n Expected n Chi-Squared Significance (p) 
Obesity (n= 14423) 
No 9734 9605.7 
0.024* 
Yes 4689 4817.3 
Hypertension (n=14422) 
No 9528 9547.4 
0.733 
Yes 4894 4874.6 
Diabetes (n =14008) 
No 13119 13461.7 
0.001** 
Yes 889 546.3 
**Significant at the 0.01 level (2-tailed) Significant at the 0.05 level (2-tailed). 
 
The percentage of the participants who had abnormal lipid profile that includes 
total serum cholesterol, serum LDL cholesterol, serum HDL cholesterol, serum 
triglycerides are listed in Table 9.3. 
Table 9.3 Percentage of participants’ abnormal lipid profile 
9.3.2. Prevalence of metabolic syndrome 
There were 2191 set of data eligible to meet the criteria for metabolic syndrome. 
MS was observed in 22.5% (n=494/2191) of the participants according to the 
IDF criteria and 20.7% (454/2191) according to the NCEP criteria. The 




High Cholesterol 17.2% (n= 1663/9696) 227.9±34.06 >200 
High LDL 36.2% (n= 791/2188) 129.91 ± 27.09 >100 
Low HDL 56.7% (n= 1242/2192) 
Male - 33.63 ± 3.83 
Female - 39.08 ± 5.71 
Male <40 
Female <50 
High Triglycerides 48.3%  (n= 4681/9689) 231.52 ± 101.91 > 150 
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percentages of individual MS risk factors among the total participants and the 
participants with MS are illustrated in Figure 9.1 and Figure 9.2. Generally, 
among the total participants and the specific participants with MS, the presence 
of abnormal lipids was higher than the other factors defining MS.   However, the 
presence of abdominal obesity was higher among MS participants using IDF 
criteria (Figure 9.2).  
 





Figure 9.2 Percentage of individual risk factors among participants with MS 
Table 9.4 provides the MS prevalence in relation to demographic and lifestyle 
factors. The females had a higher prevalence of MS than males. According to 
the NCEP criteria, the age groups 41-60 and 61-80 had a higher prevalence of 
MS then the lower age group. According to IDF criteria, the age groups 41-60 
and 20-40 had a higher prevalence of MS. The prevalence of MS was higher in 
participants with less education. The participants who worked at home had a 
high incidence of MS according to both the criteria used. The sedentary group 





Table 9.4 Demographic details and prevalence of metabolic syndrome and other risks 
 
Disease prevalence in participant category 
Obesity/ 
Overweight Diabetes Hypertension 
MS – NCEP 
Criteria 






















































































































































































































































































































The univariate correlations between cardiac risk factors are shown in Table 9.5 
and the chi-squared independence of them in the metabolic syndrome 
prevalence is listed in Table 9.6.  




 Hypertension Diabetes Metabolic syndrome 
Obesity 0.150** 0.070** 0.153** 
Hypertension  0.101** 0.234** 
Diabetes   0.384** 
** Correlation is significant at the 0.01 level (2-tailed) 
 
Table 9.6 Chi-squared independence of cardiac risk factors in the prevalence metabolic 
syndrome  









(n=2191) ** Correlation is significant at the 0.01 level (2-tailed) 
The NCEP scores had a significant positive relationship with education levels 
and physical activity. There were significant positive correlations between 
physical activity and the three individual MS components: high glucose (r=0.03, 
p<0.01), high BP (r=0.04, p<0.01) and low HDL (r= 0.23, p<0.01). There was no 
correlation between physical activity and the other two MS components: high 
triglyceride (r=0.003, p>0.05) and abdominal obesity (r=-0.003, p>0.05). There 
was no relationship with diet and work. The NCEP scores had a positive 
correlation between the family history of diabetes (r=0.83, p<0.01) and 
hypertension (r=0.115, p<0.01). Although a number of these correlations show 
high levels of significance, the common variance is extremely low, suggesting 
that the sample size is having a major impact on the significance.  As a result of 
this, it is not proposed to develop this outcome in any great detail. 
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Table 9.7 lists the chi-squared independence, odds ratios and confidence 
intervals in the association between age, gender and specific lifestyle factors in 
metabolic syndrome prevalence. The sensitivity (B) shows the direction of the 
relationship. Odds ratio (OR) values show the predicitvity of the categorical 
variables on the prevelance of metabolic syndrome. Aging, lower physical 
activity, lower education, house work and smoking showed associations with 
the higher prevelnce of metabolic syndrome.  
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Table 9.7 Chi-squared significance for the independence, Odds Ratios and 95% confidence interval of age, gender and 








SE Odds Ratio (ORs) 
95% 
Confidence Interval 
Gender NS -0.204 0.111 0.815 0.655-1.014 




-0.473 0.15 0.623** 0.464-0.837 
Secondary -0.689 0.162 0.502** 0.366-0.690 




0.15 .230 1.161 0.740-1.821 
Office 0.02 .207 1.019 0.679-1.529 
House 0.52 .164 1.675* 1.216-2.308 
Fruit/Veg in diet 
Everyday 
NS 
.649 .636 1.914 0.550-6.664 
3-5 days/week .480 .624 1.616 0.475-5.492 




.286 .189 1.332 0.919-1.929 




.966 .196 2.628** 1.789-3.859 
30-60 min/day 1.041 .175 2.833** 2.010-3.993 
<30 min/day 1.138 .173 3.121** 2.222-4.383 
** Correlation is significant at the 0.01 level (2-tailed).  *Correlation is significant at the 0.05 level (2-tailed)  




It is important to observe the prevalence of diabetes, hypertension, and obesity 
individually and also the cluster of risk factors as metabolic syndrome to predict 
the risk of cardiovascular disease.  Any association between lifestyle factors 
and these risk factors would provide the opportunity to encourage a change in 
lifestyle to promote lower levels of subsequent CVD.  
9.4.1. Education, work and physical activity 
The large number of poorly educated people and the large number of school 
dropouts could be linked to the disease prevalence. The prevalence of 
hypertension and metabolic syndrome in poorly educated people was large 
when compared with the educated participants. Though the results are not 
generalized, the relationship between education levels and the prevalence of 
hypertension agrees with earlier studies (de Gaudemaris et al. 2002; Samal et 
al. 2007).  These found that education levels significantly influence the 
knowledge of hypertension and the awareness of cardiovascular risk. This 
suggests that there is a need to improve the awareness of health and use 
education to prevent or reduce the risk of MS and cardiovascular risks in these 
groups. The office workers had a lower prevalence of MS (NCEP scores) than 
the other groups. A considerable number of office workers (64%) undertook 
regular physical activity of more than 30 min/day. This may be due to health 
awareness gained from higher education. Most of the poorly educated or less 
educated people were labourers or home workers. The labourers had a lower 
MS prevalence than the home workers did. This may be due to the physical 
activities involved in their work. The home workers education levels and 
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physical activities were comparatively lower than the other work groups. These 
findings clearly show that education and physical activity have an influence on 
the prevalence of MS. Most of the females were home workers (75.5%) and 
their education was comparatively lower than the males. This may be the 
reason for the higher prevalence of MS in females. The amount of physical 
activity involved in home workers is unknown, but the results suggest it is less 
than that undertaken by other workers. 
Asian populations continue to modernize and levels of physical activity are 
declining as (i) home and work place jobs become more automated and 
sedentary and (ii) transportation is more readily available [7]. The prevalence of 
MS among the participants who had no physical activity was surprisingly no 
different from others. This may be due to a higher than average number of 
missing values in these data (2191/14425 complete data to meet the criteria for 
MS) or to other unknown socioeconomic factors.  
9.4.2. Diet and age 
Controversially, there was a high prevalence of MS among people, who 
regularly ate fruit and vegetables. Lee et al (Lee et al. 2008) found that a higher 
intake of macronutrients such as fruits and vegetables is associated with 
general obesity. However, it is not clear how the vegetables and fruits were 
eaten e.g. overcooked, processed etc. The exact quantity of the dietary intake 
was not recorded, as it was not the primary area of focus of the study. In these 
populations, several dietary imbalances have been reported in previous studies. 
These tend to report a low intake of mono-unsaturated fats (MUFA), n-3 
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polyunsaturated fats (PUFA) and trans-fatty acids (mostly related to widespread 
use of vanaspati, a hydrogenated oil) (Misra et al. 2009). The healthy traditional 
plant-based diets are being replaced by cheaper calorie dense high fat foods. 
These changes are resulting in a rapid increase in the prevalence of obesity 
throughout Asia and the subsequent development of MS (Cheung and Thomas 
2007). Ness and Powles also found in their review (Ness and Powles 1997) that 
many studies were reporting the null or negative effects of fruit and vegetable 
intake on the prevalence of cardiovascular diseases. However, the correlations 
found in those studies were generally low, as seen in the current study. Further, 
they suggest that a food-based analysis would complement the nutrient based 
analysis to clarify these issues (Ness and Powles 1997). In Nepal, the regular 
diet in addition to fruits and vegetables, i.e. such as rice, which is high in 
carbohydrates and the methods of cooking, may be dietary causes of metabolic 
syndrome.  Generally in Nepal, a small quantity of single, locally grown 
seasonal vegetable is a common constituent of meals. This may not be 
sufficient to achieve a healthy lifestyle.  
The age groups 40-60 had a large prevalence of MS in this study. In addition, it 
is important to note that this middle-aged group had a high incidence of 
overweight or general obesity and abdominal obesity. The other age groups had 
a lower prevalence of MS than the 40-60 years old, yet it was still relatively 
high. This included the younger population (20-40 years) at nearly 10%. 
Inadequate maternal nutrition in pregnancy, low birth weight and childhood 
obesity may be important factors for the development of metabolic syndrome 
and diabetes (Misra et al. 2009). Specifically in children and young individuals, 
a high intake of n-6 PUFA is correlated with hyper-insulinaemia. In adults, high 
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carbohydrate meal consumption is related to hyper-insulinaemia, post-prandial 
hyperglycaemia and hypertricylglycerolaemia (Misra et al. 2009).  
9.4.3. Obesity and lipids 
Unger described metabolic syndrome as “a failure of the system of intracellular 
lipid homeostasis which prevents lipotoxicity in organs of over nourished 
individuals” (Unger 2003). In this study, a large number of participants had 
increased triglycerides levels and low HDL levels. In addition to low levels of 
HDL, the HDL particles are small, dense and dysfunctional in South Asians 
(Enas et al. 2007). These are strong predictors of cardiovascular disease.  
Hypertriglyceridaemia is a direct reflection of an insulin resistance condition and 
it is interrelated to the low HDL concentrations in developing endothelial 
dysfunction (Eckel et al. 2005).  
In Nepal, a high number of the participants had abdominal obesity and were 
over-weight/obese, according to their BMI. The BMI is a simple useful measure 
for overall abnormal weight, yet not a standard measure for obesity. BMI cannot 
differentiate between whether the condition was due to unusual muscular 
development or the accumulation or distribution of fat in the body (Lakka et al. 
2002; Marks 2003). Despite the low prevalence of general body obesity 
compared with western countries, metabolic syndrome is growing into a 
significant public health problem in Asia (Pan et al. 2008). This may be mainly 
due to the large number of people with central obesity, a feature that was also 
observed in this study. The higher prevalence of MS in females is also more 
likely to be due to a higher incidence of abdominal obesity. Abdominal obesity is 
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an important factor because metabolic syndrome and increased abdominal fat 
is related to a reduction of adiponectin, an adipocyte-derived hormone with anti-
atherogenic and anti-inflammatory properties (Salmenniemi et al. 2004). The 
abdominal adipose tissue results in release of free fatty acids directly in the 
portal veins and altered lipid levels in the blood (Larsson et al. 1984). Further 
abdominal adiposity increases insulin secretion and it would be exaggerated by 
decreased hepatic clearance leading to hyperinsulinemia (Bjorntorp 1990). The 
free fatty acid release also results in endothelial dysfunction that develops 
hypertension.  Thus abdominal obesity is an important indicator of 
cardiovascular disease due to its link to dyslipidaemia, hyperinsulinemia, 
hypertension and impaired fibrinolytic capacity (Folsom et al. 2000).  
9.4.4. IDF vs. NCEP definitions 
Tan et al (2004) states that if the NCEP’s criteria were applied to the Asian 
population it might underestimate the prevalence of metabolic syndrome and 
the risk of cardiovascular disease. So a reduced cut off point for abdominal 
obesity for Asians was suggested. IDF’s specific reference values for abdominal 
obesity make a substantial difference to the prevalence of MS between the two 
criteria. The IDF’s cut off points for South Asians’ waist circumference is lower 
than the NCEP’s general cut off points (≥90 cm vs ≥102 cm in men and ≥80 cm 
vs ≥88 in women). Another study on Chinese population also found a large 
increase in the prevalence of metabolic syndrome using IDF criteria compare 
with NCEP criteria (He et al. 2006). However, in the current study both the 
definitions demonstrated a higher prevalence of metabolic syndrome (20.7 – 
22.5%) in Nepal when compared with the studies done in other Southeast Asian 
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countries such as Thailand (12%-18% using NCEP definition) and India (18.3% 
using IDF definition) (Grundy 2008). These findings suggest the need for 
specific attention to control the disease prevalence in Nepal. 
9.4.5. Limitations 
The current study has several limitations that should be considered. Although 
data were prospectively collected, they may not be generalizable outside of 
Eastern Nepal. The results did not show substantiate relationship between 
smoking histories, diet, family history of cardiovascular and metabolic 
syndrome. Matched groups may be more appropriate to explore these 
relationships.  
9.5. Conclusions  
There was high prevalence of hypertension and obesity in Nepal. High 
triglycerides and low HDL levels substantially contribute the prevalence of MS in 
Nepal. Abdominal obesity, with the revised reference values, is an important 
risk due to its physiological relationship to the other MS risk factors. There was 
also a high level of blood glucose. The MS prevalence may be due to lack of 
awareness and unhealthy lifestyles, so health education and more preventive 
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CHAPTER 10.  ACUTE CHANGES IN ARTERIAL STIFFNESS FOLLOWING 
EXERCISE IN PEOPLE WITH METABOLIC SYNDROME IN INDIA 
Abstract 
Background: Metabolic syndrome is a cluster of specific cardiovascular risk 
factors. Exercise capacity is recognised as an important diagnostic and 
prognostic tool for cardiovascular disease. Non-invasive measurement of 
arterial stiffness using pulse wave analysis is a recently developed tool to 
identify cardiovascular risk. This study aims to examine the changes in arterial 
stiffness, immediately following sub-maximal exercise in people with metabolic 
syndrome. Methods: Ninety-four adult participants (19-80 years) with metabolic 
syndrome were measured for arterial stiffness using a SphygmoCor (SCOR-
PVx, Version 8.0, Atcor Medical Private Ltd, USA) immediately before and 
within 5-10 min after an incremental shuttle walk test. The arterial stiffness 
measures used were pulse wave velocity (PWV), aortic pulse pressure (PP), 
augmentation pressure, augmentation index (AI), subendocardial viability ratio 
(SEVR) and ejection duration (ED) Results: There was a significant increase in 
most of the arterial stiffness variables following exercise (p<0.05). Exercise 
capacity had a strong inverse correlation with arterial stiffness and age (p<0.01) 
Conclusion: Age influences arterial stiffness. Exercise capacity is inversely 
related to arterial stiffness and age in people with metabolic syndrome. Exercise 
induced changes in arterial stiffness measured using pulse wave analysis is an 
important tool that provides further evidence in studying cardiovascular risk in 




Metabolic syndrome (MS) is a cluster of cardiovascular risk factors. It includes a 
combination of increased blood glucose, alterations in the lipid levels, increased 
abdominal obesity and increased blood pressure. The prevalence of metabolic 
syndrome is increasing all over the world. Different countries show different 
clusters of epidemic risk factors. There is an increased risk of coronary artery 
disease as well as cerebrovascular disease in Asians with MS (Cheung and 
Thomas 2007). There is evidence for a large prevalence of MS and diabetes in 
South Asians and it is continuously escalating (Misra et al. 2007). Poor exercise 
capacity is one of the clinical characteristics of cardiovascular disease with low 
cardio respiratory fitness commonly observed in metabolic syndrome (LaMonte 
et al. 2005).  
Arterial stiffness is also identified as a marker of cardiovascular diseases. 
Generally, an increase of arterial stiffness occurs with age. The increase in 
arterial stiffness is exacerbated by common cardiac risk factors (Mitchell 2006). 
Metabolic syndrome is independently associated with arterial stiffness, with the 
presence of carotid artery plaque and increased arterial wall thickness (Rundek 
et al. 2007). Components of metabolic syndrome alter the structure and function 
of the large arteries. There is an increase in circumferential wall stress and flow 
mediated shear stress of the arterial wall. Further, metabolic syndrome can 
accelerate vascular aging (Scuteri et al. 2004).  
Exercise capacity is related to arterial stiffness as cardiac output is determined 
by aortic compliance. The reason is that proximal aortic compliance is the 
primary factor that determines pulse pressure and thus myocardial consumption 
290 
 
(Kingwell 2002). Acute exercise results in immediate changes in arterial 
compliance. Generally, there is an increase in vasodilatation of the 
vasovasorum of the aortic wall (independent of the increase in mean arterial 
pressure) due to various factors such as increase of temperature and nitric 
oxide in exercising muscles. The possible mechanism is the decrease in 
smooth muscle tone which transfers the stress forces from the stiff collagen 
fibres to the extensible elastin fibres (Kingwell et al. 1997).  
Pulse wave analysis is one of the recently developed methods to measure 
arterial stiffness non-invasively. Alterations in both structure and function of the 
microcirculation occur during aging and this may play an important role in the 
pathophysiology of cardiovascular and metabolic diseases associated with 
aging (Gates et al. 2009). To the investigators’ knowledge, the immediate 
changes in arterial stiffness following acute sub-maximal intensity exercise have 
not been studied on people with metabolic syndrome in India.   
This study was carried out to establish the immediate changes in arterial 
stiffness using pulse wave analysis following acute sub-maximal exercise in 
people with metabolic syndrome.  
10.1.1. Objectives 
For people with metabolic syndrome: 
 To establish the immediate changes in pulse wave velocity, pulse 
pressure, augmentation pressure, augmentation index, ejection duration 
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and sub-endocardial viability ratio following sub-maximal exercise using 
pulse wave analysis with applanation tonometry 
 To establish the relationship between sub-maximal exercise capacity and 
arterial stiffness 
 To establish the relationship between age, arterial stiffness and exercise 
capacity 
10.1.2. Hypotheses 
For people with metabolic syndrome 
H1- There will be a significant change in arterial stiffness following acute sub-
maximal exercise.  
H2- There will be a significant relationship between exercise capacity and 
arterial stiffness. 
H3- There will be a significant relationship between age, arterial stiffness and 
exercise capacity in people with metabolic syndrome 
10.2. Methods 
10.2.1. Subjects 
After achieving institutional ethical approval, a free health screening for 
metabolic syndrome was carried out at Father Muller Medical College & 
Hospitals, Mangalore, India. The International Diabetic Federation’s (IDF) 
definition was used to diagnose metabolic syndrome. The people diagnosed 
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with metabolic syndrome were invited to participate in the study. The 
participants were excluded if they had a resting heart rate >120 beats/ min after 
a 15 min rest, a systolic blood pressure >200 mmHg and/or a diastolic  blood 
pressure > 100 mmHg, a history of  any cardiovascular disorders such as 
unstable angina and myocardial infarction and a physical disability that 
prevented the safe performance of the test. In total, 94 eligible people with 
metabolic syndrome volunteered to participate in the study. 
10.2.2. Sub-maximal exercise and exercise testing 
The incremental shuttle walk test (ISWT) was the sub-maximal intensity 
exercise used to determine the participants’ sub-maximal exercise capacity 
(Singh et al. 1992).   
A medical history was obtained before the test to establish any 
contraindications to exercise testing. Participants rested for 15 min before 
starting the shuttle test.  All the participants completed a Physical Activity 
Readiness Questionnaire (PAR-Q) and an International Physical Activity 
Questionnaire (IPAQ) to assure the safety before the test. 
Two cones were placed nine metres apart and the distance to walk around the 
cones was 10 metres. The participant was required to walk between two cones 
in time to a set of auditory beeps played from a CD. Initially the walking speed 
was very slow and increased progressively to running. The ISWT had 12 levels 
and 1020 metres of maximum distance to be covered. The participants walked 
as long as they could until either they were too breathless to continue or not 
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able to pace themselves with the speed of the audio beeps. The completed 
number of shuttles were counted and recorded in metres.  
The ISWT was measured twice with 30 min rest between the tests. This is to 
avoid the learning effects, as many individuals tend to perform better in 
repeated administration of the test (The Australian Lung Foundation 2009). The 
best result of the two tests was recorded. Only the standardized instructions 
from the developers’ guidelines were used. The walking track was the same for 
all the participants. Exercise termination criteria was used as per the American 
Thoracic Society guidelines (2002), however none of the participants had to 
terminate the test due to any abnormal signs or symptoms.  Rate of perceived 
exertion was measured using BORG’s scale (6-20 scale) before, during (every 
min) and at the end of the test. The exercise was also terminated when the 
participants reached 17 (very hard) on BORG’s scale.  
10.2.3. Measurement of Arterial stiffness 
The procedures for measuring arterial stiffness are given in detail in Chapter 
3.2.2.   The measurements were repeated within 5-10 min after the completion 
of an incremental shuttle walk test.  
10.2.4. Statistical analysis 
Data analysis was carried out using statistical software SPSS for windows 
(18.0). A paired t test was used to compare the changes in arterial stiffness 
variables following exercise. Pearson’s correlation test was used to find the 
relationship between the variables used. A Levene’s test was used to confirm 
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the homogeneity of the variances. The baseline differences among age groups 
were analysed using ANOVA and Tukey’s test. ANCOVA was used to test the 
influence of age and sex in the arterial stiffness changes after exercise. 
10.3. Results 
10.3.1. Physical characteristics and exercise capacity 
In total, 57 females and 37 males participated in the study aged from 19 to 80 
(49.5 ± 13.8). According to age they were divided into three groups, young (19-
40 years, n= 24, 31.1 ± 7.1), middle (41-60 years, n= 45, 50.5 ± 5.9) and old 
(61-80 years, n= 25, 65.4 ± 4.9). Their physical characteristic details are given 
in table 11.1. There was no significant difference in body mass index among the 
age groups (p= 0.103). The exercise capacity, measured by the distance 
achieved in the ISWT is listed in table 11.1 with age and gender differences. 
Young age groups and males had higher exercise capacity.  











ISWT distance (m) 
Total 161.5 ± 9.6 72 ± 17.5 26.8 ± 4.0 Male Female 
Age 19-40 
years (n=24) 165.5 ± 9.2 77.1 ± 13.5 28.1 ± 3.9 950.0 ± 111.8 786.4 ± 129.6 
Age 41-60 
years (n=45) 160.9 ± 9.2 72.2 ± 19.0 26.6± 4.5 722.9 ± 221.4 557.9 ± 171.6 
Age 61-80 




10.3.2. Total group changes 
The changes in arterial stiffness variables following exercise for the total group 
are illustrated in table 11.2. There was a significant increase in augmentation 
pressure and decrease in augmentation index following exercise. The ejection 
of blood from the ventricle into the aorta generates an aortic pressure pulse. In 
many cases, the timing of the peak pressure does not coincide with the timing 
of peak flow, such that peak pressure may occur later. In this event, there is 
usually a systolic shoulder on the ascending limb pressure curve, which 
coincides with peak flow, then a rise in pressure to the systolic peak. This 
increase in pressure is described as the augmentation pressure. The amount of 
augmentation pressure is quantified in terms of the relative change over the 
whole pulse. That is, once the early systolic shoulder and the peak or the late 
systolic shoulder is identified, the absolute augmentation is calculated. Then the 
augmentation index is defined. 
There was a significant increase in ejection duration. Ejection duration is usually 
measured by detecting the beginning of the pulse and the closure of the aortic 
valve, using the incisura as a marker of the second heart sound. In the current 
study, the ejection duration was increased significantly after exercise in all the 
age groups. The heart rate significantly increased following exercise (table 
11.2). 
There was a significant decrease in SEVR following exercise. Subendocardial 
viability ratio (SEVR) is the ratio of energy supply and the demand of the heart. 
By transferring the ejection duration, the area under the systolic (atrial systole) 
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and diastolic (atrial diastole) part of the pulse curve can be calculated. The 
systolic part has been shown to be associated with the work of the heart and 
oxygen consumption. The diastolic part is associated with the pressure and time 
for coronary perfusion. Thus, they are related to energy supply of the heart. 
When the heart contracts it generates a pulse or energy wave that travels 
through the circulation. The speed of travel of this pulse wave is termed the 
pulse wave velocity. The carotid-radial pulse wave velocity significantly 
increased immediately after exercise. There was a significant increase also in 
systolic pressure, mean pressure, heart rate, aortic systolic pressure and aortic 




Table 10.2 Changes in pulse wave analysis variables following exercise 
Variable Measured time Mean ±SD Sig 
Pulse Wave Velocity 
(m/s) 
Before Exercise 8.15 ±1.48 
** 
After Exercise 8.50 ±1.40 
Augmentation 
Pressure (mmHg) 
Before Exercise 9.46 ±4.74 
* 
After Exercise 10.63 ±6.08 
Aug Index 
Before Exercise 25.83 ±10.27 
** 
After Exercise 22.50 ±12.46 
Aug Index@75 
Before Exercise 25.36 ±9.31 
NS 
After Exercise 25.86 ±10.61 
Aortic Pulse Pressure 
(mmHg) 
Before Exercise 36.17 ±9.19 
NS 
After Exercise 37.12 ±11.98 
Aortic systolic 
Pressure (mmHg) 
Before Exercise 121.33 ±13.43 
* 
After Exercise 124.65 ±17.95 
Aortic Diastolic 
Pressure (mmHg) 
Before Exercise 85.18 ±9.44 
* 
After Exercise 87.52 12.01 
Mean Pressure 
(mmHg) 
Before Exercise 101.29 ±10.42 
** 
After Exercise 104.28 ±13.80 
Ejection Duration 
(ms) 
Before Exercise 37.89 ±4.41 
** 
After Exercise 42.37 ±5.57 
Subendocardial 
Viability Ratio 
Before Exercise 142.28 ±26.44 
** 
After Exercise 117.88 ±25.22 
Systolic Pressure 
(mmHg) 
Before Exercise 131.37 ±13.80 
** 
After Exercise 136.53 ±18.65 
Diastolic Pressure 
(mmHg) 
Before Exercise 83.94 ±9.44 
NS 
After Exercise 85.73 ±11.76 
Heart Rate (bpm) 
Before Exercise 73.85 ±12.23 
** 
After Exercise 83.83 ±15.22 




10.3.3. Age group changes 
The differences in the changes in arterial stiffness variables in various age 
groups are listed in table 11.3. Changes in SEVR, heart rate and ejection 
duration were observed in all three age groups. A significant increase in pulse 
wave velocity was observed in those above 40 years. The change in 
augmentation index was significant only in young and middle age (41-60) 
groups. A significant increase in mean pressure, diastolic pressure and aortic 
diastolic pressure was observed only in the middle age group. A significant 
increase in systolic pressure  and aortic systolic pressure was observed only in 
the old (61-80) age group. The increase in pulse pressure following exercise 
was statistically significant in the elderly group. The pulse pressure was 
markedly increasing with age following exercise (Table 11.3 and Table 11.4). 
Aortic pulse pressure is the systolic pressure minus the diastolic pressure. 
Theoretically, the systemic pulse pressure can be conceptualized as being 
proportional to stroke volume and inversely proportional to the compliance of 
the aorta. In myocardial disease progression, the ischemic threshold lowers with 
stiffer arteries.  
10.3.4. Sex and age group differences 
There were significant differences between sexes in the baseline measures of 
pulse wave velocity, augmentation pressure, SEVR, heart rate, ejection duration 
and augmentation indexes (Table 11.4). There was significant difference 
between the age groups in the baseline measures of augmentation pressure, 
heart rate, ejection duration, aortic pulse pressure and augmentation indexes 
(Table 11.4). The individual age group differences are listed in table 11.5. 
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However, there were no significant differences when the age groups and sex 
were combined. The changes following ISWT were not significantly different 
between the sexes. There was a significant difference between the age groups 
in SEVR, heart rate, ejection duration, aortic PP and augmentation index. 





Table 10.3 Comparison of changes in arterial stiffness with different age groups following 
exercise 
   Age 19-40 Age 41-60 Age 61-80 
















Exercise 6.16 ±3.60 NS 








Exercise 17.48 ±10.66 ** 









Exercise 19.79 ±10.04 NS 









Exercise 29.90 ±6.59 NS 









Exercise 114.71 ±9.85 NS 



















Exercise 98.83 ±8.97 NS 









Exercise 40.11 ±3.41 ** 




Exercise 47.37 ±4.28 40.94 ±5.22 40.00 ±4.16 
SEVR 
Before 
Exercise 132.40 ±19.00 ** 









Exercise 127.33 ±10.51 NS 









Exercise 83.38 ±8.95 NS 









Exercise 79.75 ±8.55 ** 




Exercise 98.84 ±9.62 79.43 ±12.51 76.96 ±15.03 
n=94 *Significant at p<0.05 **Significant at p<0.01 NS- Non-significant PP- Pulse 
pressure, SEVR – Subendocardial viability ratio, Aug - Augmentation 
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Table 10.4 Comparison of arterial stiffness measures before and after ISWT in relation to sex and age groups 
Variables 
Comparison within pre ISWT measures-      
Significance 
Comparison of pre ISWT and post ISWT 
measures- Significance 
Sex Age Group Sex & Age Group Sex Age Group 
Sex  & 
Age Group 
PWV (m/s) ** NS NS NS NS NS 
Aug Pressure (mmHg) ** ** NS NS NS NS 
Aug Index ** ** NS NS ** NS 
Aug Index@75 ** ** NS NS NS NS 
Aortic Pulse Pressure (mmHg) NS ** NS NS * NS 
Aortic Systolic Pressure (mmHg) NS * NS NS NS NS 
Aortic Diastolic Pressure (mmHg) NS NS NS NS NS NS 
Mean Pressure (mmHg) NS NS NS NS NS NS 
Ejection Duration (ms) ** * NS NS ** NS 
SEVR ** NS NS NS ** NS 
Systolic Pressure (mmHg) NS NS NS NS NS NS 
Diastolic Pressure (mmHg) NS NS NS NS NS NS 
Heart Rate (bpm) ** * NS NS ** NS 
n=94 *Significant at p<0.05 **Significant at p<0.01 NS- Non-significant  (Aug-Augmentation, SEVR- Subendocardial Viability Ratio) 
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41-60 NS ** ** ** ** * NS NS NS NS NS NS NS 
61-80 NS ** ** ** ** ** NS NS NS NS NS NS NS 
41-60 61-80 NS * NS NS NS NS NS NS NS NS NS NS NS 
61-80 41-60 NS * NS NS NS NS NS NS NS NS NS NS NS 
n=94 *Significant at p<0.05 **Significant at p<0.01 NS- Non-significant 
PWV – Pulse Wave Velocity, SP- Systolic Pressure, DP- Diastolic Pressure, SEVR– Subendocardial Viability Ratio, HR- Heart Rate, Aug – 





In general, there was a negative correlation between shuttle walk exercise 
capacity (distance covered in metres) and certain arterial stiffness variables 
including systolic pressure, augmentation pressure, augmentation index, 
augmentation index @75 and aortic pulse pressure (Table 11.6).  The 
significance was observed in augmentation pressure and aortic pressure in both 
sexes. The relationship between age and arterial stiffness variables are also 
listed in table 11.6. Augmentation pressure, aortic pulse pressure, augmentation 
index and augmentation index@75 had positive correlations with age in general 
as well as in different sexes.  
The correlations among the arterial stiffness variables are also illustrated in 
Table 11.6.  SEVR had a negative correlation with most of the other arterial 
stiffness variables and it was significant with heart rate, ejection duration, 
augmentation pressures and augmentation index @75. Augmentation pressure 
variables had a positive relationship with aortic pulse pressure.  
The correlations between arterial stiffness and physical characteristics are given 
in Table 11.7.  Height and weight had a negative correlation with augmentation 
pressure and the augmentation indexes. Height also had negative correlation 
with ejection duration and positive correlation with SEVR.  
The exercise capacity was measured by distance covered in metres. Age had a 
strong negative correlation with exercise capacity (r= -0.678, p=0.001). The 




Table 10.6 Correlations between exercise capacity, age and arterial stiffness variables (correlation coefficients) 













Duration SEVR SP DP HR 
Exercise 
Capacity All .020 -.501** -.403** -.443** -.425** -.325 -.049 -.176 -.003 .077 -.235* -.042 -.020 
Age 
Males -.004 -.423** -.343* -.318 -.476** -.204 .122 -.017 .086 -.011 -.086 .114 .074 
Females -.275* -.349** -.240 -.253 -.346** -.386** -.206 -.300* .153 -.144 -.356 -.210 .090 




Males .036 .495** .561** .426** .522** .308 -.021 .123 -.249 .206 .137 -.011 -.347* 
Females .129 .570** .494** .497** .457** .408** .137 .271* -.257 .184 .307* .136 -.198 
Aug P 0.14  0.73** 0.87** 0.70** 0.63** 0.22* 0.46** 0.27* -0.34** 0.52** 0.20 0.19 
Aug Index 0.00  0.86** 0.45** 0.43** 0.18 0.29** -0.20 0.17 0.18 0.19 -0.35** 
Aug Index 
@75 0.07  0.35** 0.43** 0.28* 0.39** 0.26* -0.27* 0.24 0.26* 0.18 
Aortic PP 0.10  0.69** 0.03 0.35** -0.14 -0.05 0.68** 0.02 -0.23* 
Aortic SP 0.20**  0.74** 0.91** -0.04 -0.05 0.95** 0.73** -0.04 
Aortic DP 0.18  0.94** 0.07 -0.02 0.68** 1.00** 0.15 
Mean P 0.23*  0.09 -0.10 0.86** 0.93** 0.14 
Ejection 
Duration 0.13  -0.84** 0.07 0.02 0.85** 
SEVR -0.08  -0.15 0.03 -0.80** 
SP 0.20  0.66** 0.10 
DP 0.18  0.10 
Heart Rate 0.13  
n=94 *Significant at p<0.05 **Significant at p<0.01  
PWV – Pulse Wave Velocity (m/s), SP- Systolic Pressure (mmHg), DP- Diastolic Pressure (mmHg), SEVR– Subendocardial Viability Ratio, HR- 
Heart Rate, Aug – Augmentation, PP- Pulse pressure (mmHg), Ejection duration (ms), HR (bpm) 
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Table 10.7 Correlations between physical characteristics and arterial stiffness 
Variables HEIGHT WEIGHT BODY MASS 
INDEX 
PWV (m/s) .172 -.095 -.136 
Aug Pressure (mmHg) -.396** -.205* -.070 
Aug Index -.366** -.287** -.155 
Aug Index@75 -.488** -.235* -.080 
Aortic PP (mmHg) -.113 -.137 -.077 
Aortic SP (mmHg) -.130 -.129 .042 
Aortic DP (mmHg) -.084 -.051 .125 
Mean P (mmHg) -.119 -.088 .109 
Ejection Duration (ms) -.214* .013 .176 
SEVR .212* .027 -.109 
SP (mmHg) -.040 -.045 .101 
DP (mmHg) -.068 -.053 .114 
HR (bpm) -.181 .126 .154 
n=94 *Significant at p<0.05 **Significant at p<0.01 
PWV – Pulse Wave Velocity, SP- Systolic Pressure, DP- Diastolic Pressure, SEVR– 
Subendocardial Viability Ratio, HR- Heart Rate, Aug – Augmentation, Pulse pressure 
 
10.4. Discussion 
The results show that there are noticeable changes in arterial stiffness variables 
immediately after exercise.  
10.4.1. Changes in arterial stiffness following acute exercise 
10.4.1.1. Pulse wave velocity 
Similar to the currentresults, many studies found an increase in pulse wave 
velocity within 10 min after acute exercise (McClean et al. 2007; Naka et al. 
2003). Pulse wave velocity is inversely related to plasma viscosity and arterial 
distensibility (Peterson 1954). Acute exercise results in an expansion in plasma 
volume and decreased blood viscosity (Thompson et al. 2001). Following 
exercise, endothelial and neurohumoral influences results in vasodilatation and 
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the distensibility of the artery is decreased (Naka et al. 2003). Aizawa and 
Petrella (2008) studied the changes in arterial stiffness (arterial distensibility and 
β stiffness index using ultrasound following exercise in hypertensive patients. 
They found no changes in arterial stiffness immediately (10 min) and after 24 
hrs of exercise. They suggest that there is an increase in oxidative stress in 
older age and cardiovascular risks such as hypertension. It leads to an impaired 
endothelium dependant vasodilatation. Therefore, it could be assumed that the 
increase in pulse wave velocity after acute exercise depends on the severity of 
endothelial dysfunction due to either age or any other subclinical cardiovascular 
risks.  
10.4.1.2. Augmentation index 
In the current study, augmentation index reduced after acute exercise. Previous 
studies had contradictory results. Some of them had an increase (DeVan et al. 
2005; Yoon et al. 2010) and some had a decrease (Munir et al. 2008; Sharman 
et al. 2005) in augmentation index following acute exercise. Studies claim that 
the effects of vasodilatation following exercise results in this reduction (Munir et 
al. 2008). However, Munir et al (2008) found a reduction in all arterial stiffness 
variables including pulse wave velocity following acute exercise. The 
contradictions may be due to the differences in the severity of the endothelial 
dysfunction and the combined effect of the vasodilatation. Exercise increases 
the arterial distensibility by stretching and increases the intravascular diameter. 
At the same time, it decreases arterial distensibility by reducing the involvement 
of arterial muscle tone to arterial stiffness (Naka et al. 2003). Another study 
(Aizawa and Petrella 2008) found a statistically non-significant increase in 
augmentation index immediately after exercise and then a non-significant 
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decrease after 20 weeks aerobic training with hypertensives. They state that the 
changes depend on the age, the aerobic capacity, and their effects in 
vasodilatation. The augmentation index corrected for 75% (AIx@75%) heart 
rate is another important variable in arterial stiffness because of the influence of 
the heart rate on augmentation index.  Wilkinson et al.(2000) found a linear 
reduction in augmentation index when pacing the heart rate from 60 to 110 on 
pacemakers. In the current study, AIx@75%HR did not change significantly 
after exercise. Therefore, it can be assumed that the reduction in augmentation 
index in the current study was due to the influence of the increased heart rate 
during exercise.  
10.4.1.3. Aortic pulse pressure (PP) and subendocardial viability ratio (SEVR) 
Aortic pulse pressure also showed a considerable increase with age. Similar to 
the currentresults, Sharman et al.(2005) also found an increase in central and 
peripheral systolic/diastolic pressures, pulse pressure and mean arterial 
pressure. Aortic stiffness is stimulated during exercise, resulting in the increase 
in pulse pressure and decrease in myocardial perfusion (Kingwell 2002). The 
reduction in myocardial perfusion is confirmed as SEVR also significantly 
reduced following exercise. Similar reduction were found in healthy non-
smokers and light-smokers (Doonan et al. 2011; Edwards et al. 2008)  This 
becomes important because of its relationship with ischemic risk when 
combined with increased ejection duration, heart rate and shortening of the 
diastolic period (O'Rourke 2005).   
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10.4.2. Age and arterial stiffness 
The results show that the arterial stiffness increases with the age. The 
increased arterial pressure in higher age groups compared with lower age 
groups confirms the changes in vascular structure due to aging. Aging elicits 
several changes in the endothelium by gradually altering its phenotype from an 
anti-atherosclerotic to a pro-atherosclerotic one (Brandes et al. 2005). These 
changes are associated with the endothelial dysfunction mediated with nitric 
oxide deficiencies and increased production of reactive oxygen species (Versari 
et al. 2009). These lead to thick and stiff arterial walls and an increased number 
and size of smooth muscle cells. Further, it results in increased peripheral 
resistance and increased afterload  (Heckman and McKelvie 2008). This 
stiffening effect is progressive with age and reduces the cushioning function of 
the arteries and leads to devastating effect on the myocardial micro circulation 
(O'Rourke and Hashimoto 2007). Nagai et al., (1998) also found that carotid 
intima-media thickness was increasing with age.  
In the current study, the augmentation pressure increased significantly following 
exercise. Augmentation pressure and augmentation index are strong predictors 
of cardiovascular disease (Nurnberger et al. 2002; Weber et al. 2004). In the 
current study, there was statistical significance in the changes in the 
augmentation pressure. It is important to note the increase in augmentation 
pressure with age (Table 11.3) and the positive correlations with age and 
exercise capacity (table 11.6). Augmentation pressure and augmentation index 
showed nearly two-fold increase in the older ages (Table 11.3). Vaitkevicius et 
al (1993) also found relatively similar results, up to 2.5-fold increase in 
augmentation pressure in healthy people, with advancing age. Another study on 
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a Chinese population also had a similar result. There was 2.4-fold increase in 
arterial stiffness in 80 year olds compared with 20 year old groups (Avolio et al. 
1983). 
10.4.3. Exercise capacity and arterial stiffness 
Another important finding in the current study is that most of the arterial stiffness 
variables including augmentation pressure, augmentation index, and aortic 
pulse pressure had an inverse correlation with exercise capacity. That means 
that the higher the exercise capacity, the lower the arterial stiffness. Vaitkevicius 
et al (1993) also found an inverse relationship between VO2 max and arterial 
stiffness in sedentary adults. It confirms that arterial stiffness could be a 
determinant of exercise capacity in metabolic syndrome. A previous study on 
healthy volunteers also finds an association between arterial stiffness and 
exercise capacity (Hagg et al. 2005). The changes in arterial stiffness were 
correlated with echocardiograph changes in coronary flow velocity reserve, 
intima–media thickness, stiffness index of coronary artery and flow mediated 
vasodilatation of the forearm.  
Each of the components of metabolic syndrome may account for the observed 
reduction in exercise capacity. Fang et al. (2005) studied the exercise capacity, 
echocardiography and heart rate recovery of type 2 diabetic patients. They 
found that the reduced exercise capacity in patients with type 2 diabetes was 
associated with diabetes control, subclinical LV dysfunction and impaired heart 
rate recovery. Fagard et al. (1991) studied blood pressure in exercise testing on 
hypertensive men and followed them up for >7 years. They found that intra-
arterial pressure at rest, sub maximal exercise and peak exercise could 
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significantly predict mortality and the incidence of cardiovascular disease, 
independent of age. However many studies emphasize that poor exercise 
capacity can individually account for cardiovascular risk. Myers et al (2002) 
studied >6000 consecutive men, with or without a history of cardiovascular 
disease, referred for treadmill exercise test and followed them more than six 
years. They found that exercise capacity was a more powerful predictor of 
mortality than other established risk factors for cardio vascular disease. Jae et 
al (2010) found an inverse correlation between cardio respiratory fitness and 
arterial stiffness in people with and without metabolic syndrome. However, there 
was higher arterial stiffness in people with metabolic syndrome. Spies et al. 
(2005) found that metabolic syndrome with coronary artery disease is 
associated with poor exercise capacity and heart rate recovery independent of 
its components (increased glucose, blood pressure and adiposity). Another 
study found a significantly poor exercise capacity in metabolic syndrome in the 
absence of coronary artery syndrome, even though there was no systolic 
dysfunction and vascular pathology (Arat et al. 2008). Wong et al. (2005) 
studied the myocardial function with tissue Doppler imaging, arterial stiffness 
using radial applanation tonometry and exercise capacity using expired gas 
analysis in people with metabolic syndrome. They found that subclinical 
myocardial dysfunction was associated with metabolic burden and reduced 
cardio respiratory fitness. They suggest that metabolic syndrome with 
subclinical myocardial abnormalities and reduced exercise fitness may have 
higher risk of cardiovascular disease events and heart failure. Further, the low 
exercise capacity may contribute to adverse outcomes associated with 




A larger number of participants would have improved the significance of the 
arterial stiffness changes. The measurements were taken at different times both 
morning and afternoon due to participants’ schedules and availability. A same 
time measurement would have avoided any diurnal variation on the 
measurement. The study could not control for the medications used by the 
participants, who were under treatment for different conditions such as 
diabetes, hypertension and obesity. Due to lack of researchers and participants’ 
availability, no control group was studied. An age matched control group would 
be more informative in the arterial stiffness changes in people with metabolic 
syndrome.  
10.5. Conclusions 
Age influences arterial stiffness. Age is one of the major contributing factors for 
structural vascular changes. Exercise capacity is inversely related to arterial 
stiffness and age. Acute exercise increase arterial stiffness in metabolic 
syndrome. Non-invasive measurement of arterial stiffness after exercise is an 
important and easy to use tool that increases knowledge of cardiovascular risk 




American Thoracic Society (2002). "ATS statement: guidelines for the six-
minute walk test." American Journal of Respiratory Critical Care 
Medicine, 166(1), 111-7. 
Aizawa, K., and Petrella, R. J. (2008). "Acute and chronic impact of dynamic 
exercise on arterial stiffness in older hypertensives." Open 
Cardiovascular Medicine Journal, 2, 3-8. 
Arat, N., Sokmen, Y., Akpinar, I., and Golbasi, Z. (2008). "Exercise capacity in 
patients with metabolic syndrome in the presence of normal coronary 
arteries." Turk Kardiyologi Dernegi Arsivi, 36(1), 19-25. 
Avolio, A. P., Chen, S. G., Wang, R. P., Zhang, C. L., Li, M. F., and O'Rourke, 
M. F. (1983). "Effects of aging on changing arterial compliance and left 
ventricular load in a northern Chinese urban community." Circulation, 
68(1), 50-8. 
Brandes, R. P., Fleming, I., and Busse, R. (2005). "Endothelial aging." 
Cardiovascular Research, 66(2), 286-94. 
Cheung, B. M., and Thomas, G. N. (2007). "The metabolic syndrome and 
vascular disease in Asia." Cardiovascular & Hematological Disorders Drug 
Targets, 7(2), 79-85. 
DeVan, A. E., Anton, M. M., Cook, J. N., Neidre, D. B., Cortez-Cooper, M. Y., 
and Tanaka, H. (2005). "Acute effects of resistance exercise on arterial 
compliance." Journal of Applied Physiology, 98(6), 2287-91. 
Doonan, R. J., Scheffler, P., Yu, A., Egiziano, G., Mutter, A., Bacon, S., Carli, 
F., Daskalopoulos, M. E., and Daskalopoulou, S. S. (2011). "Altered 
Arterial Stiffness and Subendocardial Viability Ratio in Young Healthy 
Light Smokers after Acute Exercise." Public Library of Science One, 
6(10), e26151. 
Edwards, D. G., Mastin, C. R., and Kenefick, R. W. (2008). "Wave reflection and 
central aortic pressure are increased in response to static and dynamic 
313 
 
muscle contraction at comparable workloads." Journal of Applied 
Physiology, 104(2), 439-45. 
Gates, P. E., Strain, W. D., and Shore, A. C. (2009). "Human endothelial 
function and microvascular ageing." Experimental Physiology, 94(3), 
311-6. 
Hagg, U., Wandt, B., Bergstrom, G., Volkmann, R., and Gan, L. M. (2005). 
"Physical exercise capacity is associated with coronary and peripheral 
vascular function in healthy young adults." American Journal of 
Physiology- Heart and Circulatory Physiology, 289(4), H1627-34. 
Heckman, G. A., and McKelvie, R. S. (2008). "Cardiovascular aging and 
exercise in healthy older adults." Clinnical Journal of Sport Medicine, 
18(6), 479-85. 
Jae, S. Y., Heffernan, K. S., Fernhall, B., Oh, Y. S., Park, W. H., Lee, M. K., and 
Choi, Y. H. (2010). "Association between cardiorespiratory fitness and 
arterial stiffness in men with the metabolic syndrome." Diabetes 
Research in Clinical Practice, 90(3), 326-32. 
Kingwell, B. A. (2002). "Large artery stiffness: implications for exercise capacity 
and cardiovascular risk." Clinical and Experimental Pharmacolgy and 
Physiology, 29(3), 214-7. 
Kingwell, B. A., Berry, K. L., Cameron, J. D., Jennings, G. L., and Dart, A. M. 
(1997). "Arterial compliance increases after moderate-intensity cycling." 
American Journal of Physiology, 273(5 Pt 2), H2186-91. 
LaMonte, M. J., Barlow, C. E., Jurca, R., Kampert, J. B., Church, T. S., and 
Blair, S. N. (2005). "Cardiorespiratory fitness is inversely associated with 
the incidence of metabolic syndrome: a prospective study of men and 
women." Circulation, 112(4), 505-12. 
McClean, C. M., Mc Laughlin, J., Burke, G., Murphy, M. H., Trinick, T., Duly, E., 
and Davison, G. W. (2007). "The effect of acute aerobic exercise on 
pulse wave velocity and oxidative stress following postprandial 
314 
 
hypertriglyceridemia in healthy men." European Journal of Applied 
Physiology, 100(2), 225-34. 
Misra, A., Misra, R., Wijesuriya, M., and Banerjee, D. (2007). "The metabolic 
syndrome in South Asians: continuing escalation & possible solutions." 
Indian Journal of Medicine Research, 125(3), 345-54. 
Munir, S., Jiang, B., Guilcher, A., Brett, S., Redwood, S., Marber, M., and 
Chowienczyk, P. (2008). "Exercise reduces arterial pressure 
augmentation through vasodilation of muscular arteries in humans." 
American Journal of Physiology - Heart and Circulatroy Physiology, 
294(4), H1645-50. 
Myers, J., Prakash, M., Froelicher, V., Do, D., Partington, S., and Atwood, J. E. 
(2002). "Exercise capacity and mortality among men referred for exercise 
testing." New England Journal of Medicnie, 346(11), 793-801. 
Nagai, Y., Metter, E. J., Earley, C. J., Kemper, M. K., Becker, L. C., Lakatta, E. 
G., and Fleg, J. L. (1998). "Increased carotid artery intimal-medial 
thickness in asymptomatic older subjects with exercise-induced 
myocardial ischemia." Circulation, 98(15), 1504-9. 
Naka, K. K., Tweddel, A. C., Parthimos, D., Henderson, A., Goodfellow, J., and 
Frenneaux, M. P. (2003). "Arterial distensibility: acute changes following 
dynamic exercise in normal subjects." American Journal of Physiology - 
Heart and Circulatroy Physiology, 284(3), H970-8. 
Nurnberger, J., Keflioglu-Scheiber, A., Opazo Saez, A. M., Wenzel, R. R., 
Philipp, T., and Schafers, R. F. (2002). "Augmentation index is 
associated with cardiovascular risk." Journal of Hypertension, 20(12), 
2407-14. 
O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mallion, J. M., Mancia, G., Mengden, 
T., Myers, M., Padfield, P., Palatini, P., Parati, G., Pickering, T., Redon, J., 
Staessen, J., Stergiou, G., and Verdecchia, P. (2003). "European Society 
of Hypertension recommendations for conventional, ambulatory and home 
blood pressure measurement." Journal of Hypertension, 21(5), 821-48. 
315 
 
Oliver, J. J., and Webb, D. J. (2003). "Noninvasive assessment of arterial 
stiffness and risk of atherosclerotic events." Arteriosclerosis, Thrombosis 
and Vascular Biology, 23(4), 554-66. 
O'Rourke, M. F. (2005). "Beyond blood pressure: subtle effects of drug 
classes." Arteriosclerosis, Thrombosis and Vascular Biology, 25(11), 
2238-9. 
O'Rourke, M. F., and Hashimoto, J. (2007). "Mechanical factors in arterial 
aging: a clinical perspective." Journal of American College of Cardiology, 
50(1), 1-13. 
Peterson, L. H. (1954). "The dynamics of pulsatile blood flow." Circulation 
Research, 2(2), 127-39. 
Rietzschel, E. R., Boeykens, E., De Buyzere, M. L., Duprez, D. A., and 
Clement, D. L. (2001). "A comparison between systolic and diastolic 
pulse contour analysis in the evaluation of arterial stiffness." 
Hypertension, 37(6), E15-22. 
Rundek, T., White, H., Boden-Albala, B., Jin, Z., Elkind, M. S., and Sacco, R. L. 
(2007). "The metabolic syndrome and subclinical carotid atherosclerosis: 
the Northern Manhattan Study." Journal of Cardiometabolic Syndrome, 
2(1), 24-9. 
Scuteri, A., Najjar, S. S., Muller, D. C., Andres, R., Hougaku, H., Metter, E. J., 
and Lakatta, E. G. (2004). "Metabolic syndrome amplifies the age-
associated increases in vascular thickness and stiffness." Journal of 
American College of Cardiology, 43(8), 1388-95. 
Sharman, J. E., Lim, R., Qasem, A. M., Coombes, J. S., Burgess, M. I., Franco, 
J., Garrahy, P., Wilkinson, I. B., and Marwick, T. H. (2006). "Validation of 
a generalized transfer function to noninvasively derive central blood 
pressure during exercise." Hypertension, 47(6), 1203-8. 
Sharman, J. E., McEniery, C. M., Campbell, R. I., Coombes, J. S., Wilkinson, I. 
B., and Cockcroft, J. R. (2005). "The effect of exercise on large artery 
316 
 
haemodynamics in healthy young men." European Journal of Clinical 
Investigation, 35(12), 738-44. 
Singh, S. J., Morgan, M. D., Scott, S., Walters, D., and Hardman, A. E. (1992). 
"Development of a shuttle walking test of disability in patients with 
chronic airways obstruction." Thorax, 47(12), 1019-24. 
The Australian Lung Foundation (2009) "Incremental Shuttle Walking Test" 
Pulmonary Rahabilitation Toolkit.  
URL: http://www.pulmonaryrehab.com.au/index.asp?page=20 
Thompson, P. D., Crouse, S. F., Goodpaster, B., Kelley, D., Moyna, N., and 
Pescatello, L. (2001). "The acute versus the chronic response to 
exercise." Medicine & Science in Sports & Exercise, 33(6 Suppl), S438-
45; discussion S452-3. 
Versari, D., Daghini, E., Virdis, A., Ghiadoni, L., and Taddei, S. (2009). "The 
ageing endothelium, cardiovascular risk and disease in man." 
Experimental Physiology, 94(3), 317-21. 
Weber, T., Auer, J., O'Rourke, M. F., Kvas, E., Lassnig, E., Berent, R., and 
Eber, B. (2004). "Arterial stiffness, wave reflections, and the risk of 
coronary artery disease." Circulation, 109(2), 184-9. 
Wilkinson, I. B., MacCallum, H., Flint, L., Cockcroft, J. R., Newby, D. E., and 
Webb, D. J. (2000). "The influence of heart rate on augmentation index 
and central arterial pressure in humans." Journal of Physiology, 525 Pt 1, 
263-70. 
Yoon, E. S., Jung, S. J., Cheun, S. K., Oh, Y. S., Kim, S. H., and Jae, S. Y. 
(2010). "Effects of acute resistance exercise on arterial stiffness in young 
men." Korean Circulation Journal, 40(1), 16-22. 
317 
 
CHAPTER 11. EFFECTS OF AN IT-SUPPORTED HOME-BASED EXERCISE 
PROGRAMME ON METABOLIC SYNDROME IN INDIA 
Abstract  
Background: Lifestyle modification with more physical activity and diet control 
is an important strategy in the management of metabolic syndrome. This study 
aimed to establish the effectiveness of a home-based exercise programme with 
information technology (IT) support in people with metabolic syndrome in India. 
Methods: 94 participants with metabolic syndrome (mean age 49.5±13.8) were 
randomized into two groups. Both the groups received a 12-week customized 
home exercise programme and group-2 received additional IT support for health 
education. Before and after the exercise programme, both the groups were 
measured for arterial stiffness using pulse wave analysis, exercise capacity 
using an incremental shuttle walk test (ISWT) and quality of life (QoL) using SF-
36 questionnaire. Results: There was a significant reduction (p<0.05) in systolic 
pressure, mean pressure and aortic systolic pressure within both the groups 
following the exercise programme.  Pulse wave velocity, aortic pulse pressure 
and aortic diastolic pressure showed significant reductions (p<0.05) only in the 
IT-supported group-2. There were no changes in characteristics of quality of life 
except on vitality (p<0.05) in group-2. There were a significant improvement in 
fasting blood glucose (p<0.05) in group-2, cholesterol (p<0.05) in group-1 and 
triglycerides (p<0.05) in both the groups. Conclusion: Metabolic syndrome is 
reversible in 16% of the participants with regular home-based exercises. Home-
based exercise programmes can improve arterial stiffness, hyperglycaemia and 
dyslipidaemia in metabolic syndrome. IT support through mobile texts has an 
additional impact by increasing exercise duration and frequencies, on the home-




11.1.1. Metabolic syndrome 
Metabolic syndrome is a cluster of cardiovascular risk factors. They are 
increased blood glucose, increased blood pressure, high triglycerides, low level 
of high-density lipoproteins and abdominal obesity (Grundy et al. 2004). In 
recent decades, this condition has been given importance in numerous clinical 
studies due to its increasing prevalence all over the world. The risk of 
developing cardiovascular disease is 3-10 times higher in people with metabolic 
syndrome (Nestel et al. 2007).  Various criteria have been developed and the 
definitions of the National Cholesterol Education Programme Adult Treatment 
Panel III (NCEP ATP III) (Grundy et al. 2004) and International Diabetic 
Federation (IDF 2006) are extensively reviewed and widely used. 
Poor exercise capacity has been observed in people with metabolic syndrome 
and it was found that every individual component of metabolic syndrome is 
related to poor exercise capacity (Arat et al. 2008). An increased arterial 
stiffness was also found in people with metabolic syndrome that is independent 
of its relationship with the known cardiovascular risk factors (Sipila et al. 2007) 
People with metabolic syndrome have shown impaired health related quality of 
life compared with people without metabolic syndrome (Han et al. 2009). 
11.1.2. Exercise programmes 
A lack of physical activity is closely related to metabolic syndrome and it 
increases its risk (DuBose et al. 2004). In the management of metabolic 
syndrome, lifestyle modification with more physical activities, control of weight 
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and diet are the major recommendations by the American Heart Association 
(AHA) and the National Heart, Lung, and Blood Institute (NHLBI) (Grundy et al. 
2005). Exercise training programmes were shown to be effective in improving 
the individual criterion risk factors of metabolic syndrome. Aerobic exercise 
programmes especially, were proven as an effective treatment strategy in the 
management of metabolic syndrome (Katzmarzyk et al. 2003). Griel et al (2003) 
found that a 12-week exercise programme for people with metabolic syndrome 
was effective when using two different intensities. They observed that the higher 
the intensity, the higher the effectiveness in reducing the cardiac risk factors. 
Roberts et al (2006b) found a significant improvement in insulin sensitivity and 
vascular inflammatory markers with a short-term (21 days), intensive supervised 
exercise and diet programme. Regular exercise programmes were also 
effective in the elderly with metabolic syndrome (Kemmler et al. 2009). 
11.1.3. Home-based exercise programme 
Structured, hospital-based, 6-12 weeks exercise-based cardiac rehabilitation 
programmes have been running successfully for patients with cardiac disease. 
Hospital-based cardiac rehabilitation programmes have been effective in 
improving exercise capacity and characteristics of metabolic syndrome (Gayda 
et al. 2008; Onishi et al. 2009). However, poor attendance has been observed 
in hospital-based programmes due to various barriers. Lack of awareness, 
travelling, scheduling interference with activities of daily living, dislike of 
programme format and financial issues are the major patient oriented barriers 
for hospital-based programmes (Thomas 2007; Witt et al. 2005). Home-based 
studies are providing a viable alternative to the hospital-based programmes at a 
low cost. Many studies proved that home-based exercise programmes were as 
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equally effective as supervised hospital or centre-based group exercise 
programmes (King et al. 1991; Jolly et al. 2007; Jolly et al. 2009; Dalal et al. 
2010).  A Cochrane systemic review and meta-analysis states that home-based 
cardiac rehabilitation programmes are as equally effective as hospital-based 
programmes in improving cardiac health and health related quality of life (Dalal 
et al. 2010).  
Regular structured physical activities such as exercise, sports and dancing 
could reduce the incidence of metabolic syndrome. They are more beneficial 
than lifestyle physical activities such as house work and occupation (DuBose et 
al. 2003). Simple home-based walking exercise programmes also have been 
effective in improving functional status, symptoms and disease perception in 
cardiac disease (Corvera-Tindel et al. 2004).  
Early identification of cardiovascular threats and appropriate management can 
prevent cardiac incidents and the associated costs. However, to the 
investigators’ knowledge, in India, there are no early programmes introduced for 
people with cardiac risk factors prior to an incidence of cardiovascular disease. 
This study has been designed to establish the effectiveness of a home-based 
exercise programme for people with metabolic syndrome.  
11.1.4. Information technology (IT) support 
Telehealth counselling can increase motivational lifestyle behaviour changes 
and extend the reach and efficacy of cardiovascular risk prevention 
programmes (Nolan et al. 2011). Mobile phones are one of the important 
developments in communication and have become an unavoidable part of many 
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people’s lives. Use of text messages and phone calls through mobile phones 
have increased the uptake of home-based cardiac rehabilitation in pilot studies 
(Marlien Varnfield 2011).  Reminder text messages can improve exercise 
frequencies and so the implementation of a home-based exercise programme 
(Prestwich et al. 2009). The current study has been designed to establish the 
effects of IT support through texts and calls through mobile phones in a home-
based exercise programme for metabolic syndrome. 
11.1.5. Objectives 
For people with metabolic syndrome in India: 
 To establish the effectiveness of a home-based exercise programme on 
arterial stiffness using pulse wave analysis 
 To establish the effectiveness of a home-based exercise programme on 
exercise capacity using a shuttle walk test 
 To establish the effectiveness of a home-based exercise programme on 
health related quality of life 
 To establish the effectiveness of IT support in addition to a home-based 
exercise programme 
11.1.6. Hypotheses 
For people with metabolic syndrome in India: 
H1 - There will be significant improvement in arterial stiffness, quality of life 
and exercise capacity following a home-based exercise programme 
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H2 - There will be significant effect of IT support on arterial stiffness in 
addition to a home-based exercise programme 
11.2. Methods 
The same participants as in chapter 10, volunteered in this study. In total, there 
were 94 people (male = 43, female = 51) aged 19-80 years (mean age 
49.5±13.8) with metabolic syndrome according to the International Diabetic 
Federation’s (IDF) criterian. All the participants completed a health related 
quality of life questionnaire (SF-36 Version 2) (Ware et al, 1993 and 2000). The 
participants were randomized into two groups. Both groups underwent an 
exercise programme. In addition to that, group-2 received IT support.  
Blood tests were carried out at the time of screening for metabolic syndrome 
and then after a 12 weeks follow-up. The participants were asked to fast for a 
minimum of nine hours before sampling their blood and were measured for 
blood glucose, total cholesterol, HDL cholesterol, LDL cholesterol and 
triglycerides.  
11.2.1. Sub-maximal exercise and exercise testing 
The incremental shuttle walk test (ISWT) was the sub-maximal intensity 
exercise used to determine the participants’ sub-maximal exercise capacity 
(Singh et al. 1992). A medical history was obtained before the test to establish 
any contraindications to exercise testing. All the participants completed a 
Physical Activity Readiness Questionnaire (PAR-Q) (Adams 1999) and an 
International Physical Activity Questionnaire (IPAQ) (Booth 2000) before the 
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test. Participants were asked not to smoke for three hours before the study. 
Participants took a rest for 15 min before starting the shuttle test.   
Two cones were placed nine metres apart and the distance to walk around the 
cones was 10 metres. The participant was required to walk between two cones 
in time to a set of auditory beeps played from a CD. Initially the walking speed 
was very slow and increased progressively to running. The ISWT had 12 levels 
and 1020 metres was the maximum distance to be covered. The participants 
walked as long as they could until either they were too breathless to continue or 
not able to pace themselves with the speed of the audio beeps. The completed 
number of shuttles were counted and recorded in metres.  
The ISWT was measured twice with 30 min rest between the tests. This is to 
avoid the learning effects as many individuals tend to perform better in repeated 
administration of the test. The best result from the two tests was recorded. Only 
the standardized instructions from the developers’ guidelines were used. The 
walking track was the same for all the participants. Exercise termination criteria 
was used as per the American Thoracic Society guidelines (2002), however 
none of the participants had to terminate the test due to any abnormal signs or 
symptoms.  Rate of perceived exertion was measured using Borg’s scale (6-20 
scale) (Borg 1998) before, after each minute during the test and at the end. 
11.2.2. Arterial stiffness 
The procedures for measuring arterial stiffness are given in detail in Chapter 
3.2.2. The measurements were taken immediately before and within 5-10 min 
after incremental shuttle walk test. 
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11.2.3. Exercise programme 
All the participants were instructed in how to participate in the customized home 
exercise programme. The exercise programme was structured with aerobic 
exercises that included a sufficient warm up and cool down phases. The 
exercises included stretching of major muscle groups, walking, marching on the 
spot, sit-ups in a chair, step up and down on a stair, circuit training with small 
weights. The participants were trained to monitor their breathlessness using 
Borg’s scale and advised to maintain a target level of somewhat hard (11-13). A 
printed booklet with instructions and pictures of exercises was given to them. All 
the participants were encouraged to exercise at least for 30 min or more and 
five days per week. They were encouraged to carry out brisk walking for at least 
30 min a day as often as possible. They were issued with and asked to maintain 
an exercise record sheet. They were also advised on the importance of weight 
control, diet and implementation of a balanced diet in relation to their lifestyle. 
11.2.4. IT support 
All the participants were given an explanation and encouraged to adopt a 
healthy lifestyle with modification in diet, smoking cessation and regular 
exercise as needed. For the next 12 weeks the participants of group- 2 were 
regularly provided IT support on health education and group- 1 acted as control 
group. They were sent two personalized mobile texts per week that carried 
information on their health and management of metabolic syndrome. This 
included reminders for exercises, importance of exercises, details of diet and 
diet control, smoking cessation, information on blood glucose and lipid levels 
etc. All the text messages were sent to the participants’ mobile phones through 
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the internet using multi-messaging software. In India, too many uncontrolled 
advertising and anonymous mobile texts were limiting the participants’ ability to 
read all the texts delivered to their mobile.  In view of this limitation, the mobile 
texts were sent to the participants’ mobile phones with a specific acronym and 
the participants were familiarized to it for an easier identification. They also 
received regular phone calls at least once a week to discuss their health and 
were encouraged to exercise regularly. 
All the participants were tested again for arterial stiffness, exercise capacity and 
health related quality of life at the end of exercise programme i.e. after 12 
weeks.  
11.2.5. Statistical analysis 
The International Diabetic Federation’s (IDF) criterion for metabolic syndrome 
was used as it had specific abdominal obesity cut off points for South Asians 
(IDF 2006). It is >90 cm for men and >85 cm for women.  
Data analysis was carried out using statistical software SPSS for windows 
(18.0). Data were checked for univariate and multivariate outliers using 
standard Z-distribution cut-offs and Mahalanobis distance tests respectively. 
Normality of distribution was tested using Kolmogorov-Smirnov test. A paired t-
test was used to analyse the changes within groups following the exercise 
programme.  A mixed-within subject analysis of variance was used to compare 
the changes in the measured variables between groups following the exercise 
programme. A two-way ANCOVA test was used to find the differences in the 
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variables in relation to sex and age. Statistical significance was indicated if 
p<0.05. 
11.3. Results 
11.3.1. Changes in arterial stiffness 
Among 94 initial participants, 61 participants (Group–1 = 28: Group–2 = 33) 
completed the post intervention tests. The changes in arterial stiffness variables 
following exercise within groups and between groups are listed in table 12.1.  
There was a significant reduction in the following arterial stiffness variables in 
the particiapnts following the exercise programme: pulse wave velocity, aortic 
pulse pressure and aortic diastolic pressure in group- 2 and systolic pressure, 
mean pressure, and aortic systolic pressure in both groups. However, there was 
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Post 72.0 ±11.6 70.1 ±11.0 
*Significant at p<0.05  **Significant at p<0.01  NS- Non Significant 
Abbreviations: SEVR – Subendocardial Viability Ratio; Aug – Augmentation 
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11.3.2. Changes in health related quality of life 
The changes in quality of life are listed in table 12.2. There were no significant 
changes in any of the health related quality of life measures following the 
exercise programme within the groups. There were no significant differences in 
quality of life changes between the groups, except vitality scores. Group-2 had 
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Post 74.5 ±24.3 76.7 ±23.9 
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Post 79.5 ±31.2 74.1 ±34.4 
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Post 72.9 ±24.5 71.5 ±27.2 
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Post 65.3 ±16.9 70.0 ±19.4 
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Role Physical 
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Post 50.0 ±8.5 51.1 ±7.4 
*Statistically significant at p<0.05, **Statistically significant at p<0.01, NS- Not Significant 
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11.3.3. Changes in metabolic syndrome 
There was a significant reduction in fasting blood glucose in group-2 and 
cholesterol in group-1 (table 12.3). The level of triglycerides was significantly 
reduced in both the groups following the exercise programme. However, there 
was no difference in these changes between groups. There was a mild 
reduction in waist circumference following exercise programme in both the 
groups, although it was not statistically significant (table 12.3). Among the 
participants who returned for post programme examination, 43 complete 
datasets were available to analyse for the metabolic syndrome criteria. Among 
them, 16.3% participants (15.8% in group-1 and 16.7% in group- 2) were no 












+ IT support (n=33) 
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Groups 
Sig Mean ± SD Sig Mean ± SD Sig 
Fasting Blood glucose  
(mg.dL-1) 




Post 122.6 ±51.1 122.5 ±36.7 
High density lipoprotein (HDL)   
(mg.dL-1) 




Post 38.6 ±8.1 40.4 ±6.0 
Triglycerides  
(mg.dL-1) 




Post 168.7 ±62.3 199.1 ±142.7 
Cholesterol  
(mg.dL-1) 




Post 207.0 ±47.6 227.6 ±64.2 
Low density lipoprotein (LDL)  
(mg.dL-1) 




Post 107.0 ±31.8 113.6 ±28.4 
Waist Circumference  
(cm) 




Post 102.7 ±10.8 100.9 ±7.8 
Body Mass Index  
(kg/m2) 




Post 26.2 ±4.1 26.8 ±4.1 
*-Statistically significant at p<0.05 **-Statistically significant at p<0.01 NS- Non Significant 
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11.3.4. Effects of age and gender 
There was no significant difference in most of the arterial stiffness variables due 
to the effects of age and sex (table 12.4). A significant difference was observed 
in the following variables with a low effect size: aortic pulse pressure (sex vs. 
group effect size 0.075) and SEVR (age effect size 0.127 and age vs. group 
effect size 0.148) 
Table 11.4 Changes in arterial stiffness due to the effects of age and sex between the groups 
Variable Sex Sex vs. Group Age Age vs. Group 
Pulse Wave Velocity (m/s) NS NS NS NS 
Augmentation Pressure (mmHg) NS NS NS NS 
Augmentation index NS NS NS NS 
Augmentation index @ 75HR NS NS NS NS 
Aortic Pulse Pressure (mmHg) NS * NS NS 
Aortic Systolic Pressure (mmHg) NS NS NS NS 
Aortic Diastolic Pressure (mmHg) NS NS NS NS 
Mean Pressure (mmHg) NS NS NS NS 
SEVR NS NS * * 
Ejection Duration (ms) NS NS NS NS 
Systolic Pressure (mmHg) NS NS NS NS 
Diastolic Pressure (mmHg) NS NS NS NS 
*-Statistically significant at p<0.05 **-Statistically significant at p<0.01 NS- 
Non Significant 
11.3.5. Changes in exercise capacity 
The participants’ exercise capacity was not changed significantly, though there 
was a small improvement in the ISWT distance. The participants in group-1 
improved from 685 ± 266.4m to 690 ± 259.3m (p=0.718) and the participants in 
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group-2 improved from 732 ±230.6m to 748 ± 233.6m (p= 0.162). There was no 
significant age or sex related difference in the changes in ISWT distance 
following the exercise programme (p values: sex=0.554, sex vs. group = 0.367, 
age= 0.09, age vs. group= 0.152). From the exercise record of the participants, 
84.7% of group- 1 and 90% of group- 2 exercised for >30 min a day.  There was 
a significant difference in the exercise duration between the groups. Out of 12-
weeks exercise programme, the mean duration of regular exercise was 7.2 ± 
4.7 weeks for group-1 and 10.0 ± 4.0 for group- 2 (p=0.019).  
11.4. Discussion 
11.4.1. Changes in blood glucose, lipids and metabolic syndrome 
Previous studies have demonstrated that exercise training has been beneficial 
in the reduction of hyperglycaemia in metabolic syndrome (Dumortier et al. 
2003; Katzmarzyk et al. 2003). Exercise training increases phosphorylation of 
glucose and stimulates muscle glycogen synthesis and insulin sensitivity 
(Perseghin et al. 1996). In the current study, low to moderate intensity exercises 
(11-13 on Borg’s scale) were used for a minimum of 30 minutes. In general, at 
least 30 min of exercise is recommended as an effective physical activity by the 
American College of Sports Medicine (Pate et al. 1995). Johnson et al (2007) 
found that moderate intensity exercise is more effective than the high intensity 
exercise in improving exercise capacity. They also found that moderate intensity 
exercises improve insulin sensitivity and triglyceride response. Dumortier et al 
(2003) claim that lipid oxidation increases with exercise training. Similar 
reductions were found in the current study participants for triglycerides, glucose, 
total cholesterol and LDL cholesterol (Table 12.3). However, the waist 
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circumference and BMI were not changed significantly in the current study. In 
the current study, the IT support must have aided regular moderate physical 
activity to reduce the fasting blood glucose significantly (table 12.3).  
Roberts et al (2006a) found nine of 15 participants in their study were no longer 
categorized with metabolic syndrome following a supervised exercise and diet 
control programme for three weeks. Similar results were achieved in long-term 
studies. Kemmler et al (2009) trained elderly women with metabolic syndrome 
for 12-months using an exercise programme and found significant reduction in 
central obesity and blood lipids. Gayda et al (2008) studied the effectiveness of 
12-months cardiac rehabilitation in people with metabolic syndrome with and 
without coronary heart disease. At the end of one year 20% of their participants 
without coronary heart disease and 31% with coronary heart disease no longer 
had metabolic syndrome. In the heritage study, after a 20 weeks supervised 
exercise programme, 30.5% of the participants no longer had metabolic 
syndrome (Katzmarzyk et al. 2003). Similar results were found in the current 
study with a home-based exercise programme regardless of IT support after 12 
weeks. This may be due to the range of age groups in the current study. The 
current results confirm that for some people, metabolic syndrome is reversible 
with home-based regular exercises. 
11.4.2. Exercise capacity 
The participants showed mild improvement in exercise capacity yet it was not 
statistically significant. Laaksonen et al (2002) observed leisure time physical 
activity of 612 men and followed them up for four years. They found 107 men 
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developed metabolic syndrome and lesser physical activity was highly related to 
low cardiac fitness and the prevalence of metabolic syndrome. LaMonte et al 
(2005) found similar results on their 5.7 years follow up on 9007 men and 1491 
women. They stated that low cardiorespiratory fitness was an important 
predictor of metabolic syndrome. The current study participants showed mild 
improvement in exercise capacity yet it was not statistically significant. 
However, a longer follow-up would be appropriate to confirm the changes in 
exercise capacity.  
11.4.3. Changes in arterial stiffness 
In the current study, significant reductions were observed in many key arterial 
stiffness variables following home-based exercise programme (Table 12.1). 
Aizawa et al (2009) also found similar reduction in mean arterial pressure 
following exercise training for people with metabolic syndrome. Exercise training 
enhances endothelial function. Advanced-Glycation-End products (AGE) on the 
arterial wall induce cross-linking of collagen molecules that leads to loss of 
collagen elasticity and the compliance of the arteries. This collagen cross-
linking is associated with aging, diabetes, hyper-cholesterol and hyperlipaemia 
(Aronson 2003). Inhibition of this collagen cross-linking might have occurred 
during exercise (Aizawa et al. 2009). Secondly, the increase in blood pressure 
and heart rate during exercise might stretch collagen fibres and repeated 
stretch with regular exercise might result in the reduction of the arterial stiffness 
(Aizawa et al. 2009). Thirdly, increased vascular nitrous oxide bioavailability 
following exercise training results in an increase in microvascular density and 
reduction in inflammation (Frisbee et al. 2006).  
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No measurements were taken on inflammatory markers such as C-reactive 
protein in the current study. However, a reduction in high-sensitivity C-reactive 
protein, resistin and other inflammatory biomarkers has been established by 
exercise training in patients with diabetes and metabolic syndrome (Balducci et 
al. 2010; Kadoglou et al. 2007) and coronary heart disease (Milani et al. 2004). 
These studies claim that the anti-inflammatory effect of exercise training is 
independent of weight reduction and drugs. This statement is acceptable as the 
participants of the current study showed improvement in arterial stiffness 
variables without changes in their body mass index. 
Changing to a healthier diet such as (i) reduction of salt intake (Avolio et al. 
1986; Gates et al. 2004), (ii) use of dietary soy protein (Clarkson 2002), (iii) 
taking supplements of red clover isoflavones (Teede et al. 2003) or fish oil 
(McVeigh et al. 1994) may help to improve arterial compliance and reduce 
arterial stiffness. In the current study, all the participants were educated and 
advised to follow a healthy diet. Despite the limitation that it was not possible to 
monitor their diet, the improvement in arterial stiffness in both the groups could 
have been achieved through changes to a healthier diet.  
11.4.4. Quality of life 
The changes in quality of life with short term exercise programmes are 
debatable. Chien et al (2008) state in their systemic review that home-based 
exercise programmes can only improve exercise capacity, but not quality of life 
of patients with heart failure. Later, Chien et al (2011) found a significant 
improvement in quality of life and exercise capacity following an eight weeks 
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home-based exercise programme in patients with heart failure. Izawa et al 
(2004) found a significant improvement in all subscales (physical functioning, 
role physical, general health, and vitality) of quality of life after a home-based 
exercise programme. The current study showed improvement only in vitality. 
However, regardless of supervision by a researcher or a clinician, long-term 
exercise programmes are showing the potential for improving quality of life 
(King et al. 2000; Spirduso and Cronin 2001). The current results suggest that a 
12-week exercise programme is not long enough to produce marked changes in 
any of the subscales of quality of life.  
11.4.5. IT support and home exercise programme 
Mobile phone usage has surpassed 5 billion globally (Wireless-Intelligence 
2011) and in developing countries like India, the mobile usage is as high as 865 
million (72% of the population) and increasing rapidly (TRAI 2011). Text 
messaging in the form of SMS is available in all the handsets currently used 
globally. Many clinical studies have used this mode of communication in 
disease prevention and management. Marlien Varnfield (2011) states that 
patients can be mentored and motivated through mobile phone interactions and 
the goals of cardiac rehabilitation can be achieved through a tailored home-
based approach.  Text messaging has been demonstrated as a powerful tool for 
behavioural change towards disease prevention and management (Cole-Lewis 
and Kershaw 2010). The use of mobile phones in health promotion is cost 
effective, generally available and lower levels of skills are needed to access 
them (Blake 2008).  
338 
 
Nevertheless, this study showed no additional increase in exercise capacity in 
the participants who received IT support. The reminders with IT support were 
demonstrated to help in achieving improvements in regular exercise and total 
exercise duration. The IT support might have improved the awareness of 
cardiac diseases and importance of lifestyle modifications. 
There was no significant change in the participants BMI following the home-
based exercise programme. A 12-week programme was used in the study and 
a longer and more intensive follow-up would be more effective for a significant 
weight reduction. Patrick et al. (2009) used an everyday customized SMS and 
multimedia messages for four months in a weight reduction programme and 
found a significant reduction in weight of up to 5kg. Studies that compared the 
use of phone and mail in addition to conventional treatment showed weight 
reduction of up to 2.2 kg at the end of one year and up to 1kg at the end of two 
years (Jeffery et al. 2003; Sherwood et al. 2006). Another study followed up 
obese participants for two years with supervised and remote interventions using 
telephone, study-specific website and email. There was a significant weight 
reduction of up to 4.6kg in the remote intervention. The group who received 
supervised as well as remote programme also had a significant weight 
reduction of up to 5.1 kg. Nevertheless,  weight reduction difference between 
the groups was not significant (Appel et al. 2011). These studies confirm the 
effectiveness of long-term, remote, weight reduction programmes. 
The key findings of the current study on IT support are the improvement in 
arterial stiffness variables and hyperglycaemia following home-based exercises. 
The effect of IT support is clear as more arterial stiffness variables had 
339 
 
significant improvement compared with the control group. The current study 
promotes home-based exercise programmes in developing countries like India 
where there is a lack of availability of clinically established rehabilitation 
programmes. 
11.4.6. Limitations 
There are several limitations in the current study. The exercises were 
supervised only at the learning phase on the first day. In addition, the diet 
modifications were not measured due to huge variation in the dietary pattern of 
the participants. All the testing and measurements were carried out at various 
times on testing days, due to the availability of the participants. The medications 
and other treatment for the participants’ individual conditions were not 
controlled. These limitations may have influenced the blood lipids test results 
and variations. The effectiveness of text messaging would have been 
understood better if the participants were able to reply to the texts. This was not 
possible due to the cost limitations. A longer duration IT support and follow up 
could be more effective, but this was not possible due to the limited availability 
of the researcher in India. 
11.5. Conclusions 
Regular exercise and diet control are emphasised as primary preventive 
measures and in the management of metabolic syndrome. A home-based 
exercise programme can improve arterial stiffness, hyperglycaemia and 
dyslipidaemia for people with metabolic syndrome. Metabolic syndrome in many 
cases is reversible with regular home-based exercises. IT support, through 
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mobile texts and calls, improves the efficacy of the home-based exercises for 
those with metabolic syndrome. More structured lifestyle modification 
programmes will be beneficial in improving health care in developing countries 
like India. More cost effective methods need to be identified to improve 
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CHAPTER 12.  SUMMARY AND CONCLUSIONS 
The final chapter of this thesis presents an opportunity to review the whole 
thesis and to emphasise the main conclusions. Instead of summarising in the 
conventional prose style, this summary follows the model used in the British 
Medical Journal and others. It is presented in the form of brief bullet points 
relating to what is known on the topic and what the current research adds to the 
topic. This will provide a clear and concise summary of the work undertaken.  











CHAPTER 2: ARTERIAL STIFFNESS – A LITERATURE REVIEW  
What is already known 
 There are several molecular, cellular and genetic mechanisms 
causing arterial stiffness  
 Arterial stiffness is a marker for cardiovascular disease and is 
associated with the initial stages of CVD risk factors 
 Measurement of arterial stiffness has a long history and applanation 
tonometry is a standard non-invasive method for measuring arterial 
stiffness 
What this chapter adds 
 The reference values for non-invasive arterial stiffness measurement 
have not been established for various ethnic populations 
 Carotid-radial pulse wave analysis is a less intrusive technique, yet 
less used. More studies are needed to establish the validity of this 
technique 
 Applanation tonometry is recognised for its prognostic validity more 
than diagnostic validity. Simpler methods of the technique such as 


















CHAPTER 3: REPRODUCIBILITY OF ARTERIAL STIFFNESS 
MEASUREMENTS FROM NON-INVASIVE PULSE WAVE ANALYSIS 
What is already known 
 Validity of non-invasive pulse wave analysis has been established 
using advanced invasive techniques 
 Pulse wave analysis using applanation tonometry has a high hour-to-
hour reproducibility and a lesser week-to-week reproducibility 
What this chapter adds 
 This is the first study to produce values of carotid-radial pulse wave 
analysis using applanation tonometry on young, healthy, Indian adults 
 Carotid-radial pulse wave analysis is significantly reproducible on 
continuous measurements. However, the repeatability slightly reduces 
over a 24-hour period 
 Among the variables of carotid-radial pulse wave analysis, pulse wave 
velocity has the best reproducibility over a 24-hour period 
CHAPTER 4: ACUTE CHANGES IN ARTERIAL STIFFNESS FOLLOWING 
EXERCISE IN HEALTHY CAUCASIANS vs. SOUTH ASIANS  
What is already known 
 Exercise capacity is inversely related to arterial stiffness 
 Differences due to ethnicity are established for arterial stiffness and 
exercise capacity 
 Exercises increase arterial stiffness acutely due to increase in central 
pressures.  
What this chapter adds 
 There is an acute increase in carotid-radial arterial stiffness following 
exercise, which is similar to other techniques of pulse wave analysis  
 There is no difference between Caucasians and South Asians in the 
acute changes in the arterial stiffness following  sub-maximal exercise  
 There was no significant difference in sub-maximal exercise capacity 


















CHAPTER 5: RELATIONSHIP BETWEEN BODY ADIPOSITY AND 
ARTERIAL STIFFNESS IN YOUNG INDIAN ADULTS 
What is already known 
 There is a strong positive relationship between adiposity and arterial 
stiffness 
 Larger arterial compliance has significant negative correlations with 
skinfold thickness; also smaller arteries have a significant negative 
correlation with waist-hip-ratio 
 Obesity in young adults has a higher risk of developing arterial 
stiffness and cardiovascular disease 
What this chapter adds 
 Arterial stiffness measured by carotid radial pulse wave analysis is 
strongly related to adiposity measured from skinfold thickness in 
young Indian adults 
 Skinfold thickness may be a more valid method to measure body fat 
and associated arterial stiffness than waist-hip-ratio 
 Young Indian females had higher percentage of body fat and stronger 
associations with carotid-radial arterial stiffness than men 
CHAPTER 6: REVIEW OF LITERATURE - ERECTILE DYSFUNCTION AND 
CARDIAC REHABILITATION 
What is already known 
 Erectile dysfunction and cardiovascular disease have similar risk 
factors and erectile dysfunction is also a marker for cardiovascular 
disease 
 Arterial stiffness is the major cause of erectile dysfunction in people 
with cardiovascular risk 
 Cardiac rehabilitation programmes are effective in improving cardiac 
risks 
What this chapter adds 
 There are few studies on the benefits of sexual function from cardiac 
rehabilitation in the UK 
 Studies on the associations of arterial stiffness with erectile function in 
cardiac rehabilitation are limited 
 There are no extensive studies on the prognosis of arterial stiffness 


















CHAPTER 7: CHANGES IN ERECTILE DYSFUNCTION AND ARTERIAL 
STIFFNESS FOLLOWING CARDIAC REHABILITATION  
What is already known 
 Erectile dysfunction is highly prevalent and increasing worldwide 
 Various management methods are available to treat erectile 
dysfunction 
 Resumption of full sexual function is one of the goals of cardiac 
rehabilitation programmes, but is often omitted 
What this chapter adds 
 Cardiac rehabilitation programmes improve major arterial stiffness 
indices measured by applanation tonometry 
 In general cardiac rehabilitation programmes do not improve 
moderate to severe erectile dysfunction unless treated specifically 
 Arterial stiffness that is measured using applanation tonometry is 
associated with erectile dysfunction and can be used as a prognostic 
tool in cardiac rehabilitation programmes in the UK 
CHAPTER 8: METABOLIC SYNDROME – A LITERATURE REVIEW 
What is already known 
 Metabolic syndrome is a cluster of various cardiovascular risk factors 
and the prevalence of metabolic syndrome has been increasing all 
over the world 
 A number of criteria have been developed in diagnosing metabolic 
syndrome. Only a few of them have specific reference values for 
different ethnic populations 
 Age, gender and lifestyle have a strong influence on the prevalence of 
metabolic syndrome 
What this chapter adds 
 There are no specific programmes structured and established for the 
management of metabolic syndrome 
 The prevalence of metabolic syndrome is not known in many 
developing and poor countries 



















CHAPTER 9: PREVALENCE OF HYPERTENSION, OBESITY, DIABETES 
AND METABOLIC SYNDROME IN NEPAL 
What is already known 
 Cardiovascular disease and risks are highly prevalent worldwide. 
Populations from South Asian countries have a higher risk than many 
other countries. 
 Cardiovascular risks are often not diagnosed until the onset of 
cardiovascular disease in developing countries. 
What this chapter adds 
 Metabolic syndrome and risk factors such as hypertension, obesity 
and dyslipidaemia are highly prevalent in Nepal 
 Abdominal obesity is an important risk as the International Diabetic 
Federation’s ethnic specific reference values make a substantial 
difference in identifying the prevalence of metabolic syndrome in 
Nepal 
 Lack of awareness and unhealthy lifestyle may be the major cause of 
metabolic syndrome in Nepal 
CHAPTER 10: ACUTE CHANGES IN ARTERIAL STIFFNESS 
FOLLOWING EXERCISE IN PEOPLE WITH METABOLIC SYNDROME IN 
INDIA 
What is already known 
 Poor exercise capacity is one of the clinical characteristics of 
metabolic syndrome 
 Metabolic syndrome is associated with increased arterial stiffness 
 Acute increase in arterial stiffness following exercise is observed in 
healthy people and those with CVD, using various techniques 
What this chapter adds 
 There is an acute increase in arterial stiffness variables measured by 
carotid-radial applanation tonometry following exercise 
 The increase in arterial stiffness following exercise, in people with 
metabolic syndrome was no different from the increase observed in 
healthy people 
 Acute increase in arterial stiffness following sub-maximal exercise 
depends on the severity of endothelial dysfunction due to age or any 











12.2. Recommendations for future research 
 Larger cohort studies are needed to establish generalised reference 
values for applanation tonometry. Larger longitudinal observations are 
needed to establish the carotid-radial pulse wave analysis as a 
diagnostic tool for various cardiovascular risks  
 Future research is needed to optimize the IT support in addition to home-
based exercise programmes. The research would emphasise the 
improvement of arterial stiffness, with a focus on individual components 
of metabolic syndrome  
 Future research is needed to identify the risk of cardiovascular disease 
as early as possible, so that appropriate preventive measures can be 
undertaken. One of the important approaches may be the evaluation of 
arterial stiffness using the simple, portable non-invasive techniques. This 
could become routine in patients’ first-contact clinical centres such as 
general practices 
 A uniform definition for metabolic syndrome needs to be established that 
can be applicable for every ethnic group in the world 
 Investigations are needed on the associations of arterial stiffness in 
erectile dysfunction in patients with metabolic syndrome and 
subsequently be of use in prognostic investigations 
CHAPTER 11: EFFECTS OF AN IT SUPPORTED, HOME-BASED 
EXERCISE PROGRAMME IN PEOPLE WITH METABOLIC SYNDROME IN 
INDIA 
What is already known 
 Metabolic syndrome is highly prevalent in South Asian populations 
 Life style factors, such a lack of physical activity and an unhealthy 
diet, contribute to the prevalence of metabolic syndrome 
 Home-based exercises are effective and can be an alternative for 
centre-based exercise programmes 
What this chapter adds 
 Home-based exercise programme improves arterial stiffness, 
hyperglycemias and dyslipidaemia and reverse metabolic syndrome in 
developing countries such as India 
 Cost effective methods, such as IT support through mobile texts, 
could improve the efficacy of home-based exercise 
 Applanation tonometry can be a simple and efficient prognostic tool 
for home-based programmes 
356 
 
12.3. Practical limitations of the thesis 
For the erectile dysfunction and cardiac rehabilitation study (Chapter 7), it took 
more than a year to achieve approval from National Ethics Committee and 
research and development departments from the individual National Health 
Service Trusts. More than 400 patients were approached and only 157 patients 
agreed to participate. Among them only 114 participants completed erectile 
function questionnaires. Various reasons were observed as shyness, partner’s 
unwillingness, not important due to age, single or sexually not active etc. it was 
planned to investigate the changes in erectile dysfunction and arterial stiffness 
following an exercise programme in India. As a pilot, 12 cardiac patients were 
invited to participate in a customized exercise programme and all of them 
refused to fill the erectile dysfunction questionnaire.  It shows that sexual 
dysfunction is still considered as a socially forbidden topic in developing 
countries in South Asia. Due to the lack of participants’ interest, the study was 
withdrawn. 
Following the IT-supported home exercise programme in India for metabolic 
syndrome (Chapter 12), a study was designed to implement similar IT-
supported home exercise programme for diabetes and metabolic syndrome in 
the UK. Following National Ethics Committee‘s approval, nearly 100 GPs were 
contacted through mails, emails and telephone for participation. Surprisingly, 
only one GP agreed to participate. There were 70 eligible patients from the GP 
who were invited to participate and 12 of them consented to participate. They 
underwent initial measurements and the IT-supported home exercise 
programme. Finally, only five of them returned for the follow-up measurements. 
Due to the failure in achieving required number of participants, the study was 
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withdrawn and excluded from the thesis. The failure of the study was mainly 
due to lack of participation of GPs. It may have increased the participation of 
GPs and patients If there were a substantial amount of funds available. 
12.4. Integrated summary of the thesis 
Work on this thesis started as a development of previous research in the Bucks 
New University and it was focused on establishing the effects of cardiac 
rehabilitation on erectile dysfunction and arterial stiffness (Chapter 7). Erectile 
dysfunction is a marker of cardiovascular disease (CVD). Strong associations 
were established between arterial stiffness and erectile dysfunction. Cardiac 
rehabilitation is an established exercise-based programme in the UK. These are 
specially designed for treating CVD and reducing cardiovascular risks, and are 
effective in improving arterial stiffness. However, they are not successful in 
resuming complete sexual function for the cardiac patients, so special attentions 
and more specific approaches are needed in those patients with erectile 
dysfunction. These implications are very different for the developing countries 
such as India. The failure to initiate similar approaches in India shows that more 
emphasis is needed in health education on sexual dysfunction and its 
associations with cardiovascular diseases. Further, socially convenient 
measures are needed to initiate early diagnosis and the specific management of 
erectile dysfunction within populations with high cardiovascular health risk.  
Further, this thesis focused on other cardiovascular risks and their 
management. Metabolic syndrome is a cluster of cardiovascular risk factors and 
it is highly prevalent in developed as well as developing countries with 
differences in the severity of individual risk factors. The prevalence of metabolic 
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syndrome is not known in many developing countries. In this thesis, a high 
prevalence of metabolic syndrome and risk factors such as hypertension, 
obesity and dyslipidaemia was found in Nepal. In contrast, prevalence of 
metabolic syndrome in people having private health care in the UK is 
comparatively very low. This may be due to a more extensive and supportive 
health care system in the UK’s private sector or the patients take good care of 
their health by following a healthy lifestyle.  
Early management can reduce cardiovascular risk factors. There are no specific 
programmes structured and established for the management of metabolic 
syndrome. Home-based exercise programme can be an alternative to centre-
based programmes to reduce cardiovascular risk in those with metabolic 
syndrome. Cost effective methods, such as IT support through mobile texts, 
could improve the efficacy of home-based exercise. The support of IT in home-
based exercise programmes helps promote the regularity of exercises. In this 
thesis, the home-based exercise programme was found to be a potential and 
convenient intervention in developing countries such as India. More support and 
studies are needed to establish these programmes in other developed and 
developing countries.  
Arterial stiffness is the consistent thread throughout this thesis and arterial 
stiffness measurement using carotid-radial applanation tonometry was 
investigated. Compared with other non-invasive techniques, it is a simpler, less 
intrusive and an equally reliable prognostic tool for interventional studies. The 
associations of arterial stiffness with cardiovascular risks and its prognostic 
values are confirmed in this thesis. Obesity is a cardiovascular risk factor and 
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the prevalence is increasing globally. Carotid-radial arterial stiffness is strongly 
associated with body adiposity in young South Asian females and there are 
gender differences in the stiffness indices. These findings emphasize the need 
to establish gender and ethnic based reference values.  Similarly, age also had 
a strong influence on arterial stiffness measures. Age based reference values 
also need to be established.  
All the previous studies, discussed in the chapters, have measured only few of 
the arterial stiffness variables. Mostly, pulse wave velocity, augmentation 
pressure and augmentation index were studied and emphasized on their clinical 
importance on arterial stiffness. In addition to these variables, for the first time, 
this thesis has measured many additional variables from the carotid-radial 
applanation tonometry such as ejection duration and subendocardial viability 
ratio. The findings on these variables showed a non-significant improvement on 
interventional studies on arterial stiffness. However, these findings may be 
useful for the further studies on these variables. This thesis demonstrated 
significant improvement in arterial stiffness variables following centre-based as 
well as home-based exercise programmes. It has also been shown that 
exercise can improve arterial stiffness without or before showing significant 
improvement in exercise capacity.  The possible mechanisms for the 
improvement in arterial stiffness may be (i) acute increase blood pressure and 
heart rate during each bout of exercise results in repeated pulsatile stretching of 
collagen fibres and break down of collagen cross links in the arteries (ii) 
increase in elastin content replacing collagen cross links (iii) reduced basal 
sympathetic activity and enhanced vagal sympathetic activity that results in 
reduced vascular tone (iv) inhibited smooth muscle proliferation and improved 
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endothelial function due to increased production and availability of nitric oxide 
availability (v) decreased left ventricular afterload and increased endocardial 
perfusion. 
Overall, this thesis has established the associations of arterial stiffness with the 
most prevalent and specific cardiovascular risk factors. Further, the thesis has 
explored the possibilities of using convenient exercise programmes in improving 
arterial stiffness in economically and culturally different countries. These 
findings could help in improving health care and promoting further research in 
such countries.  
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APPENDIX I. Bland- Altman plots showing reliability of arterial stiffness 
variables with gender difference for Chapter 3 
 

















Figure A.1.4 Bland - Altman limits of agreement in augmentation index at 75% heart rate 































Figure A.1.10 Bland - Altman limits of agreement in subendocardial viability ratio (consecutive 








APPENDIX II. Scatter graphs showing relationship between VO2 Peak 
and arterial stiffness variables with gender differences for Chapter 4 
 













Fig. A.2.4 VO2 Peak vs. augmentation pressure (Aug P) befor and after exercise in South Asians 
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Fig. A.2.5 VO2 Peak vs.augmentation index before and after exercise in Caucasians 
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Fig. A.2.9 VO2 Peak vs. aortic pulse pressure (PP) before and after exercise in Caucasians 
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Fig. A.2.10 VO2 Peak vs. aortic pulse pressure (PP) before and after exercise in South Asians 
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Fig. A.2.11 VO2 Peak vs. aortic systolic pressure before and after exercise in Caucasians 
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Fig. A.2.22 VO2 Peak vs. heart rate before and after exercise in South Asians 
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APPENDIX III. Previous literatures showing the prevalence of metabolic syndrome worldwide 
Author and year Country/ Area Age (yr) 




Men Women Total Men Women 
Central and South Asia 
Gu et al  (2005) China  35–74 15540 ATP III  9.8% 17.8% 
Fan et al. (2005) China (Shanghai) Mean 52.4 1218 1957 ATP III 22.9%   









Yang et al (2007) China  35–74 15838 
IDF 16.52%   
ATP III 23.3%   




20–88 1524 2379 ATP III 15.3%   
Li et al (2006) China (Beijing) 20–90 8807 7541 CDS 13.2% 15.7% 10.2% 








Ko et al (2006) China, Hong Kong 16-95 5202 diabetic WHO 49.2-58.1%   











Lao et al (2006) China 50–85 10362 ATP III IDF 
15.7% 
25.8%   












FCHL - 36.7 
FHTG - 33.3% 








>18 170 362 ATP III  13.3% 15.6% 




≥20 1070 EGIR 11.22%   





20–75 4752 ATP III  36.4% 46.5% 


















>20 532 559 ATP III  22.9% 39.9% 




Mean; 38.9 6402 ATP III  11% 10.5% 




>20 532 559 ATP III  22.9% 31.6% 
Chow et al (2008) India (rural) ≥30 4535 ATPIII  32.5% 23.9% 
Eastern Countries 
Boonyavarakul et al 
(2005) Thailand 35+ 404 ATP III 18%   
Lohsoonthorn et al (2006) Thailand 20–70 1383 ATP III 12.8% 15.7% 11.7% 
Pongchaiyakul et al 
(2007) Thailand 20-90 602 ATP III 15% 15.3% 14.6% 
Huang et al (2008) Taiwan 20-94 124,513 IDF AHA 
13.9% 
22.4%   
Lin et al (2007) Taiwan, Taichung 
40-64 






Heng et al (2006) Singapore Adult 3954 ATP III  14.1% 12.3% 














26.2%   
Son le et al (2005) Vietnam, Ho Chi Minh 18+ 611 ATP III 12%   
Ishizaka et al (2005) Japan 19–88 8144 ATP III  19% 7% 
Tanaka et al (2005) Japan 30–79 6985 ATP III  30.2% 10.3% 
Yoshinaga et al (2005) Japan, Kagoshima 06-11 
471 overweight or 
obese ATP III 
8.7% in 
overweight, 17.7% 
in obese   
Arai et al (2006) Japan 20-79 3264 ATP III Modified 7.8% 12.1% 1.7% 
Aizawa et al (2006) Japan 40+ 11941 ATP III 14.9   
Oh et al (2004) Korea (urban) 30–80 2692 ATP III  29% 16.8% 
Park et al (2006) Korea 20–80 6824 IDF  13.5 % 15.5% 








>20 4397 5971 ATP III  24% 42% 
Sharifi et al (2009) Iran (urban) >20 1396 1545 ATP III 23.7% 23.1% 24.4% 
Esmaillzadeh et al (2006) Iran 10-19 1413 1623 ATP III 10.10% 10.3% 9.9% 
Al-Lawati et al (2003) Oman >20 695 724 ATP III  19.5% 23% 
Ozsahin et al (2004) Turkey 20–79 1637 ATP III  23.7% 39.1% 
Agirbasli et al (2006) Turkey 10-17 1385 ATP III 2.20%   
Demiral et al (2006) Turkey, Izmir 24-60 450 men ATP III 17.80%   
Onat et al (2002) Turkey >31 1130 1166 ATP III  27% 38.6% 
Cameron et al (2007) Mauritius >24 3198 ATPIII  20.3% 
Australia and New Zealand 
Alberti et al (2006) Australia 25–75 11,247  
EGIR 15.8%   
ATPIII 18.2%   
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Gentles et al (2007) New Zealand 35-74 4022 ATP III 
32% (Maori), 39% 
(Pacific/Polynesia










30–89 6156 5356 WHO 15% 15.7% 14.2% 






 2109 2184 ATP III 
 10.0% 7.0% 
   











Dallongeville et al (2005) France 35–64 3359 ATP III  23% 16.9% 
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Gustiene et al.(2005) Lithuania (Kaunas) Mean 38.8 192 241 IDF  28.1% 16.6% 
Bonora et al (2003) Italy, Bruneck 40-79 888 adults ATPIII WHO 
17.8% 
34.1%   
Bo et al (2005) Italy, Asti in northwest 45-64 1877 ATP III 22.2% 24% 22% 
Invitti et al (2006) Italy, North 6-16 588 obese WHO 23.30%   
Alegria et al.(2005) Spain, Valencia 45.4 ± 9.8 7256 ATP III 10.20% 8.7% 3% 
Jerico et al (2005) Spain 41.9±9.2 HIV 710 ATP III 17%   
Lopez-Capape et 
al.(2006) Spain 4-18 429 ATP III 
18% 
Hispanic (32%) 
Caucasian (16%)   



















Gorter et al (2004) Netherlands 18–80 CHD 1117 ATP III 46%   
Santos and Barros (2003) Portugal 18–90 1436 ATP III 23.9% 19.1% 27% 
Athyros et al (2005) Greece Adults 9669 ATP III IDF 
24.5 % 
43.4%   
Kolcic et al (2006) Croatia 18–88 996 ATP III 34%   
Lawlor et al (2006) UK 60–79  3589 
ATP III 
IDF 






































Skoumas et al (2007) Greece Adults FCHL 706 ATP III 41.8% 63% 37% 
Herva et al.(2006) Finland Adults with Depression and Anxiety 5698 ATP III 37% 47% 25% 
North and South America 
Park et al (2003) USA, 3rd NHANES survey 20 12,363 ATP III 23% 22.8% 22.6% 




≥20 3601 IDF 34.5% 33.7% 38.1% 




≥20 8814 ATP III 23.7%   
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Goodpaster et al (2005) USA, Pittsburgh & Membis 70-79 3075 ATP III 39%   








Hidalgo et al (2006) Ecuador ≥40 Post menopausal Women  325 ATP III   41.5% 




risk factors 14%   
Tull et al (2005) US Virgin Islands 
Caribbean-Born Adults 
– No history of diabetes 893 ATP III 20.5%   
Hashimoto et al (2007) Brazil 30–60 Japanese Brazilian 721 ATP III 53%   
Damiao et al (2006) Brazil 40–79 Japanese Brazilian 151 ATP III  36.9% 38.8% 
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Lanz et al (2006) Brazil Adults Going Under 1st Time Angiography 385 WHO  39.7% 58.7% 
Freire et al (2005) Brazil ≥30 Japanese Brazilians 877 ATP III  49.8% 43% 
Pousada et al (2006) Brazil Spanish Migrants 479 ATP III 26.3% 29.6% 22.6% 
Alvarez et al.(2006) Brazil 12–19 overweight and non- overweight  388 ATP III   





Barbieri et al (2006) Brazil (Ribeirao Preto) 23–25 2063  ATP III  10.7% 











I BGDT MS First Brazilian Guideline for Diagnosis and Treatment of Metabolic syndrome,   CDS - (Chinese Diabetes Society), EGIR- European Group for the 
Study of Insulin Resistance, FCHL- Familial Combined Hyperlipaemia; FHTG- Familial Hypertriglyceridaemia, FH- Familial Hypercholesterolaemia 
